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Summary
An uncommon side effect of treatment with antithyroid 
drugs is agranulocytosis» These compounds are also known 
to be capable of modifying immune function in humans»
The polymorphonuclear leukocytes are responsible for clearing 
invading foreign bodies from the bloodstream, and as such 
are the first line of defence against infection» The 
effect of methimazole, a thioureylene antithyroid drug 
commonly used in the treatment of hyperthyroidism, on 
selected parameters of polymorphonuclear leukocyte function, 
was investigated» Methimazole is metabolised by polymorpho­
nuclear leukocytes, therefore the influence of some of 
its putative metabolites, namely 3-methylthiohydantoin, 
methylhydantoin and N-methylimidazole, was also assessed»
The chemotactic, phagocytic and cidal capabilities of 
human polymorphonuclear leukocytes were examined»
The ability of polymorphonuclear leukocytes to migrate 
under agarose towards the chemo-attractant, zymosan-stimulated 
serum, was found to be unaffected by methimazole, 3-methylthio­
hydantoin, methylhydantoin and methylimidazole at concentrations 
between lO"^ and lO"^ M» Phagocytosis of S» aureus,
S» pyogenes, E» coli, L» casei and C» albicans proceded 
normally in the presence of 10“  ^M methimazole, S» pyogenes 
and S» aureus, as representatives of hydrogen peroxide- and 
non—hydrogen peroxide producing bacteria respectively were the 
subject of further investigation which established that
20
methimazole, 3-methylthiohydantoizi, methylhydantoin and N- 
methylimidazole did not significantly affect their ingestion 
at concentrations between 10~^ and lO”  ^M.
Intracellular killing of all five pre-opsonised micro­
organisms by human polymorphonuclear leukocytes treated 
with 10 M methimazole was stimulated by between ten and
4-0 per cent after 30 minutes co-incubation. Between 60 
and 120 minutes there was no evidence of any significant 
stimulation* Further investigation with S. pyogenes and 
S, aureus revealed that methimazole, 3-methylthiohydantoin, 
methylhydantoin and N-methylimidazole exerted no significant 
effect on the killing of S. pyogenes, however dose-related
—3
inhibition was evident on treatment with between 10 and
10~^ M methimazole and 3-methylthiohydantoin during 
phagocytosis of S* aureus. Methylhydantoin and N-methyl- 
imidazole produced no significant effects.
The oxygen consumption of latex-stimulated polymorphonuclear 
leukocytes was found to be stimulated by 4-8 and 58 per cent 
respectively by methimazole and N-methylimidazole at 10  ^M, 
3-methylthiohydantoin and methylhydantoin producing no 
significant change. The hexose monophosphate shunt activity 
of similarly stimulated polymorphonuclear leulvocytes significantly 
increased by up to 20 per cent in the presence of methimazole, 
3-methylthiohydantoin and N-methylimidazole.
21
None of .the compounds exerted any influence on the release 
of lysosomal enzymes by stimulated polymorphonuclear 
leukocytes, however methimazole, 3-methylthiohydantoin and 
N-methylimidazole inhibited myeloperoxidase activity by 
between 36 and 100 per cent at 10  ^M, this irhiibrbion 
was dose-related at concentrations between 10~^ and 10~^ M. 
Lysozyme and lactoferrin activity from the released lysosomal 
enzymes was unaffected by any of the four compounds, neither 
was the lysozyme activity of intact polymorphonuclear 
leulcocytes. Alkaline phosphatase activity however was 
inhibited by around 50 per cent by methimazole and 3-methyl­
thiohydantoin at concentrations of 10  ^H; again the inhibitory 
effect was significantly dose-related.
Thus it would appear that methimazole acts, not by inhibiting 
the microbicidal oxidase system, as might have been expected, 
but by altering myeloperoxidase activity# It may combine 
in some way with myeloperoxidase so that it can no longer 
react with hydrogen peroxide.
The killing of S. pyogenes was unaffected by methimazole, 
perhaps due to the many backup systems of the polymorpho­
nuclear leulcocyte, which are believed to be stimulated 
in polymorphonuclear leulcocytes with reduced or no myeloperoxidase 
activity. S. aureus was killed less efficiently: this 
organism contains the enzyme catalase, which catalyses
22
the decomposition of hydrogen peroxide to water and oxygen, 
rendering S. aureus more resistant to attack by non- 
myeloperoxidase-mediated killing by hydrogen peroxide, 
simply by decomposing the hydrogen peroxide.
3-Methylthiohydantoin and to a lesser extent N-methylimidazole 
acted in a similar fashion to methimazole, except that 
3-methylthiohydantoin appeared to be slightly more potent 
in its inhibitory action on the polymorphonuclear leukocyte, 
and N-methylimidazole less so. Methylhydantoin did not 
significantly affect polymorphonuclear leukocyte function.
Fosfestrol is a water-soluble oestrogen compound with a 
similar oxidation potential to methimazole. It is used 
in the treatment of pro static carcinoma. It was thought 
that it might act on the polymorphonuclear leukocyte in 
a similar way to methimazole, therefore its effect on the 
various polyraoiphonuclear leukocyte functions was assessed.
Like methimazole, fosfestrol at concentrations between
lO"^ and lO"^ M did not significantly affect chemotaxis,
random movement or phagocytosis, neither did it possess
any chemo-attractant or -repellant activity. However
killing of S. aureus after 30 minutes incubation was significantly
inliibited (14 per cent) by lO"^ M fosfestrol. Killing of
S. pyogenes, E. coli, L. casei and C. albicans was not
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significantly altered. After 60 and 120 minutes there 
was a trend towards slight stimulation of killing. G. albicans 
showed 12 per cent greater killing after 60 minutes with lO”  ^M 
fosfestrol treatment, this stimulation being dose-related.
Oxygen consumption was inhibited by 16-18 per cent and 
hexose monophosphate shunt activity stimulated by 18 per cent. 
Myeloperoxidase, alkaline phosphatase, lysozyme and lactoferrin 
activity was not significantly affected by up to 10  ^M 
fosfestrol. Electron microscopic examination of C. albicans 
within control and fosfestrol-treated polymorphonuclear 
leukocytes revealed slightly more degradation of Candida within 
fosfestrol-treated polymorphonuclear leukocytes. This was 
manifest as loss of striations within the thick cell wall, 
loss of organelles within the yeast cells, which became less 
electron dense and eventual detachment of the plasma membrane 
from the cell wall#
In a clinical situation, therefore, neither methimazole, fosfestrol, 
nor any of the proposed metabolites investigated in this study 
would be expected to exert any significant effect on the ability 
of an otherwise non-compromised individual to combat infection 
whilst undergoing treatment.
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CHAPTER 1
REVIEW OF THE PROCESSES OF PHAGOCYTOSIS A m  KILLING OF 
MICRO-ORGANISMS BY POLYMORPHONUCLEAR LEUKOCYTES, AMD THE 
ACTION OF METHIMAZOLE ON THESE
1.0 Historical Aspects.
In 1882, the Russian zoologist Elie Metchnikoff, while 
studying the behaviour of mobile cells in the transparent 
starfish larva, noted that the introduction of a sharp 
thorn into the body of the larva caused the mobile cells to 
surround the foreign body and apparently to attack it. 
Moreover, these cells could also ingest and destroy foreign 
particles, including bacteria. Cohnhein had earlier seen 
white blood cells migrating from tissue capillaries to form 
pus at sites of injury. Metchnikoff concluded that in­
flammation served as an important defence reaction of the 
body. "In man", he wrote "microbes are usually the cause 
which provokes inflammation, therefore, it is against these 
intruders that the mobile mesodermic cells have to strive.
The mobile cells must destroy the microbes by digesting 
them and thus bring about a cure. Inflammation, therefore, 
is a curative reaction in the organism and morbid s^ nnptoms 
are no other than the signs of the struggle between the 
mesodermic cells and the microbes." Metchnikoff’s theory 
was attacked by his colleagues and a controversy arose 
between the followers of Metchnikoff's theory of cellular 
immunity and the majority of clinicians and pathologists
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who adhered to the theory of humoral immunity. Both are now 
known to play a part in the body's defence against infection.
The humoral immune system, comprising antibody and complement, 
is often able to deal with invading pathogens. However, the 
cellular and humoral components must co-operate to destroy 
better-equipped pathogens by the process of phagocytosis.
One such phagocyte is the polymorphonuclear leukocyte (PMN). 
PMN comprise about 65% of the white blood cell population 
in humans and are mainly involved in defence against micro­
organisms which elicit an acute inflammatory response.
Phagocytosis refers to the physical act of engulfment, the 
process by which particles recognised by the phagocyte as 
foreign are taken up by the cell and sequestered in an 
intra-cellular vacuole. The process can be divided into a 
number of phases:- i) chemotaxis, ii) recognition of foreign 
particles, iii) attachment of particles to the phagocyte 
surface and iv) ingestion of particles.
1.1 Chemotaxis.
Chemotaxis is defined as directed movement of cells or 
of organisms in response to a concentration gradient of a 
mediator. PMN are mobile cells. The accumulation of 
leukocytes in inflammatory sites is an important aspect of 
normal host defence and motility plays a central role in
26
this function.
Chemotaxis must be clearly distinguished from random 
migration. Random motility is movement which occurs with 
equal probability in all directions, (Miller, 1975a,b: 
Bandmann ejb al, 1974) and is an inherent property of 
leukocytes; however their exposure to a uniform concentration 
of a chemotactic agent, ie. no gradient, can result in 
increased random migration. (Keller and Sorkin, I966, 19&7; 
Gallin and Rosenthal, 1974)« Chemotaxis is also distinct 
from chemokinesis; chemotaxis is a reaction by which the 
direction of locomotion is changed; chemokinesis is an 
alteration in the speed of mobilisation.
The acute inflammatory response involves mobilisation of 
leukocytes. This requires active locomotion from the blood 
vessels through the capillary endothelium and into the site 
of injury. This directed migration occurs under the in­
fluence of soluble mediators, the precise nature of which 
varies according to the type of injury. Microbial invasion, 
immunologic injury and non-specific tissue damage may all 
involve the formation of PMN chemotactic factors. Thus 
chemotaxis is the first step in the phagocytic process; 
the directional movement towards the material to be engulfed.
Chemotactic Factors
A large number of neutrophil chemotactic factors have been 
described. Historically, bacterial chemotactic factors were
27
recognised first, but much research has gone into chemotactic 
factors of host origin, such as those derived from the complement 
system.
Bacterial Chemotactic Factors
Bacteria frequently produce chemotactic factors that attract 
leukocytes directly and do not require the presence of serum.
Such factors have been termed "cytotaxins". However, the 
direct attractive effect of bacteria is often weak, and a 
strong effect is seen only in the presence of serum. Factors 
that generate chemotactic activity by activating serum components 
have been termed "cytotaxigens".
The early research into chemotaxis did not distinguish between 
cytotaxins and cytotaxigens, as the role of complement components 
in chemotaxis was not appreciated.
Leber (I888) using an extract of Staphylococcus aureus as an 
attractant, first demonstrated chemotaxis in PMN. McCutcheon 
(1946) and Harris (1954) reviewed the early literature on 
chemotaxis, confirming that a wide variety of microorganisms 
release cytotaxins.
Most organisms studied up to the present time are capable of 
generating complement-mediated chemotactic activity (Wilkinson, 
I98O). Many bacterial surface structures alone are capable 
of this. The endotoxins of Gram-negative bacteria are examples 
of substances with little direct chemotactic activity, but are
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powerful activators of complement. (Shin _et aJ, I968;
Snyderman e_t al, 1969)»
The precise nature of bacterial chemotactic factors has been 
studied by many investigators. Keller and Sorkin (1967) 
found serum-independent activity in culture filtrates of 
Staphylococcus albus. A chemotactic factor precipitable by 
ammonium sulphate was partially purified from filtrates of 
Staphylococcus aureus (Walker et al, I969). Staphylococcal 
enterotoxin B generates chemotactic activity in the presence 
of serum (Craig_et 1971). Protein A in combination with 
the P(c) fragments of IgG can activate complement and produce 
chemotactic activity (Harvey et al, 1970).
Russell ejt a^ , (1976) using chloroform-methanol-water extraction 
showed that some of the chemotactic activity of staphylococci 
was present in chloroform-soluble lipid fractions and the 
methanol-water fraction also contained some activity.
Ward ejt a^ (1968), found direct attractant activity in culture 
filtrates of alpha-haemolytic streptococci and of Streptococcus 
pneumoniae. The pneumococcal factor had a molecular weight 
of less than ?,600 and was not related to the pneumococcal 
polysaccharide. Streptococci contain proteases that can 
activate chemotactic complement peptides (Ward et al, 1975). 
Taylor ejb (1967) and Ward (1967) independently reported 
that streptokinase which converts plasminogen to plasmin, 
generates chemotactic activity in serum by a proteolytic
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action of plasmin on C5. It has since been shown that C3a 
and other C5 derived peptides have no chemotactic activity, 
(Fernandez _e^  al, 1978) therefore their conclusions 
probably require reassessment.
Culture filtrates of Escherichia coli have probably been the 
most extensively studied of all bacterial chemotactic factors, 
and are used by many as standard stimuli in chemotaxis assays. 
Trainer at al ( 1975) found chemotactic activity in chloroform- 
methanol extracts of E.coli that had fatty acid-like properties. 
Sahu and Lynn (1977) found around 759^  of the total chemotactic 
activity in the filtrates they examined was due to lipids. 
Schiffman et al (l975) extracted chemotactically active 
peptides with molecular weights of 150-1,500 from filtrates of 
E.coli. These peptides were anionic, had blocked N-termini 
and were heterogeneous. These findings led to the discovery 
of the formyl-methionine peptides, which are probably the 
most widely used chemotactic factors at the present time.
E.coli initiates the sequence of events involved in protein 
synthesis with N-formyl-methionine. This initiating amino 
acid is cleaved from the newly synthesised protein before 
its release. Since eukaryotic cells do not commence protein 
synthesis with formyl-methionine, except in mitochondria, the 
initiating sequence in prokaryotic cells could be a con­
venient signal that allows phagocytic cells to recognise 
invading pathogens as foreign. Marasco et.^  (1985) 
identified and purified formyl-methionyl-leucyl-phenyblanine 
(f-met-leu-phe) as the major peptide neutrophil chemotactic
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factor produced by E.coli.
Schultz and Miller (1974) showed an elastase produced by 
Pseudomonas aeruginosa could cleave a number of complement 
components and caused release of C5a from C5 when used at low 
doses, but destroyed the peptide at high doses.
Candida albicans, a yeast, is also known to generate 
chemotactic activity in the presence of complement (Cutler, 
1977)• Ofek and Bekierkunst (1976) have reported direct 
chemotactic activity generated by mycobacterial cord factor 
(trehalose 6,6-dimycolate) for macrophages and PMN.
Thus most bacteria produce or induce chemotactic factor(s), 
the nature of which is diverse.
Complement-derived Chemotactic Factors
Boyden (I962) observed that certain serum components could 
generate PMN leukocyte chemotactic factors,. He found that 
incubation of mixtures of antigen and specific antibody with 
fresh serum resulted in the appearance of chemotactic activity. 
Preheating the serum at 56°C for 30 minutes destroyed the 
activity, but once the factor was produced, it was heat stable. 
Similar findings were reported by Keller and Sorkin (1965)* 
Boyden interpretted the results as "antibody and antigen 
combine to form a complex which interacts with a heat-labile 
substance (probably an enzyme, perhaps a component of comple­
ment) and that as a consequence of this interaction a heat-
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Figure 1. Proposed pathways of complement activation. 
Agents with chemotactic activity are indicated- in bold 
face. A bar above a component indicates an enzymatically 
active nrotein.
stable substance is produced which has a direct chemotactic 
influence on the leukocytes". Subsequent studies fully 
supported these conclusions.
Complement refers to a series of serum proteins which are
activated sequentially and function as a mechanism for the
destruction of foreign cells and the production of a number
of biologically active mediators. Two pathways of complement
activation have been descrioed: the classical pathway and 
the alternative (properdin) pathway (Fig 1).
Activation of the complement system via the classical pathway 
or the alternative pathway releases a number of chemotactically 
active compounds. The most important of these is C5a» which 
accounts for most of the chemotactic activity produced on 
complement activation.
Human C5a is a glycoprotein which contains a polypeptide 
portion of 74 amino acids which has been sequenced, accounting 
for a molecular weight of 8,200, and a carbohydrate portion 
accounting for $,000 Dalton (Fernandez and Hugli, 1976). C$a 
is chemotactically active in doses as low as I.OnK. The most 
prevalent form of human C$a found vive is a
molecule from which the COOK- terminal arginine has been 
removed by endogenous carboxypeptidase enzymes (Fernandez 
et aJ, 1978).
C5a exhibits classical anaphylotoxic activity; it contracts
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smooth muscle and degranulates mast cells (Shin _et aJ, I968; 
Jensen _e_t a^ , 1969)» It has been identified at sites of 
experimental inflammation in vivo (Snyderman e_fc a2, 1971) and 
also in the synovial effusions of patients with inflammatory 
arthritis (Ward and Zvaifler, 1971).
P M  Leukocyte-derived Chemotactic Factors
Evidence of chemotactic properties of a number of other agents 
have been published, these include a cell-derived chemotactic 
factor produced by P M  that have ingested crystalline material 
such as monosodium urate or calcium pyrophosphate dihydrate 
(Spilberg and Mehta, 1979» Spilberg_et al, 1976). Products of 
arachidonic acid lipo-oxygenation have also been shown to be 
chemoattractants (Goetzl and Pickett, I98O; Turner et al, 1975)» 
Leukotriene is the most potent chemo-attractant of arachi­
donic acid metabolism (Ford-Hutchinson et al, I98O, I98I).
The Cellular Chemotactic Response 
Detection Of The Chemotactic Stimulus
Contact between the chemotactic factor and the phagocyte cell 
surface results in activation of receptor sites which initiates 
movement. The directional character of the response could 
result from one of two mechanisms. A single receptor unit 
might sense a concentration of a chemotactic factor at one 
point and then, after migration in some arbitrary direction, 
sense the concentration again, comparing the new level with 
the previous one to determine the directionality of the con­
centration gradient. Alternatively, multiple receptor sites
might simultaneously assess concentrations at various locations 
on the cell and detect a gradient of chemotactic factor across 
the cell’s own dimensions. Support for the latter has been 
gained from the observations of Ramsey (1972a, b) and Zigmond 
(1974)* Their direct observations of single migrating P M  
demonstrate that the initial direction of migration, immediately 
after exposure to a chemo-attractant, is towards the stimulus 
in the majority of instances. Movement of the stimulus after 
migration has begun results in a rapid change in direction of 
migration towards the new stimulus location. Migration 
consists of a series of short, straight movements separated 
by relatively sharp turns, such that the direction and magnitude 
of each turn tends on the average to bring the cell closer to 
the stimulus, Nossal and Zigmond (1976) have developed a 
mathematical model characterising the movement of individual 
cells as related to the turn-angle probability distributions; 
experimental observations suggested that both the direction 
of turning and the turn-angle distribution was modified by a 
chemotactic gradient. This data is consistent with the 
sensing of a spatial gradient of the attractant, and monitoring 
of the direction of migration by continuous sensing of the 
attractant gradient. Under most circumstances, the concent­
ration difference of a diffusing chemo-attractant across the 
diameter of a neutrophil (up to I6^ura) would be extremely small, 
necessitating very precise sensing mechanisms. PMN are known 
to respond to as little as a 1% gradient of formyl peptide 
across their length (Zigmond and Sullivan, 1979). Seligman 
et al (1982) have suggested that decreases in f-met-leu-phe
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receptor affinity, "through either heterogeneity or negative 
CO—operativity", is important in neutrophil adaptation and 
could allow the cell to sense very small changes in attractant 
concentration when the ambient peptide concentration was low 
(conditions required for sensing a gradient during directed 
locomotion) and still respond at high peptide concentrations 
with degranulation and respiratory burst activities (conditions 
expected when cells have arrived at inflammatory foci).
These proposals have been investigated and experimental data 
demonstrate that the optimal chemotactic concentration of f- 
met-leu-phe is one to twofold lower than that for secretion 
or superoxide production (Lohr and Snydermen, 1982). Jt 
appears that adaptation represents a decrease in the affinity 
of neutrophil responsiveness to f-met-leu-phe, with no effect 
on the maximal responsiveness of cells so long as the initial 
stimulus concentration is less than 10  ^M. At concentrations 
greater than 10  ^M, not only does the apparent affinity 
decrease but the maximal responsiveness of the cells decreases.
Studies of the dependence of the second (S2) stimulus on the 
first stimulus (Sl) concentration indicated that with SI 
concentrations below 10”® M, small increases in S2 were needed 
to elicit responses. However with SI concentrations greater 
than 10“® M, large increases in 82 were required to give a 
later response (Oallin _et al, 1983). Gallin and Seligman 
(1984) using information from these studies and the observation 
that it takes about one and a half minutes for cells to adapt
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to a chemo-attractant stimulus, predicted the rate at which 
cells would have to move in a gradient of chemo-attractant 
to keep up with, or just ahead of,.the change in receptor 
affinity as they move up a gradient of stimulus. When cells 
are exposed to concentrations of f-met-leu-phe of less than 
10  ^M the predicted rate of locomotion would be 3-10 jum/min, 
compatible with measured rates. With f-met-leu-phe con­
centrations of greater than 10~^  M, the predicted rate of 
cell migration would be much faster, 30-40 ^ m/min, to remain 
equivalently stimulated, rates which PMN cannot achieve.
Hence, the cells would stop moving at the higher concentrations 
of chemo-attractant.
This progressive modulation of receptor affinity after stimu­
lation may be initially important for sustaining chemotaxis 
and later for converting cells whose predominant function is 
chemotaxis, into cells whose predominant function is degranu­
lation and production of highly reactive products of oxidative 
metabolism.
It has been proposed that there exists within PMN a pool of 
receptors, which are expressed at the cell surface after 
stimulation. Gallin _et al (1984) have proposed the idea of 
receptor recycling. After f-met-leu-phe interaction with its 
receptor on PMN, there is internalisation of bound ligand, 
with down regulation of receptor expression (Niedel e_t al, 
1979; Zigmond and Sullivan, 1979» Donabedian and Gallin,
I98I; Sullivan and Zigmond, 1982). Later the receptors
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reappear. There is no direct evidence for receptor recycling, 
but the final steady state of f—met—leu—phe receptor expression 
exceeds prestimulation levels (Fletcher and Gallin, 1980;
Fletcher _et ad, 1982). Therefore, either synthesis of a new 
pool of receptors, or mobilisation of an intracellular com­
partment of receptors must exist. Gallin et al (1979) proposed 
that the new receptors come from specific granules or other 
organelles such as Golgi vesicles, as increases in the number 
of receptors occurs in the absence of protein synthesis.
Jesaitis ^  ad (1982) also proposed a spare pool of f-met- 
leu-phe receptors in Golgi vesicles.
The expression of these receptors and the addition of new 
membrane may be critical in the localisation of cells at 
specific sites in the circulation, and for the transduction 
of signals to launch such processes as chemotaxis, degranulation, 
oxidative metabolism; phagocytosis and destruction of micro­
organisms .
The Nature Of Chemo-attractant Recertors
The identification of a series of formylated peptides with 
potent chemotactic activity eg f-met-leu-phe, has made possible 
the investigation of receptor sites on PMN. The strict structure- 
function relationships of synthetic N-formylated oligopeptides 
for initiating chemotactic and secretory activities led to 
the suggestion that leukocytes recognised chemo-attractants 
via receptors (Showell ed ad, 1976; Freer _et ad, I98O).
Williams ejk ad (1977), using radio-labelled f-met-leu-phe 
showed that PMN possessed receptors and that binding was
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saturable, the number of binding sites per cell ranged from 
40,000-60,000. Niedel e^ ad (1979), demonstrated receptors 
for f-nle-phe-nle-tyr-lys and estimated 120,000 receptors 
per human PMN.
Niedel .ejt ad (198O) attempted to characterise chemo-attractant 
receptors biochemically. He found the receptor for f-nle-phe- 
nle-tyr-lys to be a polypeptide with an apparent molecular 
weight of 55,000-70,000. Schmitt ad (1985) using photo­
affinity labelling to investigate the N-formylated peptide 
receptor, found a polypeptide with molecular weight of 50,000- 
60,000 Daltons.
Signalling Mechanisms Within The Cell
The affinity of the chemo-attractant receptor is heterogeneous 
and dynamically regulated both by guanine nucleotides and 
prior agonist exposure (Snyderman and Pike, I984).
Transduction of chemo-attractant-related signals requires 
transmethylation reactions mediated by S-adenosylmethionine 
and leads to the activation of phospholipases that liberate 
arachidonic acid from membrane phospholipids. Recent evidence 
suggests that protein kinase C is also involved in the trans­
duction of some chemo-attractant-induced signals (Hirata _et ad, 
1979; Snyderman _et ad, I98O; McPhail _e;t ad, 1984).
Snyderman and Pike (1984) found that the effect of the non- 
hydrolysable analogue of GTP (p(NH)ppG), was to convert
^8
f-met-leu-phe receptors originally present in the high affinity 
state to a low affinity state. This effect was also brought 
about by GTP and GDP, however ATP, ADP, AMP, cAMP, GMP and 
CMP had no effect.
It is known that chemo-attractants have the ability to regulate 
the affinity of the receptors to which they bind. Koo and 
Snyderman (1983) showed an increase in the percentage of high- 
affinity receptors expressed on stimulation of human PMN 
membranes with f-met-leu-phe. Snyderman and Pike (1984) have 
suggested that the high-affinity site might be an immediate 
form of the receptor which triggers internalisation oh perhaps 
transduction of a signal for secretion.
Changes in membrane lipids also appear to be required for 
chemo-attractant-mediated functions. Rapid release of arach­
idonic acid from membrane phospholipids in PMN occurs following 
chemo-attractant receptor occupancy (Hirata e_t 1979» Pike 
and Snyderman, I98I). The free arachidonic acid is then avail­
able for synthesis of prostaglandins, thromboxanes, prostacyclins 
and leukotrienes, all of which are potent mediators of in­
flammatory and vasomotor responses. Free arachidonic acid 
itself may be an important second messenger of chemo- 
attractant-mediated responses (McPhail and Snyderman, I984).
It has been suggested that chemoattractants mobilize 
arachidonic acid via a phospholipase C activation (Pike and 
Snyderman, 1981).
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Over the past few years, studies have shown that transmethyl­
ation reactions mediated by S-adenosyl-m.ethionine play an 
important role in the chemotactic response of leukocytes 
(O'Dea ejt Êl.» 1978; Pike _et 1978). Méthylation reactions 
are also required for other chemo-attractant-mediated functions 
in mononuclear cells, such as superoxide production and 
arachidonic acid release from phospholipids (Pike and Snyderman, 
I98I; 1982). Inhibition of méthylation lowers the receptor's 
affinity by producing an aliosteric alteration in the receptor.
A phospholipid- and calcium-dependent protein kinase (protein 
kinase C) has been identified (Castagna _et al, 1982) and found 
to be widely distributed in tissues. The activity of this 
enzyme is enhanced by diolein, a substance formed through the 
action of phospholipase C on membrane phospholipids. It has 
been shown that chemo-attractants do not activate adenylate 
cyclase in leukocyte membranes (Verghese and Snyderman, 1983) 
and from this it has been reasoned that protein kinase C may 
mediate certain chemo-attractant-receptor functions. Snyderman 
and Pike (198A) have found that human PMN contain substantial 
protein kinase activity. Under conditions that initiate 
secretion and the respiratory burst, f-met-leu-phe also 
produces translocation of the enzyme from the cytosolic 
fraction of cells to the particulate fraction.
Arachidonic acid, as well as other unsaturated long-chain 
fatty acids, are capable of activating leukocyte protein 
kinase C directly in leukocyte cytosolic fractions in the
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Figure 2. Model of chemoattractant receptor transduction.
It is hypothesized that binding of the chemoattractant to 
its receptor leads to the formation of a reversible high- 
affinity state (hatched line receptor) regulated by guanine 
nucleotides. At high concentrations of the chemoattractant, 
a nonnucleotide-sensitive high-affinity receptor is formed 
(blackened receptor). This receptor may be rapidly inter­
nalized, perhaps via coated pits, which are present on PMNs. 
Associated with receptor occupancy, phospholipases are 
activated and intracellular cAMP increases (not shown). 
Portrayed here is one of the pathways that appears to be 
activated by chemoattractants in leukocytes.
Reproduced from Pike and Snyderman (I98A).
absence of any other added phospholipids (McPhail et al, I984). 
It is believed that the activation of phospholipases by chemo- 
attractants releases unsaturated fatty acids such as arachi­
donic acid, which can serve as second messengers to stimulate 
protein kinase C, which transduces certain chemotactic signals 
(Fig 2).
Movement Of The Cells
Chemo-attractant receptors on PMN can trigger a number of 
responses, as have been discussed, however the final outcome 
of these processes results in movement of the cell. The 
mechanism whereby the cell exhibits motility will be discussed 
fully, while dealing with ingestion.
PMN exposed to a gradient of a chemotactic factor become 
polarised, with the advancing front of the cell exhibiting a 
broad, thin veil (lamellipodium) while a knob-like tail and 
trailing retraction fibres are seen at the rear (Ramsey, 1972b, 
Zigmond and Hirsch, 1973)» The nature of the contractile 
system producing pseudopods, cytoplasmic streaming and cell 
movement, has begun to be understood.
As neutrophils initiate movement, actin microfilaments increase 
in number and distribute themselves towards the leading portion 
of the moving cell (Oliver et al, 1978). For sustained move­
ment to occur, the microfilament network must be continuously 
remodeled, actin polymerisation and microfilament production 
are important determinants of cell motility. Actin comprises
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lOf/r of neutrophil cytoplasmic protein (Boxer and Stossel, 1976) 
and has two interchangeable states with widely different 
polymerisation potentials (Harwell et al, I98O; Korn, 1982).
Much of what is known about the process of motility was dis­
covered by studying macrophages, Stossel (1975» 1976, 1977) 
elucidated the organisation and co-ordination of the contr­
actile elements of rabbit pulmonary macrophages. His 
findings are discussed in a later section.
Thus, the first step towards elimination of invading micro­
organisms, chemotaxis, is extremely complicated itself composed 
of many stages, and although its various mechanisms begin to 
be understood, many questions about these processes remain to 
be answered.
1.2 Recognition.
Mammalian phagocytes have the capacity to discriminate about 
the material they phagocytose. They will engulf foreign cells, 
but reject homologous ones, they ingest some micro-organisms, 
but tend to overlook others, particularly encapsulated ones 
(Stossel, 1975).
The mechanism of recognition is poorly understood. Some 
knowledge has been gained about this process from the surface 
modifications brought about by the serum of higher organisms, 
opsonins.
42
Hinge region
COO"
Papain site
Pepsin siteNH‘
■ Fab' Fc-
Figure 5» Diagrammatic presentation of the Ig molecule,
Cpsor.ins
In 1905» Wright and Douglas observed that fresh serum promoted 
the ingestion of micro-organisms by phagocytes, they originated 
the term "opsonin", derived from the Greek "opsonein", meaning 
"to prepare food for". An opsonin has come to represent any 
agent in serum which acts on particles to increase their 
palatability to the phagocyte. From further studies, it was 
gathered that two forms of opsonins existed in serum, one heat- 
labile, the other heat-stable. The opsonic activity of normal 
human serum was found by Wright and Douglas (1903) to be re­
duced by exposure to temperatures above with complete
inactivation occuring in some cases when serum was heated to 
60° - 65°C for IC-I5 minutes. In contrast Neufeld and Fimpau 
(1904) demonstrated opsonins in immune serum which were 
effective in high dilution against the immunizing strain and 
were stable at 5é°C.
It is now known that the heat-stable opsonins are immuno­
globulins and the heat-labile opsonins are components of the 
complement system.
Immunoglobulin (Fig 3) acts both to identify the invading 
organism and to initiate adjacent complement activation.
These serum components are not mutually exclusive as opsonins, 
rather they function by acting through different mechanisms 
of opsonisation. Depending on the choice of test particle, 
the phagocytic cell type, and the opsonising medium, one
mechanism may be favoured over another.
Specific Antibody
Antibodies of either IgG or IgM class are able to act as opsonins 
(Robbins _et al, 1965; Rowley and Turner, I966; Smith _et al,
1967) and IgA particularly in crevicular PMN (Fanger _et al,
1985)• It is not known whether they act by neutralising anti­
phagocytic surface properties of bacteria or by forming a 
ligand between bacteria and phagocyte, or both. There is 
some evidence that they do not act solely by neutralising the 
anti-phagocytic surface properties of organisms (Rowley and 
Turner, I966).
The antibody combines with the surface antigens of bacteria 
through the antibody combining site located in the F(ab')2 
portion of the molecule. (Fig 5) The F(c) portion of the 
molecule, which is critical to its function as an opsonin,
(Q.uie jet al, I968) is then free to attach to specific receptors 
on the surface of the phagocyte (Messner and Selinek, 1970), 
and complete the bridge between bacteria and phagocyte.
The action of specific antibody alone is probably only sign­
ificant in vivo in the hyperimmune animal with its large excess 
of specific antibody.
Complement
Complement is able to accelerate the rate of phagocytosis of
44
pneumococci opsonised by capsular antibody (Ward and Ender, 
1933)» It is thought that the sequence of events is parallel 
to that of the initial steps of the haemolysis of red blood 
cells by antibody and complement.
The bacterial antigen and opsonising antibody unite, the F(c) 
portion of the antibody then binds and activates the first 
component of complement (Cl). Cl then activates the fourth 
(C4) and second (C2) components of complement. This bimo- 
lecular complex may activate and lead to the attachment of 
hundreds of molecules of the third component (C3). Receptor 
sites for activated C3 or C3b have been demonstrated on the 
surface of phagocytes (Huber e_t sd, I968; Lay and Nussenzweig,
1968). The C3b on the surface of bacteria acts as a ligand 
between bacteria and phagocytes.
The Alternative Complement Pathway (Properdin Pathway)
This appears to be a non-specific mechanism of opsonisation 
that is found in non-immune and gorm-free animals, its activity 
is destroyed by heating the serum at 56°C for 30 minutes 
(Smith and Wood, I969).
Some investigators have considered this system to represent 
the combined action of small amounts of "natural" antibody 
and complement (Slopex et al, 1962), others have suggested 
it is distinct from both antibody and complement (Hirsch 
and Strauss, I964).
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The pathway involves activation of C3 and fixation of C3o 
on bacterial cells surface (Shin I969). The activation
of C3 occurs in the absence of Cl, C4 and C2, therefore it 
does not follow the classical pathway of C3 activation, but 
rather follows an alternative pathway, the properdin pathway 
(Pillemer _et al, 1954; Marcus et I97I).
The properdin pathway appears to be composed of properdin 
itself, a hydrazine sensitive factor (factor A) and a heat- 
labile factor (factor B-). The fifth component of complement 
(C5) has also been shown to participate in the pathway for 
pneumococci, but plays a minor role compared to C3 (Ruddy 
et 1972).
Thus although not completely understood, the properdin pathway 
represents a unique antibacterial defence system, which is 
composed of 7S immunoglobin and C3, and in which the activation 
of C3 proceeds via the alternate complement pathway.
1.3 Adhesion.
Adhesion depends on the surface properties of both particles 
and host cell. One of the factors which could play a role in 
cell adhesion is surface electrostatic charges. However, in 
most cases PTH and micro-organisms are both negatively charged 
and one would expect repulsive forces to prevent adhesion 
between them, as this does not happen, it may be concluded 
that electrostatic forces do not play the main role in adhesion 
or alternatively surface charge is modified by the presence
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of charged ions (Weiss, 1969; Beveridge, I98G; Ryter and De 
Chastelier, 1983).
The specific and un-specific receptor sites that have been 
discovered in recent years play a more critical role. Un­
specific binding refers to the adhesion of latex, oil- 
droplets and any undefined attachment, and appears to be 
mediated by the hydrophobicity of particles or molecules that 
can promote physical forces leading to adhesion between 
particle and cell surface (Stossel, 1975; Rabinovitch, 196?; 
Benoliel e_t I960; Vogel ejt al, I98O).
In addition to hydrophobic forces, more specific binding sites 
have been found. Some of them behave as lectin receptors and 
recognise a specific sugar eg. glucose, mannose and are 
located on the phagocyte cell surface ( Stahl ejt al, 1978;
Vogel _et aJ, 1980; Glass _et al, 1981; Sung et al, 1983).
Other binding sites seem to exist on pili. These proteinaceous 
thin filaments have been shown to favour adherence to various 
kinds of cells (Smith, 1977; Beveridge, 198O; Pearce and 
Buchanan, I98O).
Truly specific receptors were discovered on macrophages and 
leukocytes. Two receptors react specifically with the P(c) 
portion of IgG molecules (Silverstein _et 1975; Unkeless 
_et I98I). One F(c) receptor mediates the efficient
binding and ingestion of IgG-antigen complexes (Arend and 
Mannik, 1972) and IgG-coated particles (Mantuani et al, 1972;
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Figure 4* Model of proposed phagocytic mechanism (reproduced 
from Griffin ejb ^  (1975) I = IgG molecule or other ligand.
'‘rf = Fc receptor or other membrane receptor in an inactive 
state. 5^ = Fc receptor or other membrane receptor in an
activated state. ^  = Cytoplasmic contractile proteins.
Griffin ^  1975)» the other ?(c) receptor binds to sub­
classes of IgG. (Fig 4), Immunoglobins of these sub-classes 
bind with high affinity to macrophages in the absence of 
antigens (Arend and Mannik, 1972). The other type of specific 
receptor found in "professional" phagocytes (PMN, mononuclear 
cells and tissue macrophages) binds to C5, one of the compon­
ents of complement present in serum. C5 is an inactive pre­
cursor molecule consisting of a heavy and a light chain joined 
by disulphide bidges (Silverstein e ^ 1977), specific 
proteases cleave a small fragment of the heavy chain, converting 
this inactive form into C3b, that specifically binds to 05 
receptors (Reid and Porter, I98I). Both kinds of receptors 
are different and independent from non-specific receptors 
(Griffin and Silverstein, 1974; Michl £t aT, 1976). Some 
studies have shown that C5b receptors of both neutrophils 
and mononuclear phagocytes mediate attachment only, whereas 
F(c) receptors induce particle engulfment (Red, 1981; Griffin, 
1982; Red and Stendahl, 1982). Others indicate that C3b also 
promotes ingestion (Muschel e_t al, 1977; Shaw and Griffin,
I98I; Segerling et 1982). Griffin (1982) discussed the 
difficulties linked to these studies and possible reasons for 
contradictory results. He finally proposed as Ehlenberger 
and Nussenzweig (1977) that the "chief role of C3b and its 
receptors is to promote particle binding, the chief role of 
IgG and its receptors is to promote particle ingestion; the 
enhanced particle binding by C3b and its receptors serves to 
facilitate: engagement of the cell's phagocytic signal-
generating F(c) receptors by IgG."
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Particle adhesion to cells tearing ligand surface receptors 
is generally temperature and energy-independent, whereas 
unspecific binding may not depend upon these factors (Griffin 
et al, 1975b; Benoliel, I98O; Glynn, I98I).
IgG-coated erythrocytes form tight and continuous contact 
areas with host cells surface (Kaplan, 1977; Benoliel et al, 
I98O), whereas C3 receptors establish discontinuous contacts 
(Munthe-Kaas et al, 1976; Kaplan, 1977). For unspecific or 
more specific binding sites, contacts differ according to the 
particle and cell. This shows that no general rules can be 
established on the mode of attachment to specific or unspecific 
receptors.
Although it is clear that certain well-defined serum proteins, 
IgG and activated C3 coat particles and render them ingestible, 
the physical and chemical properties of the coat have not been 
fully elucidated. It is known that antibody will bind to 
particles via the F(ab) region, and that papain- or pepsin- 
digested antibody will bind to particles, but lacks opsonic 
activity. It appears that the F(c) region of the immuno- 
globin activates ingestion and the C$b receptor appears to 
function primarily to bind the particle to the PMM.
Therefore f(c) and G3 receptors found on "professional" 
phagocytes* surfaces are of great importance in defence 
mechanisms. The many studies on the effects of opsonisation 
illustrate the importance of these receptors for microbe
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Figure 5» Diagram of the zipper mechanism of phagocytosis. 
Top: Particle diffusely coated with serum ligands attaches 
to membrane receptors on the surface of a phagocyte.
Middle and Bottom: Additional receptor ligand interactions 
guide the movement of the phagocyte plasma membrane over the 
surface of the particle.
Reproduced from Silverstein _et al (1977).
adherence and ingestion.
1.4 Ingestion.
Ingestion is the process by which particle(s) are captured by 
membrane extensions that surround and finally fully enclose the 
particles in phagocytic vacuoles.
Particle-associated immunoglobin and complement bind to 
receptor sites on the surface of the phagocyte, cellular 
pseudopods surround the particle by the process of circum­
ferential adherence, and in this way the phagocyte membranes 
move about the particle and fully enclose it within a phago­
cytic vacuole. This has been termed the "zipper mechanism" 
of phagocytes (Griffin al, 1976).
The zipper model (Pig 5) predicts that a particle with ligand 
distributed over its entire surface will bind continuously 
and circumferentially to receptors on the surface of the 
phagocyte and be totally engulfed, whereas particles with 
ligands on one portion of the particle surface will be bound, 
but not ingested by the phagocyte. Studies by Griffin (1976) 
confirmed this prediction. (Fig 6)
Ingestion is a temperature dependent and energy requiring 
process (Griffin, 1975; Stossel, 1975). Metabolic inhibitors 
or low temperatures permit binding of particles to the cell's 
surface in the absence of phagocytosis.
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Figure 6. Evidence in support of the zipper model of 
phagocytosis. Particles with diffusely distributed 
ligands are ingested, whereas particles with capped 
ligands adhere to the surface of the phagocyte but are 
not ingested.
Reproduced from Silverstein ejk ^  ('1977).
The Plasma Membrane
Since the initiating events of ingestion occur at the plasma 
membrane, various investigators have turned their attention 
to the PMN plasma membrane. Due to difficulties in achieving 
good yields of purified plasma membranes, more investigators 
turned to phagosomes, which are more easily isolated due to 
ingested material conferring unique densities to these 
structures (De Pierre et al, 1973)•
Phagosomes, which include membranes of lysosomes that fuse with 
the phagocytic vesicle, have been purified from Acanthamoeba, 
fibroblasts, human, rabbit and guinea pig PMN and rabbit 
alveolar macrophages (Stossel, 1975)* Comparative analyses 
of phospholipid composition of Acanthamoeba plasma membranes 
with phagosomal membranes of guinea pig and human PMN phagosomal 
membranes with total cellular membrane phospholipids failed 
to reveal striking differences in composition between the 
respective membranes (Stossel, 1975), suggesting that phagosomal 
membranes simply reflect the phospholipid content of the 
plasma membranes from which they are derived, despite the 
potential for membrane alteration by peroxidases and phospho- 
lipases available within the cell.
Surface charge could influence ingestion, once contact has 
occured, by its effect on interfacial tension (Ponder, 1928). 
However, Noseworthy and co—workers (1972) observed that treat­
ment of intact guinea pig PMN with neuraminidase released
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approximately '^ 0% of the total sialic acid of the cell, (sialic 
acid being a contributor to the net negative surface charge of 
the PMM) without affecting either phagocytosis of glycolysis. 
This suggests that maintenance of the negative surface charge 
on neutrophils is not crucial to ingestion.
Phagosome Formation
Ligand attachment to membrane receptors on the phagocyte 
initiates changes in the submembrane region. Organelles are 
generally excluded from this area and a filamentous network 
forms. The process continues with sequential attachment of 
ligand to receptor until pseudopods fully enclose the particle 
in a vacuole consisting of internalised extracellular space 
surrounded by plasma membrane. The apposed membranes initially 
form a stalk which connects the vacuolar space with the outside 
of the cell; however fusion and lysis occur and the phagosome 
is set free. Klebanoff and Clark (1978) suggest that fusion 
and lysis may not be instantaneous; channels connecting the 
phagosome to the outside have been seen, with degranulation 
cccuring both into the vacuolar space and into the stalk.
The phagosome may thus remain connected to the surface of the 
cell by sheets of apposed plasma membrane for appreciable 
periods. Jacques and Bainton (1978) also noted this phenomenon 
whilst studying changes in pH in vacuoles. Cech and Lehrer 
(1984.) specifically investigated this phenomenon and concluded 
that during "phagocytosis of Candida albicans, 40^ of the 
resulting vacuoles were unsealed.
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In contrast, it is known that ingestion accelerates the rate 
at which phagocytes acylate lysophosphatides added to the 
medium bathing cells (Elsbach, 1972). Lysophosphatides can 
induce the fusion of cell membranes, and presumably are in­
volved in phagolysosome formation.
Actin-myosin Contractile Filaments
On thin section electron micrographs, immediately below the 
membrane of the phagocytic cup, can be seen a thick zone from 
which all cytoplasmic organelles are excluded by a meshwork 
of filaments. This meshwork has been shown to contain actin, 
actin-binding proteins and myosin (Taylor and Condeelis, 1979). 
There is considerable evidence to suggest that these structures 
play an important role in the phagocytic process.
The organisation and co-ordination of the contractile elements 
of rabbit pulmonary macrophages have been extensively studied 
(Stbssel and Hartwig, 1975, 1976, 1977). The contractile 
elements include actin- and myosin-containing microfilaments, 
actin-binding protein, and at least in macrophages, a cofactor 
protein that stimulates Mg^""" -dependent ATPase activity 
(Stossel, 1975) and gelsolin, a calcium-dependent regulatory 
protein (Yin _et _aT, 1979).
Gelation occurs in vitro when actin filaments are cross-linked 
by actin-binding protein, a process controlled by gelsolin, so 
named because of its influence on reversible gel-sol trans­
formations of actin filaments. A solid gel is formed at room
ACTfN-BfNDING
p b o t e ;n
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T MYOSIN + 
*  COFACTOR
Fignre ?• Proposed mechanism for pseudopod formation. 
Contact between particle and phagocyte causes the activation 
or release of actin-binding protein from the cell membrane, 
which initiates an interaction between actin and myosin 
plus cofactor. Gelation of the cytoplasm occurs and 
contraction of this cytoplasmic gel causes the formation 
of a narrow hyaline pseudopod. Reproduced from Stossel 
and Hartwig, 1976.
temperature, this process is inhibited by cytochalasin B, a 
compound which disrupts microfilaments and functions dependent 
on them. Cytochalasin B is known to inhibit phagocytosis by 
P M  (Klebanoff and Clark, 1978).
Contraction occurs in vitro when myosin contracts the actin
gel into an aggregate, a process accelerated by the co-factor
2+protein and occuring in the presence of Mg and ATP.
Plasma membrane movement may occur as a result of gelation and 
contraction phenomena involving actin and myosin (Stossel, 1976) 
(Fig 7) Contact of the particle with the macrophage plasma 
membrane results in activation of the actin-binding protein.
This protein causes the assembly and gelation of actin at the 
periphery of the cell and contraction of this gel to form 
pseudopodia is induced by myosin and the co-factor. Circum­
ferential adherence of plasma membrane to the particle with 
the associated sol to gel transformation in the adjacent 
cytoplasm causes the pseudopodia to move gradually around the 
particle.
Although comparable studies have not been done in P M  the 
presence of actin and myosin in P M  and the description of a 
patient with recurrent bacterial infections, P M  actin 
dysfunction and depressed phagocytosis (Boxer ej^  1974) 
support a role for contractile proteins in the phagocytic
process.
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Microtubules do not appear to be as crucial to the phagocytic 
process in FNN as microfilaments. Colchicine, an inhibitor 
of mictotubule assembly, has been reported to inhibit P M  
phagocytosis by some investigators, but not by others 
(Klebanoff and Clark, 1978).
It has been proposed that microtubules may serve in the control 
of membrane microviscosity (Berlin and Fera, 1977). Certain 
lectin-binding sites are selectively removed from the surface 
of PlIN during phagocytosis, whereas other transport proteins 
are selectively excluded from the sections of invaginated 
membrane (Tsan and Berlin, 1971; Oliver et. al, 1974)* Colchicine 
at doses which do not affect the rate or extent of phagocytosis, 
prevent this movement of membrane proteins (Ukena and Berlin, 
1972; Oliver at 1974). Phagocytosis by rabbit P M  was 
found by Berlin and Fera (1977) to decrease membrane micro­
viscosity as measured by fluorescence depolarisation of 
lipophilic probes embedded in the membrane. This is a 
microtubule-dependent re-organisation of membrane lipids 
and proteins, leading to decreased microviscosity.
Role Of Calcium In Transmembrane Signalling
Griffin (1976) proposed that in the case of IgG-coated particles, 
ligand—receptor interaction generates a signal, perhaps the 
release of actin-binding protein from the plasma membrane, 
that would initiate polymerization and aggregation of contractile 
proteins resulting in the extension of pseudopodia. Pseudopod
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extension would result in further receptor—ligand interaction, 
which in turn would elicit further contractile protein 
association. The factor(s) triggering the dissociation of 
the filament network once a particle has been ingested remain 
unknown. De Chastelier and Ryter (1981, 1982) showed in 
Dictyostelium discoideum that calcium deposits were especially 
abundant along the inner face of the filopod and phagocytic 
cup plasma membrane, that is where the membrane was under­
layered with a filament network. They proposed that formation 
of calcium deposits was related to mobilisation of contractile 
proteins and not to their dissociation. These calcium deposits 
seem to result from a phosphatase activity, but their exact meaning 
is not yet established. The most attractive hypothesis is 
that they correspond to calcium channels, especially as many 
authors have shown that calcium promotes phagocytosis (Stossel, 
1975; Hartwig et al, I960) and is more abundant in actin 
filament-rich regions (Taylor et al, I98O).
In PMN, one of the first molecular events elicited by extra­
cellular ligands is displacement of calcium from membraneous 
stores into the cytosol (Naccache et al, 1979; Mottola et al,
1982) where it can be extruded by a high-affinity ATP-dependent 
pump localised in the plasma membrane (Mottola et. al» 1980,
1982).
Histochemical and kinetic evidence suggests that the site of 
calcium mobilisation is the area on the plasma membrane involved 
interaction with the stimulant (Hoffstein, 1979» Mottola,
1980, 1982). Mottola (198O), using phorbol myristic acetate
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(pma) showed mobilisation of membrane Ca^^ can cause an 
increase in cytosolic free ion concentration from 10“  ^- 1C”®M 
to 5 K 10 within a few seconds. This enhancement in 
cytosolic calcium is sufficient to activate several calcium- 
dependent processes, including the calmodulin-dependent 
superoxide-forming enzyme, protein kinase(s) and gel-sol 
transformation of actin.
Stossel ejk ^  (1975) purified a calcium-binding protein called 
gelsolin from macrophages. This protein severs actin filaments 
and dissolves the gels of cross-linked actin at Ca^^ concentr­
ations exceeding 2 X 10
Romeo (1982) proposed that a sequence of Ca^^ mobilisation 
from the plasma membrane, diffusion into nearby cytoplasm and 
extrusion from the cell by the plasma membrane Ca^^ pump could 
create gradients of Ca^^ concentrations in the cortical cyto­
plasm. Thus if gelsolin was also present in neutrophils, a 
discontinuity in peripheral distribution of Ca^^ could cause 
a discontinuity in the gel-sol state of actin, with water 
moving from the less to more cross-linked domains.
Hence fluctuations in Ca^^ concentration in the cell cortex 
could control pseudopod development and ingestion of particles
Energy Requirements
The ingestion process is dependent on metabolic energy. It
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is generally believed tr.at the source of this energy in PMN 
is ATP generated by glycolysis (Jemelin and Prei, 1970).
Studies with various inhibitors of glycolysis such as 
iodoacetate, fluoride and deoxyglucose, reviewed by Klebanoff 
and Clark (1978) suggests that glycolysis is required for 
optimum phagocytosis. Active glycolytic activity may not be 
required for phagocytosis if adequate pre-formed ATP is present 
(Bodel and Malawista, 19o9). Phagocytosis by PMN is associated 
with heat (Levin, 1975) and chemiluminescence (Allen et al,
1972) production, and the rapid depletion of cellular ATP 
(Bodel and Malawista, I969). Few mitochondria are present in 
the mature PMN, and hypoxia or inhibitors of oxidative 
phosphorylation such as dinitrophenol do not inhibit the 
ingestion process (Becker _et 1958; Sbarra and Karnovsky, 
1959; Cohn and Morse, I96O).
1.3 Degranulation.
A critical aspect of the phagocytic process is the concentration 
within the phagocytic vacuole of agents which are toxic to 
the ingested micro-organism. These agents include granule 
components as well as metabolic products. During particle 
ingestion these constituents are released into the extra­
cellular fluid. The process of degranulation involves the 
ggPivery of granule components into the phagosome or the 
intracellular space. After particle ingestion, granules 
adjacent to the phagocytic vacuole fuse with the vacuole, the 
common membrane ruptures and the granule contents are
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discharged into the vacuolar space, converting the phagosome 
into a phagolysosome. Both specific granules and azurophilic 
granules participate in the degranulation process. If the 
phagocytic load is large, there can be almost complete dis­
appearance of granules from the cytoplasm (Klebanoff and 
Clark, 1978).
Initiation Of The Respiratory Burst
The respiratory burst refers to a co-ordinated series of 
metabolic events that take place on stimulation of the PMN 
plasma membrane by a variety of stimuli including bacteria, 
surface active agents (Graham et al, 1967; Kakinuma, 1974), 
such as fatty acids and digitonin (Graham ejk 1967; 
Kakinuma, 1974), lectins such as concanavalin_A(Romeo et al, 
1975) and phorbol myristate acetate (PMA) (Repine _et ad, 1974) 
These events are responsible for all oxygen dependent killing 
by phagocytes, and include increased oxygen consumption by 
the cell (Baldridge and Gerald, 1955; Sbarra and Karnovsky, 
1959), increased oxidation of glucose via the hexose mono­
phosphate shunt pathway (HMPS) (Sbarra and Karnovsky, 1959), 
increased production of hydrogen peroxide (E^ O^ ) (lyer _et ad, 
1961 ; Root ejt 1975), production of superoxide anion 
(o’"), (Babior et al_, 1975; Curnette and Babior, 1974) and 
generation of chemiluminescence (Allen ed ad, 1972).
The initiation of the respiratory burst does not require 
either phagocytosis or degranulation, but simply contact 
between the phagocyte and stimulant (Curnette e_t ad, 1979)*
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A number of different types of membrane perturbations will 
activate the respiratory burst independent of phagocytosis. 
These include FMA, detergents, concanavalin A, complement 
components (Goetzl and Austen, 1974) and non—ingestible 
particles such as mycoplasma (Simberkoff and Elsbach, 1971). 
Therefore phagocytosis is not a necessary pre-requisite for 
the oxidative responses.
After contact the conversion time from the resting state to 
the fully stimulated state is approximately 20-70 seconds 
(Cohen and Chovaniec, 1978; Segal and Coade, 1978; Newburger 
_et I98O). This event corresponds to the induction of a 
plasma membrane enzyme, the NADH or KADPH oxidase (Ryter and 
De Chastelier, 1985).
Romeo _et ad (1975) hypothesised that the trigger mechanism 
for stimulating the respiratory burst consists of a rapid 
shift of divalent cations from the environment and/or plasma 
membrane binding sites towards "special zones of the cytoplasm" 
This model is supported by the known requirement for extra­
cellular Ca^^ or Mg^ "*” for 0 g production to occur (Schell- 
Frederick, 1974; Romeo et al, 1975; Curnette et 1979; 
Lehmeyer, 1979). Various ionophores are able to stimulate 
the oxidative metabolism of these cells in the presence of 
exogenous Ca^^ or Mg (Schell—Frederick, 1974, Romeo at ad,
1975). Phosphatidylinositol breakdown has been implicated 
in the control of the Ca channels in a wide variety of 
tissues (Michell, 1975; Michell ^  1976). This early
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event in Ca transport is commonly linked to an increased 
labelling of phosphatidylinositol, due to its subsequent 
resynthesis. An increased labelling of this phospholipid, 
plus phosphatidic acid, during phagocytosis by guinea pig 
neutrophils has been reported (Karnovsky and Wallach, I96I; 
Sastry and Hokin, I966).
The precise mechanism of the initiation of the respiratory 
burst therefore remains to be clarified, but transmembrane 
signalling mechanisms are proving to be extremely complex.
1.6 The Microbicidal Oxidase System.
The Primary Oxidase
The identity of the enzyme responsible for the primary oxygen­
consuming reaction of the respiratory burst has remained 
controversial for many years. It is agreed that the enzyme 
catalyses the reduction of oxygen to superoxide by a reduced 
pyridine nucleotide. There is conflicting evidence as to 
whether the immediate electron donor is NADH or NADPH. However, 
it is believed by most authors that the evidence favours NADPH 
(Babior, 1978; Badwey and Karnovsky, 1980; Michell, 1983;
Segal, 1984). The activity of the HMPS, the main pathway 
of electrons to NADPH, is markedly increased in association 
with oxidase activity (Zatti and Rossi, 1965). 7^ addition,
impaired function of this pathway due to extreme deficiency 
of the key enzyme g l u c o s e — 6 — phosphate dehydrogenase results 
in failure of oxidase activity (Gray et al, 1975).
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The terms NADH and NADPK oxidase have been superceded by the 
increased understanding of the mechanism responsible for the 
reduction of oxygen. It is accomplished by an electron 
transport chain terminating in an unusual b type cytochrome 
(Segal and Peters, I976; Segal and Jones, 1978, 1979a,b, I98O; 
Light e_t al, 1981; Segal e_t 1981; Borregaard ejt al, 1982, 
1983; Jones, 1982; Michell, 1983; Borregaard and Tauber, 1984; 
Segal, 1984).
Extensive studies have shown that it has the lowest midpoint 
potential of any mammalian cytochrome b (E^   ^^=-245 mV)
(Cross _et 1981), it binds carbon monoxide and has the 
oxidation-reduction characteristics of a true oxidase (Cross 
e_t al, I98I, 1982), it is found in neutrophils, monocytes, 
macrophages and eosinophils but none of the "non-professionally" 
phagocytic cells of man and a variety of other mammals and 
fish (Segal .et I98I).
The cytochrome is located in the plasma membrane of neutrophils 
(Segal and Jones, 1979), Neutrophils also have a second pool 
of the cytochrome in the membrane of the specific granules 
which fuse with the plasma membrane, probably that lining the 
phagocytic vacuole, in association with degranulation 
(Segal and Jones, 1970; Borregaard al.» 1983; Garcia and 
Segal, 1984). There is disagreement as to whether the 
complement of b cytochrome in the plasma membrane of the 
neutrophil occurs novo, or only as a resulu of specific 
granule fusion. Cytochrome b_g^^ becomes reduced when the
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cells are stimulated with PMA in the absence of oxygen and is 
rapidly re—oxidised when oxygen is re-introduced into the 
system (Segal and Jones, I96O, 1979). It has been purified 
to homogeneity and has a molecular weight of 70,000 (Harper 
et al, 1984).
Abnormalities of this cytochrome have been clearly implicated 
in the pathogenesis of Chronic Granulomatous Disease, a 
syndrome in which the patients are unusually susceptible to 
infection (Segal ejt al, I983).
A FAD-containing flavoprotein appears to be another component 
of this electron transport chain. It probably donates electrons 
to the cytochrome b. It has a similar subcellular distribution 
to the cytochrome and largely co-purifies with it. However, 
it is a separate molecule as it is known to demonstrate a 
different pattern of detergent extraction from membranes 
(Segal, 1984).
It has also been suggested that ubiquinone is an electron 
carrier in this system (Sloan al, 1981; Cunningham et al, 
1982; Crawford and Schneider, 1983, 1982), however Segal et 
(1984) believed that most ubiquinone in leukocyte preparations 
comes from contaminating mononuclear cells and platelets, and 
that in PMN the only detectable quinone is located in 
mitochondria.
Michell (1983) proposed a hypothetical pathway for the electron
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Active Oxygen Species
During phagocytosis, PMN produce substantial quantities of 
superoxide and hydrogen peroxide. These substances may 
subsequently interact to produce hydroxyl radicals and singlet 
oxygen. Their formation and role in the bactericidal function 
of PMN has been extensively investigated.
Hydrogen Peroxide
Hydrogen peroxide is formed by the reaction of 0^ with itself, 
either spontaneously, or under catalysis by superoxide 
dismutase: 20 ^ + 2H"^  —♦ HgOg + 0^
HgOg has a certain amount of bactericidal potency, and has 
been proposed to act in conjunction with ascorbic acid (Miller, 
1969) and certain metal ions to kill ingested micro-organisms 
by non-enzymatic means (Repine at al, I98I). The toxicity of 
H-O- is increased in the presence of certain low molecular 
weight reducing substances, such as iodide (Klebanoff and 
White, 1969).
Karnovsky et ^  (198I) determined that HgO. could be detected 
on the cell surface and within the phagosome, following 
phagocytic stimulation of the respiratory burst. Thus inter- 
i^ aXisation of the plasma membrane, with components capable of 
generating H^O^, accounts for the presence of H^O^ within the 
phagosomes.
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HgO- And Myeloperoxidase
Myeloperoxidase (MPO), a haemprotein with molecular weight of 
approximately 150,000, is an enzyme present in high concentrations 
in PMN. It catalyses the oxidation of halide ions to hypohalite 
ions by HgOg: X“ + H^O^ ~ » XO" + E 0
01 , Br and I can all be oxidised by this enzyme (Klebanoff, 
1967» Harrison et al, 1976).
Klebanoff (1967) showed that H^O^, myeloperoxidase and a 
halide formed a potent anti-microbial system, the peroxidase 
greatly augmented the killing power of H^O^.
It is likely that Cl is the most important halide involved 
in the myeloperoxidase system in PMN, as it is the most 
abundant physiologically within the cell. Incubation of 
bacteria with H^O^, myeloperoxidase and 01 results in 
efficient killing at concentrations as low as 1(]uM.
In the absence of myeloperoxidase, similar levels of killing 
are not achieved until the concentration of HgOg reaches 
0,5mM, (Babior, 1978).
Several mechanisms have been proposed to explain bacterial 
killing by the H.Og-halide-MPO system. Early research using 
l" as the halide ion, showed incorporation of iodine into 
the bacterial cell wall (Klebanoff, 1967)* Similar experiments 
with radio-active Ol“ have shown that chlorine can be incorporated
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into bacteria both by whole neutrophils and by the H^O^— 
halide-MPO system (Zgliczynski and Stelmaszynska, 1975). It 
was postulated that loss of integrity of the halogenated cell 
wall brought about cell death, however the correlation of 
halogénation and bacterial death is indefinite (McCall et ad,
1971)' Therefore although halogénation could contribute to 
cell death under some circumstances, this is not the only 
mechanism by which the MPO system kills bacteria.
The myeloperoxidase system is capable of decarboxylating 
amino acids, converting them to aldehydes, carbon dioxide and 
ammonia R-CH^H^kCOOH — > R-CHO + CO^ + NH^. Zgliczynski 
èZ àL (1968) postulated that organisms were killed by the 
toxic aldehydes produced by this reaction. However, it has 
since been found that free aldehydes are not toxic enough to 
account for the observed bacterial killing (Paul _et ad, 1970). 
Another version of this mechanism postulates that amino acid 
constituents of the bacterial cell wall are degraded by this 
reaction, with disruption of the bacterial surface and cell 
death (Strauss et 1971). However, bacteria are killed 
efficiently by the H Og-halide-MPO system even under conditions 
in which amino acid decarboxylation is completely inhibited 
(McCall et ad, 1971), indicating that amino acid decarboxylation, 
if at all relevant, only plays a minor role in killing.
It is known that the H^O^-WPO-Cl system is able to generate 
a number of other toxic oxidant species. It is thought that 
hypochlorous acid (HOCl) is the most important of these
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(V/eiss al, 1982).
myeloperoxidase 
%2°2   T-------->  HOCl + H„0
HOCl is a powerful oxidant capable of reacting with a wide 
variety of biological substrates (Selvaraj ^  al, 1980;
Albrich et al, 1981; Weiss and LoBuglio, 1982). Albrich and 
Hurst (1982) reported that as little as InM of HOCl could 
kill 4 X 10^  E.coli.
"Activated chloride" (Cl"^ ) species generated as above can 
react with nitrogenous compounds to form chloramines 
(Zgliczynski _et 1971, Lamport and Weiss, 198$). Klebanoff 
and Clark (1978) postulated a number of ways in which chloramine 
formation could contribute to the death of micro-organisms.
They suggested that chloramines may be directly toxic to the 
micro-organism, that chloramines hydrolyse continuously with 
the release of activated chloride (Sykes, 1965), thus acting 
as storage forms of available chlorine, prolonging the toxicity 
of the peroxidase system, and that degradation of chloramines 
may result in the conversion of unstable compounds to substance(s) 
with anti—microbial properties, such as aldehydes, as has 
already been discussed.
The precise mechanism(s) involved in bacterial killing by the 
^2^2”^ ^^”^^”* system remains unclear, but it seems likely that 
a number of processes are involved. Current ideas seem to 
favour hypochlorite and other oxidised derivatives of chloride
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as the anti—microbial agents.
Superoxide Anion
The superoxide anion is generated as a result of the reduction 
of molecular oxygen by the electron transport chain in PM.
The Og is localised on the plasma membrane and as such is 
present in phagosomes, after phagocytosis has taken place.
Thus it was believed that the superoxide anion played a role 
in the destruction of invading micro-organisms (Sabior al,
1973)» This idea has since been disputed. Evidence from 
experiments using artificial O^-generating systems has shown 
that, except under unusual circumstances, 0^ plays a very 
minor role in bacterial killing (Gregory ejt al, 1973; Gregory 
and Fridovich, 1974). The local rates of 0^ produced by, for 
example the xanthine-xanthine oxidase O^-generating system 
is orders of magnitude smaller than the rates characteristic 
of stimulated PM. However, Roos (1984) has shown that 
"cytoplast" preparations of P M  which are greatly depleted 
of granule proteins, but which still phagocytose bacteria and 
produce a respiratory burst, fail to kill S. aureus and 
E. coli normally. This is a strong indication that 0^ and 
H Og have a limited toxic effect in the absence of granule 
proteins. Additional support for this is the evidence from 
Klebanoff (1974), using the xanthine-xanthine oxidase system, 
he found that E. coli, S. aureus and Candida tropicalis 
grown in complete medium are unaffected by 0^ , however when 
this system was supplemented with MPO and additional chloride.
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the organisms were rapidly killed. Thus 0^ alone does not 
contribute significantly to the microbicidal capacity of the 
PM.
Singlet Oxygen
Singlet oxygen is another highly reactive species which has 
been implicated in the killing of bacteria by PM.
Upon absorption of energy, the outer electrons of oxygen can 
change their spin and occupy the same or different orbitals. 
Thus excited states of oxygen can be formed, termed singlet 
oxygen (^0^). Although it has the same molecular formula as 
atmospheric oxygen (O^ ), it differs from the latter in the 
distribution of the electrons around the two oxygen nuclei 
(Kearns, 1971). In atmospheric oxygen, the electrons form 
a cylindrical cloud whose axis is the line joining the 
nuclei. In singlet oxygen this cloud is distorted away from 
a cylindrical configuration. This distortion so alters the 
chemical properties of the molecule that it confers entirely 
different patterns of reactivity. Singlet oxygen is far 
more reactive than molecular oxygen. It attacks especially 
molecules that contain carbon-carbon double bonds. The 
reactive nature of singlet oxygen means that it is capable 
of inflicting lethal damage on biological systems.
A number of reactions are capable of generating singlet 
oxygen under conditions that may be physiologically relevant.
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Klebanoff (198O) reviewed these reactions:-
(A) HOg.. + 0; + H+ -
(B) 0; + HgOg metal ^ O^g + OH" + OH
(c) o c l " + HgO2 'Og + 01" 4. H^O
(B) 0; + OH. + OH-
0 0 2
(E)
II II 1
2 o : + R—C—0—0—C—R — > 2 0, + 2RC0"
The reactions include the dismutation of 0^ (a ) « Production 
of by this reaction is controversial (Kahn, 1970, 1976). 
The modified Haber-Weiss reaction (b) is believed to be 
responsible for the production of both OH. and O^g. The 
interaction of hypochlorite ( O C l “ ) with H ^ O ^  ( c )  is of 
particular interest as hypochlorous acid is produced by the 
MPO-H^O^-halide antimicrobial system (Harrison and Schultz,
1976). ^Og may also be formed from the interaction of 0^ 
with either hydroxyl radicals (d) or diacyl peroxides (e) 
(Panen and Arudi, 1978).
Evidence for the role of singlet oxygen in bacterial killing 
has been difficult to gather due to unsatisfactory methods 
for its detection. However Krinsky (1974) reported that 
human granulocytes are incapable of killing wild-type 
Sarcina lutea in vitro over a 90 minute period in the 
presence of serum. A mutant strain that lacks carotenoid 
pigments was rapidly killed under similar circumstances. 
Since carotenoids function as efficient quenchers of O2» 
these data are suggestive both of the production of 0^ Dy
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these cells and oi a role for the latter as a bactericidal 
agent. A direct chemical determination of 0^ production 
By phagocytosing leukocytes has not yet been performed for 
any cell type.
Hydroxyl Radicals
The hydroxyl radical (OH.) is a highly unstable oxidising 
species that reacts almost instantaneously with most organic 
molecules that it meets.
The first evidence that human neutrophils produce OH. during 
phagocytosis came from studies in which the bactericidal 
activity of granulocytes was inhibited by superoxide dismutase 
(sop), catalase and scavengers of OH, (mannitol and benzoate) 
(Johnston _et al, 1975). This action of either catalase or 
SOP is consistent with an interaction between H^O^ and 0^ to 
generate CH., which also produces 0^^  (See reaction (b) in 
previous section). Chemical evidence was also reported by 
Tauber and Babior and independently by Weiss and co-workers 
in 1977. However, their results were based on the assumption 
that conversion of methional to ethylene indicates that there 
has been OH. formation, but unless they could show participation 
of the Haber-Weiss reaction, it did not constitute proof that 
OH. had been produced. Weiss £t 1978 re-examined this 
question and using a system that employed an alternative 
substrate, the non-aldehyde 2-keto-d-thiomethylbutyric acid, 
showed ethylene production and that it was substantially 
inhibited by both catalase and SOP.
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A possible reason for the discrepancy between the two methods 
is that methional, like all aldehydes, will oxidise spontaneously
to a hydroperoxide, a class of compound that reacts rapidly
with to produce OH. (Babior, 1978). With 2-keto-4-meth- 
ylthiobutyric acid, spontaneous oxidation to a hydroperoxide 
is not possible, so that H^O^ becomes a necessary participant 
in OH. formation. These findings suggest that OH. may be 
formed in phagocytes by a reaction between 0^ and a peroxy 
compound: 0^ + R-OOH — ^ OH. + OR- + 0^
Repine e_t al (l98l) implicated the hydroxyl radical in the 
killing of S.aureus. The OH. being formed from H^O^ 
reacting with staphylococcal iron by the Fenton reaction:
Fe^+ + H O — 5» Fe^+ + OH. + OH-
They found that growing the organism in increasing concentrations
of iron increased their content of iron and dramatically 
increased their susceptibility to killing by H^O^. In addition 
to this they used a number of OK. scavengers and found that 
they inhibited H O  -mediated killing. The extent of the 
inhibition was in direct relation to their effectiveness as 
OH. scavengers.
There is evidence from spin trapping studies to suggest that 
OH. radicals are generated within the vacuole (Green et al,
1979). This might be stimulated or inhibited by lactoferrin, 
depending upon the degree to which it is saturated with iron 
(Ambruso and Johnston, 1981; Gutteridge .sjb aJ, 1981).
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OH. and 0^ have been implicated as causitive agents in lipid 
peroxidation (Kellog and Fridovich, 1975; Lynch and Fridovich, 
1978). They are also known to cause oxidation and damage 
to nucleic acids (Myers, I975; Ito, 1978).
Therefore it is probable that OH. and 0^ play a role in 
bacterial killing, but the extent of this role is as yet 
unknown.
1.7 Oxygen-independent Anti-microbial Systems.
The azurophilic and specific granules are known to contain a 
number of enzymes and proteins which play a role in bacterial 
killing in the phagosomes. These include lysozyme, lactoferrin, 
acid and alkaline phosphatase, a number of hydrolases, and 
many granule cationic proteins (Klebanoff and Clark, 1978).
The role of lysozyme, lactoferrin and alkaline phosphatase 
will be considered in some detail.
Lysozyme
In 1922, Alexander Fleming discovered a substance in his own 
nasal mucus capable of dissolving or lysing certain bacteria.
The substance, which turned out to be an enzyme was named 
"lysozyme" and was found to be widely distributed in nature 
(Fleming, 1922). Of all the materials examined, egg white 
was the richest source of lysozyme (Fleming, 1922).
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Fleming also isolated a gram positive coccus which he called 
Micrococcus lysodeikticus ("lysis indicator") and this organism 
proved to be particularly susceptible to the lytic action of 
lysozyme.
The enzyme could only be defined by its ability to lyse 
certain bacteria until Meyer et al (1936) discovered that 
lysozyme digestion of bacterial substrates was accompanied 
by a liberation of reducing groups. Hallauer ejk ^  (1929) 
reported that lysozyme action was accompanied by a liberation 
of amino nitrogen. Various groups then went on to find 
lysozyme activity in egg white, saliva, tears, PMN, ficus 
and papaya extracts (Meyer, 1956; Barnes, 1940; Epstein and
Chain, I940).
In 1965, Jolies and Canfield independently elucidated the 
primary structure of the low molecular weight (14,500) enzyme 
which is comprised of a single chain of 129 amino acids 
(Jolies, I96O; Jolies et 1965), and in 1965 David Philips 
and his colleagues described the three-dimensional structure 
of lysozyme, based on X-ray crystallographic studies.
In 1952, Salton showed that the substrate for lysozyme in 
M. lysodeikticus is the cell wall mucopolysaccharide, a complex 
material containing both sugars and peptides, known as 
peptidoglycan. Subsequently similar glycopeptides were found 
in all other bacteria examined. The bacterial cell wall 
basically consists of linear polysaccaride chains containing
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repeating units of L-acetylglucosamine and N—acetylmuramic 
acid residues in p 1-4 linkage (Strominger and Ghuysen, 1967).
A variable number of acetylmuramic acid residues have 
tetrapeptide chains attached in N—acetylmuramyl—L—alanine
linkage. Cross links between tetrapeptide chains result in
the tightness of which 
the formation of a 5-dimensional net^will depend on the
proportion of the N-acetylmuramic acid residues which contain
tetrapeptide chains and on the extent of the cross-linkage.
Lysozyme hydrolyses the glycosidic bond between acetylmuramic
acid and acetylglucosamine. It must penetrate the mesh and
hydrolyse these bonds in sufficient numbers to solubilise
the cell wall peptidoglycan. Organisms vary widely in their
susceptibility to the lytic action of lysozyme based on
differences in the structure of the cell wall material.
Lysozyme is present in both the specific and azurophilic 
granules of PMN. It is also present in mononuclear cells 
(Bretz and Baggiolini, 1974; Spitznagel et 1974).
Presumably it is released into the phagocytic vacuole following 
phagocytosis. Although a wide variety of bacteria are sensitive 
to the action of lysozyme, resistance is frequently encountered. 
For example, group A streptococci, staphylococci and almost 
all gram negative organisms resist the action of lysozyme 
unless treated concomitantly in some other manner (Root and 
Cohen, I98I). To be active, lysozyme must reach the glyco­
sidic bonds and cleave enough of them to bring about fracture 
of the murein backbone of the peptidoglycan (Strominger and 
Ghuysen, I967). The presence or absence of a protective outer
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envelope, the extent of cross-linking and length of cross- 
bridges, as well as the 0-acetylation of the peptidoglycans, 
are all factors that can modify lysozyme activity (Repaske, 
1956; Brumfitt, 1959; Freese et I975). Other physical 
procedures or chemical agents that increase the susceptibility 
of organisms to lysozyme include, the serum antibody-compleraent 
system, a combination of E^O^ and ascorbate (free radical 
generation) , and both high and low pH, Treatment of bacteria 
with EDTA, a variety of antibiotics active against cell walls, 
proteases, butanol extraction and Triton X (a non-ionic 
detergent) render these organisms more susceptible to the 
action of lysozyme (Klebanoff and Clark, 1978; Root and Cohen, 
I98I). It is believed that such treatments affect the cell 
envelope of gram negative species or alter the cell wall it­
self, allowing lysozyme access to its substrate.
While most bacteria of clinical significance are resistant to 
lysozyme itself, the major function of this enzyme may be to 
act in conjunction with other neutrophil factors. It is 
thought that the primary function of lysozyme may not be as 
a bactericidal agent, but rather its most important function 
is the degradation of already phagocytosed bacteria.
Lactoferrin
Lactoferrin is a high molecular weight protein (77,000), 
long known to be present in milk (Sorenson and Sorenson, 1959; 
Schafer, 1951), and a variety of other biological fluids 
(Masson et al, I966). It has also been recovered from human.
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guinea pig, and rabbit PMN, and appears to be packaged in the 
specific granules (Baggiolini _et 1970; Green _et ad, I97I; 
Pryzwansky ejt al, I978).
The identification of lactoferrin in biological fluids was 
made possible through the use of a rabbit antiserum specifically 
reacting with this protein. Masson and Heremans (I966) 
detected lactoferrin in parotid saliva, bronchial secretions, 
nasal secretions, tears, seminal fluid and mucus from the 
uterine cervix.
Lactoferrin is an iron-binding protein. It retards the 
growth of bacteria and fungi iu vitro (Masson e_t al, I966;
Oram and Reiter, 1968; Kirkpatrick et al, 1971; Bullen et al,
1972). It has been suggested as a possible contributor to 
defense against local mucosal infections.
The antimicrobial action of lactoferrin has been attributed 
to its ability to chelate iron, an action that makes this 
essential nutrient inaccessible to invading micro-organisms 
(Weinberg, 1974; Arnold al, 1977). When not fully iron- 
saturated, bovine, human and goat lactoferrins were bacter­
iostatic for Bacillus stearothermouhilus and Bacillus subtilus 
in both the presence and absence of trace amounts of metal.
The bacterio -static action of lactoferrin was suppressed by 
Fe^^ and enhanced by Zn^ ,^ Co , Mn , Ni and Cu (Oram 
and Reiter, I968). Masson and Heremans (1966) found iron- 
poor preparations of lactoferrin displayed bacteriostatic 
activity against a variety of microbial species, including
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£r, aureus, and Fs. aeruginosa. This effect was 
abolished by the addition of ionised iron.
The ready reversibility of this antimicrobial effect when an 
excess of iron is supplied to the deprived organisms suggests 
a simple bacteriostatic effect for lactoferrin. However, 
Arnold et al (1977), using purified iron—free (APO) human 
lactoferrin found the growth of Streutococcus mutans totally 
inhibited by prior incubation with lactoferrin. Vibrio cholera 
was similarly inhibited, but E. coli was not inhibited by 
apo-lactoferrin concentrations as high as 80juM. Saturated 
lactoferrin in similar concentrations did not affect growth of 
any of these bacteria. Thus it was suggested that lactoferrin 
is capable of exerting a direct bactericidal effect based 
upon its chelating properties. Various organisms have been 
shown to be highly susceptible to the bactericidal action of 
lactoferrin at concentrations within the physiological range 
of many secretions.
However, studies by Ambruso and Johnston (l98l), suggested 
another way in which lactoferrin may contribute to the anti­
microbial function of PMN. They found that iron—saturated 
human milk lactoferrin and human neutrophil lactoferrin 
enhanced ethylene generation fromo(-keto-g- methiolbutyric 
acid. This was taken as a measure of OH. production. They 
found that iron bound to lactoferrin was about 5,000 times 
more effective in producing an enhancement in ethylene 
production than iron derived fr^ FeCl, or ferric EDTA.
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(The OH. is believed to be produced by an interaction between 
Og and HgOg in the presence of iron). The ability of neutro­
phil lactoferrin to provide iron efficiently to the oxygen 
radical-generating systems is compatible with a role for 
lactoferrin as regulator of OH. production.
Plasma lactoferrin levels are known to increase during 
inflammation, this is accompanied by a decrease in the PMN 
lactoferrin content (Hansen ejt 1975; Wright and Gallin,
1979)' Bacterial sepsis and burn injuries are associated with 
loss of specific granules from PMN and defects in PMN chemo- 
taxis (Wright and Gallin, 1979). Since lactoferrin can bind 
to other blood cells, it seems likely that this same highly 
charged molecule could participate in the PMN hyper-adherent 
response upon chemotactic stimulation (Van Snick and Masson,
1976; Broxmeyer _e^  aJ, 1978). Oseas e_t ^  (I98I) showed that 
the PMN lysosomal lactoferrin promoted aggregation of the PMN 
to itself and adherence of the PMN to endothelial cells. This 
implicates lactoferrin as a regulator of the adherent properties 
of the PMN during inflammation. They found that anti-lactoferrin 
antibodies largely inhibited the aggregation responses of PMN to 
chemotactic stimuli. Therefore it seems likely that lactoferrin 
rather than any other granule constituent was responsible for 
the sustained aggregation shown in this study and that lacto­
ferrin has a role to play in retention of PMN at inflammatory 
sites.
Ambruso £t ^  (I984) studied neutrophil function in a patient
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with recurrent uvcgenic infections and absence of specific 
granules. They found that the levels of cobalmin (vitamin 
-binding protein and lactoferrin were markedly reduced. They 
also found that the patient’s neutrophils were defective in 
the killing of E. coli and S. aureus. degranulation and 
adherence were normal, superoxide anion production was normal, 
but hydroxyl radical production was decreased in response to 
opsonised zymosan.
This data supports the role of lactoferrin in the bactericidal 
function of the PMN.
Alkaline Phosphatase
Alkaline phosphatase is the name given to a group of enzymes 
which hydrolyze phosphoric acid esters at an alkaline pH (pH 
optimum 9-10). The enzyme contains zinc as an essential 
component and is effective on a variety of substrates. It 
has been localised in the specific granules of rabbit PMN by 
both cytochemical (Wetzel et aT, 19&7; Bainton and Farquhar,
1968) and fractionation (Baggiolini et al, I969) techniques. 
Alkaline phosphatase is associated with the membrane of rabbit 
specific granules with the catalytic site on the inner face 
(Bretz and Baggiolini, 1975). In human PMN, cytochemical 
techniques applied to immature granulocytes suggest the presence 
of alkaline phosphatase in specific granules (Bainton _et al,
1971 ; Geddes et al, 1975)i however, a number of groups have 
found the alkaline phosphatase of mature PMN in a membrane 
fraction largely devoid of granules (Bretz and Baggiolini,
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1974; Spitznagel I974; Olsson, I969). Some enzyme
activity is observed in unfixed human neutrophils (Nakatsui,
1969) and in the perinuclear cisternae, Golgi complex and 
granules of some minimally fixed circulating PMN (Geddes e_t al, 
1975). Thus the localisation of alkaline phosphatase in 
human PMN remains controversial. It is known however that 
during neutrophil maturation, alkaline phosphatase activity 
appears first in the myelocyte stage and gradually increases 
in more mature forms until it reaches the highest values in 
the mature neutrophil (Lisiewcz, I98O). Hormonal factors are 
believed to alter alkaline phosphatase activity (Polishuk e_t 
al, 1970).
It is probable that alkaline phosphatase serves a degradative 
purpose in the PMN rather than acting as a cidal agent.
Other Oxygen—independent Anti-microbial Systems
The enzymes previously mentioned form only a portion of the 
enzymes and cationic proteins present within the PMN granules. 
They have been found to possess anti—microbial activity 
(Miller et al, 1942; Miller and Watson, 1969). This is thought 
to result from the binding of the highly charged proteins to 
the negatively charged surface of the organisms, which inter­
feres with the growth and viability of the cells.
pH also has a role in the microbicidal process. During 
phagocytosis, the hydrogen ion concentration in the phagosome
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increases (Mandell, 1970; Jensen and Bainton, 1973). The 
mechanism of intravacuolar pH depression is unknown, but 
several possibilities have been proposed: increased lactic 
acid formation as a consequence of the metabolic burst which 
accompanies phagocytosis, a redox pump, the presence of H”^ 
pumping ATPase (Jacques and Bainton, 1978).
Estimates of the pH of phagocytic vacuoles range from 3.0 
to 6.0, depending on the species studied (Mandell, 1970;
Jensen and Bainton, 1973). Mandell (1970) showed that the 
fall in the intraphagosomal pH within human PMN is not as 
great (pH 6.5) as that in macrophages, and it may require 60 
minutes to reach this level. Jacques and Bainton (1978) re­
investigated this phenomenon and came to the conclusion that 
the maximal fall in pH vivo and vitro was to pH 5.0, 
although the pH fall vivo could be lower, they could only 
demonstrate it to be between 4.O and 5.0.
It has since been shown that the pH first undergoes an elevation 
to between 7.8 and 8.0, before slowly falling to about 6.0 
over the next few hours (Segal 6_t aJ, 1981). The alkaline 
phase within the vacuole may be very important for the anti­
bacterial activity of cationic granule proteins.
Human PMN contain two types of distinct granules, peroxidase 
positive azurophils, which also contain the lysosomal enzymes 
elastase, cathepsin G, chymotrypsin-1ike cationic proteins 
and lysozyme, and peroxidase-negative specific granules, which
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contain lysozyme, lactoferrin and probably collagenase and 
vitamin ^-binding protein (Jacques and Bainton, 1981).
These substances have pH optima varying over a wide range 
(Avila, 1977). Both types of granules have been demonstrated 
to enter the phagocytic vacuole (Bainton, 1973).
The intravacuolar environment changes, which means that the 
substances within the phagocytic vacuole are subject to changes 
in pH, with both subsequent activation and/or acid dénaturation 
of its contents. Therefore the pH may have an important role 
to play in the activation and "switching off" of cidal and 
degradative enzymes.
Thus the PMN has been endowed with an "overkill" capacity.
It contains many enzymes and produces a number of substances 
which play a role in bacterial killing. The co-operation 
between oxidative and non-oxidative antimicrobial systems 
recuires further investigation, as the efficient elimination 
of invading micro-organisms appears to be the result of a 
synergy between these systems.
1.8 Methimazole And Its Metabolites.
Introduction
Methimazole is one of a group of compounds which exerts anti- 
thyroid activity, known as the thiourylene drugs. These 
compounds are used in the treatment of hyper-thyroidism. 
Methimazole (l-methyl-2-thioimidazole) inhibits thyroid 
peroxidase, one of the enzymes involved in the biosynthesis
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of thyroid hormones. The precise mechanism(s) whereby the
peroxidase is inhibited is unclear, however, there are a 
number of theories concerning the mechanism(s) of action, 
which will be discussed in a later section.
Methimazole is known to be metabolised by rats, (Skellern and 
Steer, 1981) humans, (Skellern at ad, 1977) and more recently 
by human PMN (Skellern at in press). Several of its 
metabolites have been identified. The PMN contains a number 
of peroxidases and oxygenases which could potentially be 
inhibited by methimazole, or one of its metabolites.
Structure And Function Of Methimazole
The majority of organic compounds tested and found to possess 
anti-thyroid activity, have been of two main types, one contain­
ing the thiocarbamide group -NH-ÇJ-, and the other having a
S
heterocyclic or polyhydric phenol type nucleus with one or
more polar groups attached such as amino or hydroxyl groups. (Fig 9)
In 1949, methimazole was introduced as an anti—thyroid drug.
It was found to have a high degree of anti-thyroid activity, 
but still exhibited the toxic side-effects of the thiouracils 
(Stanley and Astwood, 1949)» These side-effects include 
agranulocytosis, rashes, eosinophilia, fever, vasculitis, 
lupus-like illnesses and neutropenia (McCormick, 1950; Wing 
and Asper, 1952; Walzer and Einbinder, 1965; Best and Duncan; 
Amrheinjet ah, 1970; Cooper et al, 1985; Weitzman and Stossel,
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1978). These side-effects are uncommon, and there has been 
little effort made to search for more potent anti-thyroid 
drugs with fewer toxic side-effects since the 1950's. At 
present, mainly j.or commercial reasons, carbimazole, which is 
rapidly converted to methimazole in human plasma, is the drug 
of choice in Ehirope, whereas propylthiouracil and methimazole 
are used almost exclusively in North America.
Anti-thyroid drugs such as M I  are used in the treatment of 
hyperthyroidism in three ways: as definitive treatment to 
control excessive production of thyroid hormone while awaiting 
a spontaneous remission, before and/or after radio-iodine 
therapy to hasten recovery while awaiting the effects of 
irradiation and to control the disorder in preparation for 
surgical treatment (Marchant et al, 1978).
Mechanism Of Action Of Methimazole 
Biosynthesis Of Thyroid Hormones
The thyroid gland is the source of the hormones, thyroxine 
and triiodothyronine which are essential for normal growth 
and development, and play an important role in energy 
metabolism.
A summary of the steps believed to be involved in the 
biosynthesis and secretion of thyroid hormones is presented 
in Pig 10 (De Groot and Niepomniszcze, 1977)-
The possibility that anti-thyroid drugs worked by inhibiting
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thyroid peroxidase activity was suggested even before there 
was convincing evidence that peroxidase activity plays a role 
in thyroid hormone formation (Astwood, 1949). With the 
isolation and purification of thyroid peroxidase (De Groot 
and Davis, 1962; De Groot et al, I965; Hosoya et al, 1962; 
Klebanoff et. * 1962; I go _et ah, I964; Mahoney and Igo, I964; 
Hosoya and Morrison, 1967; Coral and Taurog, I967; Taurog 
st al, I97O; Pommier ejt ah, 1972), it became clear that most 
compounds with anti-thyroid activity are inhibitors of 
thyroid peroxidase-catalysed iodination.
Mechanism Of Action Of The Thiourylene Drugs
There have been several proposals for the precise mechanisms 
by which anti-thyroid compounds inhibit thyroid peroxidase 
catalysed reactions. Morris and Hager (I966) proposed a 
mechanism based on studies with a mould chloroperoxidase, 
which catalysed halogénation at acid pH. They found that 
chloroperoxidase catalysed the oxidation of thiouracil 
only in the presence of iodide or another halogen, and 
concluded that tyrosine and thiouracil were competitive 
substrates for a common reactant. They proposed the 
formation of a peroxidase—iodinium complex (E—I ) which 
could act as an iodinating agent towards tyrosine, or as 
an oxidising agent towards thiouracil. According to this 
hypothesis anti-thyroid drugs of the thiourylene type 
inhibit iodination by competing with tyrosine or tyrosyl 
residues of thyroglobulin for E-I .
Maloof and Soodak (1965) proposed a similar mechanism based
on their observation that thiourea is oxidised by crude 
thyroid peroxidase in the presence, but not in the absence 
of iodide. This implies that the thiourylene drugs should 
inhibit only peroxidase activity involving iodide oxidation. 
However, it is known that MMl, PTU and carbimazole are also 
potent inhibitors of thyroid—peroxidase (TFO) —catalysed 
oxidation of guaiacol, a reaction that does not involve 
iodide, as well as inhibiting TPO-catalysed iodination of 
proteins and tyrosine. Therefore the thiourylene drugs 
must be considered to act as general inhibitors of TPO- 
catalysed reactions and not as specific inhibitors of TPO- 
catalysed iodination.
Nagasaka and Hidaka (1976), in a study using partially 
purified human TPO concluded that the mechanism of PTU 
inhibition is essentially different from that of MI, the 
former being reversible, the latter irreversible. However, 
Taurog (1976) proposed a scheme in which both PTU and M I  
display reversible or irreversible inhibition depending on 
the relative concentrations of drug and iodide. The main 
points of the scheme were that at high drug to iodide 
concentrations, the inhibition of iodination was irreversible, 
at low ratios of drug to iodide concentration, iodination 
was not inhibited. Iodide antagonised inhibition by low 
drug concentrations, but not by moderately elevated drug 
concentrations, at low iodide concentrations iodination was 
more sensitive to inhibition. Increased tyrosine concentrations
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Figure 11a shows dose-inhibition curves for inhibition by thioureylene 
drugs of TPO-catalyzed oxidation of guaiacol. Incubation tubes contained 
1 jj-g/ml TPO, 1 ïïiM guaiacol, 0.5 irg/ml ESA, and lOOpM H^O^. The reaction
was initiated with H^O^ and was read after 1 min at 25°C.
(Taurog, 1976).
Figure 11b shows proposed scheme for mechanism of inhibition by thio— 
tirylene drugs of TPO-catalyzed iodination. (Taurog, 1976).
could not overcome inhibition by low drug concentrations.
Mil and PTU were capable of inhibiting their own and each 
others oxidation. A summary of the scheme is shown on Fig.Ha^b,
It was subsequently shown by Davidson et al (1978) that
thiourylene drugs could irreversibly inactivate TPO in the
presence of HgO^ (a reaction not considered by Taurog e_t al),
providing an explanation for the irreversible inhibition of
TPO-catalysed iodination. Engler et al (1982), using a more
highly purified TPO also investigated this mechanism and
concluded that the inactivation of TPO by MMl and PTU involves
a reaction between the drugs and the oxidised haem group
produced by an interaction between TPO and H^Og. This
conclusion was supported by the observation that addition of
a low concentration of H^O^ to a solution of TPO shifted the
A of the Soret band from to 420nm, reflecting the 
max
formation of an oxidised form of TPO (TPO^ )^. Addition of 
MMl or PTU to TPO^^ produced a Soret spectrum significantly 
different from the spectrum of native TPO or TPO^^, whereas 
addition of MMl or PTU to native TPO produced no significant 
change in the haem spectrum. Studies with radiolabelled MMl 
and PTU combined with simultaneous assays of enzyme activity 
(guaiacol assay) showed that firm binding of the drugs to 
TPO and inactiviation of the enzyme occurred on addition of 
the drugs to TPO . However, neither binding not inactivation 
occured on addition of the drugs to native TPO. Lastly, the 
presence of a low concentration of iodide prevented 
the shift in the Soret spectrum, binding of labelled drug,
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and loss of enzyme activity associated with the addition of
thiourylene drugs to TPO + H^ O^ . Under these conditions
they assumed the enzyme was present as TPO.I , a form in
ox
which the haem is present in the same reduced state as native
TPO, explaining the protective action of iodide on the
inactivation of TPO^^ by MMI and PTU.
Inactivation of lactoperoxidase (LFO) by thiour^ene drugs
was studied by Edelhoch and co—workers (1979)* They studied
LPO-catalysed oxidation of N-acetyltyrosylamide at pH 8.8,
measuring rate constants for oxidation of thioureyiene drugs
by LPO as well as for inactivation of LPO by the^same drugs» The influence
of iodide on both rate constants was studied to distinguish between the
roles of iodide in iodination and drug oxidation. They concluded that iodide
inhibited goitrogenic activity either by increasing the rate
of drug oxidation or by reducing the rate of enzyme activation,
or both, depending on the particular drug. The mechanism by
which the thioureylene drugs inhibit peroxidase-catalysed
iodination was not explicitly discussed, leaving the
implication that they inhibit iodination solely by inactivating
the peroxidase. Edelhoch et ^  (1979) also suggested that
iodide was bound to a regulatory site on the peroxidase and
that oxidation of iodide was not involved in drug oxidation.
Engler et ^  (1985) further investigated the role of iodide 
in overcoming inhibition of iodination by thioureylcnc drugs 
and in contrast to Edelhoch and co-workers proposed an 
oxidising iodine species as an intermediate in TPO-catalysed 
oxidation of thioureylane drugs. They updated their previous
scheme for the mechanism of reversible and irreversible
inhibition of TPO-catalysed iodination by thioureylene drugs,
(Fig. 12). Reaction 1 shows inactivation of the native form
of TPO by thiourglene drugs, but in the presence of H^O^ this
is a minor pathway (dotted lines) (Engler et al, 1982).
Reaction 2 shows the oxidation of native TPO by HgOg to
yield the functional form of the enzyme, designated TPO^^.
The major difference between this scheme and the previously
reported one (Taurog, 1976) is that the revised scheme shows
the thioureylene drugs can irreversibly inactivate TPO
(Reaction 5)* Reaction 4 shows inactivation of TPO^^ by
excess H^O^; the dashed lines indicate that the reaction is
minor to reaction 5* Reaction 5 shows the oxidation of I
by TPO to form oxidised iodine. It is likelv that the ox
active iodinating agent is a complex between TPO and oxidised 
iodine (TPO-I^^) (Taurog, 1976). Evidence by Ohtaki et al 
(I98I) suggests that TPO-catalysed oxidation of I involves 
a two electron change, if this is the case then the active 
iodinating agent in TPO-catalysed iodination should be written 
as TPO-I^. The formation of an intermediate oxidation 
product in the reaction between TPO-I^^ and drug is indicated 
in reaction 6, there is evidence to suggest that the same 
intermediate is formed under conditions of both reversible 
and irreversible inhibition of iodination. Since no metabolic 
product was observed in the absence of iodide, and since 
sulphenyl iodide has been implicated as an intermediate in the 
oxidation of thiourgjiene drugs by iodide (Davidson _et al, 1978; 
Morris and Hager, I966; Danehy, 1971). Engler et al assumed
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Figure 12. Proposed scheme for mechanism of inhibition 
of TPO-catalyzed iodination by thioureylene drugs (Engler 
et al, 1982).
that the spectrally determined early stage intermediate,
shown in reaction 6, might he the sulphenyl iodide. This
intermediate, whatever its nature appears in the case of MMI
to be able to reform the parent compound (reaction 7) • This
does not appear to be the case with PTU. The metabolism of
the thiour^ene drugs that occurs under conditions of
irreversible inhibition (reaction 6) is very limited.
Oxidation of MMI and PTU beyond the intermediate stage
(reaction 6) requires a relatively high concentration of
iodide, this is shown in reaction 8 as a part of the scheme
leading to higher oxidation products and reversible inhibition
of iodination. Under these conditions the rate of production
of TPO-I is sufficient to further oxidise the drugs before ox
the TPO is largely inactivated in reaction 3* Higher 
oxidation products of both MT(I and PTU have been identified 
both vivo (Marchant and Alexander, 1972; Pharmakiotis and 
Alexander, 1975; Hakashima _et al, 1978; Lindsay _et al, 1979) 
and in vitro (Taurog, 1976). Sulphate is a major thyroidal 
end-product of PTU and MMI oxidation (Taurog, 1976; Marchant 
and Alexander, 1972; Uakashima _et al, 1978).
The basic assumption underlying this mechanism is that both
iodination and drug oxidation are mediated by the same enz;/Tne-
iodine complex (TPO-I^^). Drug oxidation is the preferred
pathway when MMI or PTU competes with tyrosyl residues for
oxidised iodine, and as long as sufficient drug is present,
TPO-I will be diverted from iodination to drug oxidation, 
ox
After the drug concentration is reduced to a low level, TPO-I^^
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will be used to iodinate tyrosyl residues. Native TPO is 
regenerated during both oxidation and iodination.
It is well accepted that TPO catalyses both iodination 
and coupling in the thyroid gland. The thiourejLene drugs 
are known to inhibit TPO-catalysed iodination. Richards 
and Ingbar (1959) suggested that PTU may have a specific 
inhibitory effect on the coupling reaction, independent of 
its effect on iodination. Taurog (1970) apparently confirmed 
this with a series of experiments in which graded doses of 
PTC were added to a TPO model iodination system, however 
these experiments had a number of short comings which were 
remedied by Engler et al, ( 1982a). They showed that under 
certain conditions of incubation, it was possible to 
demonstrate a significant inhibitory effect on T^ and T^  
formation without any decrease in diiodotyrosine formation. 
Their observations indicate that, at least under some 
conditions PTU and M I  can exert a specific inhibitory effect 
on the coupling reaction. In the case of PTU, a specific 
inhibitory effect on coupling was also demonstrated with an 
incubation system in which TPO-catalysed coupling was 
measured in the absence of iodination.
The mechanism of TPO and LPO-catalysed iodination of tyrosine 
and tyrosyl residues in protein has been discussed. According 
to these schemes it would be expected that one mol. of H^O^ 
is required for the organic binding of one mol. of iodide. 
Magnusson ^  al (1984) examined the stoiciometric relationship
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Figure 1$. 'Proposed scheme to explain iodide-dependent 
catalatic activity of thyroid peroxidase and lactoperoxidase, 
showing relationship of this activity to peroxidative 
functions of the enzymes (represented in scheme as E) .
(Magnusson e_t al, 1984).
between organic iodide formation and utilisation in
iodination reactions catalysed by TPO and LPO. Iodination 
of tyrosine, bovine serum albumin, or low iodine thyrogiobulin 
was carried out under conditions where H^O^ was limiting.
The ratio of moles of iodide bound per mol. of HgO^ used was 
always less than 1.0. All the H^O^ disappeared from the 
reaction mixture, indicating that H^O^ was being used in 
some reaction other than iodination. Magnus son et al (I984) 
proposed that TPO and LPO possess catalase-like activity, 
this catalatic activity was established by demonstrating 
that Og is readily evolved from H^O^ by TPO and LPO. This 
activity was completely iodide dependent. It is believed that 
iodide is catalytically involved in the enzymatic reaction 
leading to the H^O^ disappearance, (Fig I5)
This reaction may be inhibited reversibly or irreversibly 
by MMI, depending on the concentration of the drug. They 
have postulated that oxidation of I by compound I of the 
peroxidases to form enzyme—bound hypoiodite. They suggest 
that this compound can react with HgOg in a catalase—like 
reaction with evolution of 0^ . This same form of oxidised 
iodine would be involved in the iodination of tyrosine, 
oxidation of the thioure)iene drugs and oxidation of I and 
that inhibition of catalatic activity by these agents occurs 
through competition with HgOg for oxidised iodine.
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Metacol ism Of MMI 
Methimazole Pharmacology In Man
Little was known of MT^ I pharmacology until relatively recently 
when isotopic (Alexander ^ et ad, 1969; Marchant and Alexander, 
1972; Papapetrou £t al, 1972; Sitar and Thornhill, 1973; 
Skellern £t £l, 1973), colorimetric (Pittman et I97I; 
Vessell et al, 1975), chromatographic and mass spectroscopic 
(Skellern _et al, 1976; Bending and Stevenson, 1978; Ploberg 
al, I98O) methods were devised to measure MMI concentrations 
in body fluids. Cooper _et al (1984) developed a radio­
immunoassay for MMI. A MMI derivative, 5-CCOH-MMI, was 
conjugated to porcine thyrogiobulin and antibodies to the 
conjugate were raised in rabbits. Radiolabelled (^ S^-) MMI 
was used as the tracer, the assay could detect r#1I in 
amounts as low as 2.5ng. The putative MT'"I metabolites
3-methyl-2-thiohydantoin and 1-methyl-iraidazole had minor 
cross-reactivities of 2.1^ and 0.5^ ' respectively. They found 
considerable in ter-individual variation in peak serum Mil 
levels, which may have been due to differences in drug 
absorption or metabolism. It has been reported that there
is almost complete absorption of MMI from the gastrointestinal 
tract (Shimmins, 1969)*
Peak serum levels of hMI occurred after about 1—2 hours, with 
a second, smaller peak of MMI immunoactivity occuring after
4-6 hours in 80% of human subjects (Cooper et al, 1984).
Similar observations have been made with carbimazole, but
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metebolism. Reproduced from Skellern and Steer, 1981).
the phenomenon remains to he explained (Skellern e_t al, I9SO). 
The serum half-life for was found to vary slightly between 
investigators. Cooper et. (1984) found it to be around 
six hours, Johansen et al (l982) found it to be around five 
hours, and several other investigators three to four hours 
(Skellern et 1974, 1980, 1980b; Melander ^  I98O;
Hallengren _et al, 1982). Vessell et al (1975) found by 
colorjmetric methods, an increase in half-life in hyper­
thyroid patients, Hallengren e_t al (I982) and Cooper et al 
(1984) found no differences in the serum half-life between 
euthyroid and hyperthyroid individuals, in contrast, the 
serum half-life was prolonged in patients with hepatic 
disease suggesting a role for the liver in M l  metabolism.
Williams ej;_ al ( 1.9^ 4) recommended that breast-feeding should 
be avoided by mothers taking any antithyroid drugs. It has 
been found that the mean serum and milk MMI concentrations 
were equal over an 8-hour period, with 'JO ug MMI passing 
into the milk after a single dose of 40-mg (Cooper _et al, 
1904). Johansen (1982) found a mean milk to serum ratio 
of 0.98. PTU is one tenth as potent as MMI, therefore the 
daily dosage taken is ten times that of MM, however it 
crosses into milk one tenth as well as MMI with the net resul 0 
that PTÜ is the drug of choice where a mother chooses to 
breast feed, during which time the baby's thyroid function 
would be monitored.
Metabolism Of MMI In Man And Animals
TPO oxidises MMI (Taurog, 1976; Nakashima and Taurog, 1979)
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(3-MTH), has been detected in the thyroid, in plasma and in 
the urine of patients treated with MMI or carbimazole 
(skellern ejt al, 1977, 1980a, 1981). The biologic half-life 
of this metabolite is 15.5 hours. Whether the metabolites 
of antithyroid drugs still exert anti—thyroid effects in man 
is unknown. 5-MTH has antithyroid activity in rats (Searle 
1951), hut apparently not in humans (Alexander ^ t al, 
in press).
N—methyl imidazole ( Ml) and 3-MTE have been identified as 
metabolic products when MMI was incubated with rat liver 
microscmes (Lee and Neal, 1978). When MMI was incubated with 
a pig liver microsomal flavoprotein mixed-function oxidase 
(Poulsen et al, 1974), N-MI and sulphite were identified as 
oxidation products. MMI has been shown to be S-methylated 
in the presence of a purified rat liver S-methyltransferase 
(Weisiger and Jakoby, 1979)*
Skellern and Steer (198I) proposed a metabolic pathway for 
(2-^^C) MMI metabolism (Pig I4). Their study confirmed that 
after chronic intraperitoneal administration of (2— C) MMI 
to rats (l7.6mg/kg for three days), the radioactivity is 
rapidly and appreciably eliminated in the urine and that 
MMI is extensively metabolised, since only 6,1°/ of the dose 
was excreted unchanged. Six solvent-extractable metabolites 
were isolated and characterised as N-methylimidazole,
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3-inethyl-2-thiohydantoin, l-methyl-2-thlohydantoic acid, 
N-methylthiourea and a methylhydantoin.
After and administration, the ratio of
tissue to plasma concentration is less than one in all 
tissues except for the thyroid, liver, kidney and salivary 
gland (Marchant et al, 1972a; Ferguson et I984). Maximal 
concentration in the thyroid is reached after 24 hours, in 
liver and kidney after 6 hours (Skellern et al, 1973). A 
significant percentage of circulating drug radioactivity is 
contained within the blood cells (Marchant and Alexander, 1972b)
The Effect Of MMI On Granulocytes.
An uncommon side effect on treatment with antithyroid drugs 
is agranulocytosis, the prevalence is not known. 
Agranulocytosis is most common in PTU treatment, and it has 
been suggested that it is a hypersensitivity reaction (Wall 
_et al, 1984). These patients may develop agranulocytosis as 
a result of underlying immunologic abnormalities. Because 
there is bone marrow depression in these patients, the 
immunologic ally—mediated damage presumably affects the stem 
cells rather than mature, circulating neutrophils. It is 
thought that the thioamide group of anti-thyroid drugs acts 
as the antigen or becomes antigenic by forming a complex with 
granulocyte stem—cell protein. This complex may act as 
an adjuvant to the immune system, with bystander neutrophil 
damage (Schoen and Trentham, 1981). Another possibility is
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that antibody-dependent killer lymphocyte-mediated 
cytotoxicity against sensitized granulocytes may be a 
mechanism for anti-thyroid drug-associated agranulocytosis.
Antithyroid drugs also have a well established association 
with severe neutropenia (Huguley, I964; McGavack and 
Chevalley 1954). Weitzman and Stossell (1978) showed 
neutrophils opsonised by a complement—dependent mechanism 
apparently initiated by an IgM antibody in a patient treated 
with MMI. They proposed that neutrophil destruction occurs 
in patients like this by sequestration and phagocytosis of 
opsonized cells by macrophages, as has been shown in spleens 
of patients with autoimmune neutropenia (Boxer et al, 1975).
The Effect Of MMI On PMN
Although PMN are vastly different from thyroid cells in 
primary function, both are able to concentrate and metabolise 
iodide (Stole, 1971). It seemed likely that the PMN would 
also be capable of accumulating anti thyroid drugs. Lam and 
Lindsay (1979) showed this to be the case. Phagocytosing 
PMN accumulate radioactive ( ^C)—PTU and MMI at rates 
eight to ten fold those of resting cells. However this 
accumulation was independent of iodide transport and 
metabolism which is in contrast to that observed in the 
thyroid. These findings suggested that the PMN may be 
another important site for the metabolism and disposition 
of MMI and may exert their biological effects.
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MMI inhibits iodination by the thyroid gland; Klebanoff 
(1967) showed that it also inhibits iodination by phago­
cytosing PMN, MMI inhibits iodide organification, but not 
iodide transport (Lam and Lindsay, I98O), It was shown 
that iodide uptake by phagocytosing PMN was not affected by 
, or by the classical inhibitors of active anion transport 
such as perchlorate or antimycin A at concentrations producing 
over inhibition in thyroid cells. Therefore it was
concluded that iodide uptake in the PMN is not an active 
process (Lam and Lindsay, I98O; Ferguson et al, I984).
The antimicrobial activity of myeloperoxidase and is
considerably increased by the addition of a co-factor such 
as a halide, of the co-factors tested, iodide is the most 
effective (Klebanoff, 1?67, 1968). Complete killing of 
microorganisms was observed at a concentration of 5 % 10 M 
(60ug%). The inorganic iodide concentration of serum is 
very low ( 1ug%) and it is unlikely that sufficient iodide 
can enter the cell from this source to produce a significant 
microbicidal effect in vivo (Lam and Lindsay, 1980). The 
thyroid hormones thyroxine (T^ ) and triiodothyronine (T^ ) 
can replace iodide as the co—factor in the isolated MPC— 
mediated antimicrobial system (Klebanoff, 1967). The 
hormones are de-iodinated by MPO and under these conditions
(Klebanoff and Green, 1975). The thyroid hormones bind to 
intact leukocytes (Roche et 1962; Siegel and Sachs, 1964;
Klebanoff and Hamon, 1972). and are degraded by intact.
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phagocytosing PMN with the release of the iodine as inorganic
iodide (Woeber et al, 1972; Klebanoff and Hamon, 1972; 
Klebanoff and Green, 1973; Woeber and Ingbar, 1972). Rao 
and Sagone (1984) postulated that a reactive oxygen species 
such as a chloramine produced by the MPO—H^Og—halide system 
was responsible for the oxidation and fixation of iodide to 
protein. However they found that PMN stimulated by opsonised 
zymosan particles were capable of carrying out the iodination 
of to in the presence of excess I , this makes the 
availability of extra iodide being present for the MPO-H^O^- 
halide system questionable. Therefore although the MPC-K^O^- 
I system is inhibited by MMI, its relevance vivo is 
doubtful.
In early studies by Klebanoff and White (1969) T^ MI did not 
significantly affect the killing of L. acidophilus by normal 
leukocytes, but consistently decreased the rate of killing 
of this organism by chronic granulomatous disease leukocytes. 
MMI was subsequently found to have a small but significant 
inhibitory effect on the staphylocidal activity of normal 
leukocytes (Klebanoff, 1972; Klebanoff and Hamon, 1972).
The antithyroid drug PTÜ also inhibits iodination and the 
killing of staphylococci by human PMN (Klebanoff and Hamon, 
1972). MMI did not affect the phagocytosis or viability of 
any organism tested by Klebanoff (Klebanoff, 1969; Klebanoff 
and Hammon, 1972). Ferguson et (1984) similarly found 
phagocytosis of opsonised zymosan unaffected by MMI or PTU.
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Resting PMN from PTU-treated rats have been shown to have
increased rates of oxygen consumption, glucose uptake, 
lactate production, glucose—1— oxidation and glucose—6— 
oxidation and the increment in oxygen uptake and glucose—1—^^ C 
oxidation during phagocytosis also was increased (Reed and 
Tepperman, 1969). PTU, MMI, thiouracil and thiourea were 
found to stimulate glucose—1— oxidation by phagocytosing 
human PMN iui vitro fTsan and McIntyre, 1975).
Resting hexcse monophosphate shunt activity was increased by 
PTU only in the presence of added HgOg, suggesting a dependence 
on HgOg for the stimulation observed with phagocytic cells.
Lehrer (1975) tested the ability of human monocytes to kill 
Candida albicans and Candida parapsilosis in the presence of 
MMI, he found it was unaffected by concentrations of ImM MMI, 
although iodination was inhibited.
Weetman et ^  (1934) using measurement of lurainol-dependent 
chemiluminescence as an assay for oxygen radical production, 
found that in stimulated, human monocytes, MMI inhibited 
oxygen radical production. Ferguson ejt (I984) found a 
similar effect in human PMN. They postulated this to be as 
a result of MMI inhibiting the cells' peroxidase/oxygenase 
system.
Thus MMI has been implicated as having a role in the PMN, 
however further information is required to assess the 
significance of this role.
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CHAPTER 2
THE EFFECT OF METHIMAZOLE AND SOME OF ITS PROPOSED 
METABOLITES ON THE CHEMOTACTIC RESPONSE OF HUMAN PMN 
TO ZYMOSAN-ACTIVATED SERUM.
2.0 Introduction.
Chemotaxis denotes the directional movement of motile cells 
in response to a chemical gradient and is thought to account 
for the accumulation of granulocytes and lymphoid cells at 
sites of tissue injury or infectious invasion. In these 
situations, the primary attracting agent may be activated 
complement, chemical factors released by the pathogen, 
and/or altered products of other host or microbial components 
(Wilkinson, I98O).
Thus chemotaxis can be thought of as the primary response of 
PMN to invading pathogens, being the first step towards their 
phagocytosis and ultimate destruction. Thus it is necessary 
to know whether methimazole or any of its proposed metabolites 
affect the chemotaxis of human PMN.
2.1 Materials And Methods. .
Isolation Of Granulocytes
Venous blood was withdrawn, at the same time each morning, 
between 9 and 10 a.m. from healthy, human, male volunteers.
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aged between 20 and 30 years. The blood was immediately
mixed with preservative-free heparin in phosphate buffered 
saline (PBS) . The blood was mixed with Plasmagel 
(Laboratoire Roger Bellon) in a ratio of 1 part Plasmagel 
to 2 parts blood, and the red blood cells were left to 
sediment at 37 0 for 30 minutes. The top layer containing 
leukocytes and plasma was withdrawn and any remaining 
erythrocytes were hypotonically lysed and the granulocytes 
were washed and resuspended in Minimal Essential Medium (’‘'EM)
7
to give a concentration of 10 cells per ml.
The cell preparations were stained with Wright's stain (Ourr), 
and contained on average 95% PMN. Viability was checked by 
trypan blue exclusion.
Preparation Of Chemotactic Factors 
E.coli Supernatant
A dense innoculum of E.coli (clinical strain) was put into 
80 ml Medium 199 (C-ibco Ltd), and incubated at 37°C for 30 
hours. The culture was spun at 1,500 g for 10 minutes, and 
the supernatant was removed and filtered through 0.22 um 
filters. The filtered supernatant was aliquotted into sterile, 
plastic bijoux bottles and stored at —20 C.
Normal Human Serum
Twenty ml of venous blood was withdrawn from healthy, human
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volunteers in sterile syringes and transferred to glass 
clotting bottles, the blood was allowed to clot at room 
temperature and was then spun at 600 g. The serum was
pipetted off and filtered through 0.22 /um millipore filters, 
and used fresh as a chemo-attractant.
Zymosan Activated Serum.
50 ug per ml zymosan A (Sigma) was added to fresh human 
serum. The mixture was incubated at 37°C for 30 minutes with 
end-over-end rotation, and spun at 2,000 g for 5 minutes to 
sediment the zymosan. The serum was removed and used fresh 
or was stored at -20^0.
Preparation Of Agarose Plates
The plates were prepared according to the method of Nelson 
ejt (1975). Solution A was prepared as follows: 750 mg of 
agarose (Gibco) was dissolved in 50 ml of double distilled 
water in a boiling weter bath for 10 to 15 minutes. Solution 
B consists of 10 ml of 10 X MEM, 10 ml of heat-inactivated 
fetal calf serum (Gibco), 1 ml of glutamine (Gibco), 1 ml 
of Fen/strep containing 100 U per ml penicillin and 100 p.g 
per ml streptomycin (Gibco), 0.09 g NaHCO^ and 28 ml of 
double distilled water. This was warmed to 48 C.
Solutions A and B were mixed together and aliquotted into 
tissue culture dishes. (60 X 15 mm) in 5 ml amounts. The
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plates were refrigerated for JO to 60 minutes, then using a 
template, wells were cut in the plates.
Chemotactic Assay
The wells of the agarose plates were loaded with 10 ^ 1 of 
cells, chemotactic factors or MEM. The inside wells received 
aliquots of cells, and the outside wells received either 
chemotactic factor or MEM as a control.
The plates were incubated in a moist CO incubator at 37°C 
for A hours. The cells were fixed by the addition of 3 ml 
of methanol to each plate, which were left for 30 minutes 
followed by en equal volume of formal saline for 30 minutes.
The agarose was then removed with a spatula and the plates 
stained with either filtered Wright's or Giemsa stain and 
air dried. The plates were examined under a microscope and 
chemotaxis was quantified, using an ocular micrometer, in 
arbitrary units.
The Effect Of Methimazole And Its Putative Metabolites On 
The Chemotaxis Of Human PMN
Methimazole (Sigma), 3-methylthiohydantoin (a gift from 
Dr G.G. Skellern), methylhydantoin (Sigma), and N-methylimidazole 
(Sigma) were dissolved in sterile saline to give final 
concentrations of 10  ^to 10  ^M when added to the PMN 
suspensions. The chemotaxis assay was conducted as above.
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All the assays were performed in triplicate.
2.2 Results.
Comparison Of Chemoattractants And Incubation Times
The chemotactic assay was carried out to compare the chemo— 
a.ttractants : normal human serum, zymosan activated serum and 
E.coli supernatant. The assay was also carried out with 
incubation times of two and four hours. The chemoattractants 
varied in potency, with zymosan activated serum giving the 
greatest chemotactic index (the linear distance the cells 
have moved from the margin of the well towards the chemotactic 
factor (distance A) over the linear distance the cells have 
moved from the margin of the well towards the control medium 
(distance B)), and chemotactic differential (distance A-B). 
Normal human serum was next best and E.coli supernatant was 
the least potent of the three.
It was found that an incubation time of four hours resulted 
in a greater amount of locomotion than two hours. Incubation 
times of longer than four hours did not result in a greater 
amount of chemotaxis.
The Effect Of Methimazole (Ml). Methyl thiohydantoin (MTH)..,_ 
Methylhydantoin (MH) And M e t h y l  imidazole (Ml)—On The 
Chemotactic Response Of Human PMN To Zymosan-activated Serum
The results indicate that MMI, MTH, MH and MI do not affect
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Table 1
Table of linear distance travelled by PMN away from (b) and 
towards (a ) the control substance MEM (minimal essential 
medium). Correlation Coefficient statistics were performed 
on the chemotactic index (a/b) and chemotactic differential 
(A-B) results. No significant dose-related effect on random 
movement of PMN was found as a result of treatment with any 
of the tested drugs. The mean values presented represent the 
average of 3 separate determinations performed in triplicate.
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Table 2
Table of linear distance travelled by PMN away from (b ) and 
towards (a ) zymosan-activated serum. Correlation Coefficient 
statistics were applied to the results, no significant dose- 
related effect on chemotaxis or chemokinesis was found.
The results represent the means of 3 separate determinations 
performed in triplicate.
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chemotaxis. (Table 2 ) The chemotactic index and differential 
was calculated for each drug and correlation coefficient 
statistics applied to these data. (Table 2 )
The chemotactic index for the P M  moving away from and 
towards the control substance (MEM) was approximately 1.0, 
in the presence or absence of all four drugs, indicating 
that there was no directed movement towards the control 
substance. This gives a measure of the amount of random 
migration by the P M  in a given period of time. The chemo­
tactic index for the P M  travelling towards zymosan-activated 
serum was between 2.5 and 3.0, indicating that there was no 
significant difference between the chemotactic index of the 
cells in the presence and absence of MMX, MTH, MH or MI.
Thus, there was a significant amount of directed movement 
by the P M  towards zymosan-activated serum, a recognised 
chemotactic factor. However, this movement was unaffected 
by the presence of any of the tested drugs.
Controls were included to establish that the drugs themselves 
did not act as at tractants or repellents to the PM.
2.3 Discussion.
In the absence of a stimulus, P M  display a slow level of 
random movement. A number of chemical stimuli increase the
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motility of FMT. When stimuli act in the absence of a
concentration gradient, the rate and degree of random motility 
is enhanced» This chemically enhanced non—directional 
locomotion is referred to as chemokinesis. When the PMN are 
exposed to a concentration gradient of the chemical stimulus, 
the cells respond by moving towards or away from the stimulus. 
This directed locomotion is known as chemotaxis, and accounts 
for the accumulation of granulocytes and macrophages/monocytes 
at sites of tissue injury or infectious invasion. It is 
therefore, in vivo the important first step towards elimination 
of invading micro-organisms.
A comparison of chemotactic factors was made, namely E.coli 
supernatant, normal human serum and zymosan-stimulated serum. 
E.coli produces N-f-mlp as its major peptide neutrophil 
chemotactic factor (Marasco _et 1985)» human serum contains 
chemotactic factors, but on stimulation of the classical or 
alternative complement pathways by eg. zymosan, a number of 
chemotactically active compounds are produced, the most 
important of which is C5a» a.nd it was found to be the 
strongest attractant with normal human serum next and the 
E.coli supernatant weakest.
Pour hours was chosen as the incubation time for the assay, 
as no significantly greater amount of chemotaxis was observed 
with incubation times of greater than four hours. PMN have
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a limited lifespan in vitro, and their activity deteriorates 
rapidly after isolation. It is possible that following the 
■lengthier incubation times suggested by some authors, the 
cells have become extremely sluggish or non-viable and thus 
no greater amount of chemotactic activity is demonstrated.
Many different compounds have been shown to affect chemo­
taxis in a number of different ways, therefore it was important 
to assess the effect of M I  and some of its putative meta­
bolites on human PMN chemotaxis. A number of imidazole 
compounds were tested by Rowan-Kelly ^  ^  (1984), who found 
that metrinidazole and tinidazole did not affect chemotaxis, 
but clotrimazole, miconazole and ketoconazole inhibited 
human P M  chemotaxis and depressed their ability to kill 
bacteria and fungi. The authors suggested that these imidazoles 
interfere with lipid biosynthesis and exert their effects 
by causing changes in the PMN cell membrane (Van den Bosscne 
et al, 1978). However MMI and MI did not affect the chemo­
taxis, chemokinesis or random movement of human as 
assayed by the method of Nelson et al (1975)» and it was 
concluded that these imidazoles, like the less substituted 
ones, metrinidazole and tinidazole do not affect membrane 
permeability and thus do not affect chemotaxis.
Interaction of a leuko-attractant with Fffls in vivo causes 
increased EMPS activity, with resultant and 0 g production
111
as well as degranulation with the release of myeloneroxidase 
(Badwey and Karnovsky, I98O; Klebanoff, I968). It has been 
shown that release of these compounds into the extra-cellular 
environment can cause auto-oxidation of the PM, and thus 
decreased motility (Anderson, 1981a,b; Theron ^  af 1981;
Jones and Anderson, 1983)* The MPO-HgO -halide system has 
been shown to cause oxidation of, for example, sulphydryl 
groups to sulphenic acids (Thomas and Aune, 1977; 1978).
Jones and Anderson (1983) using horseradish peroxidase (HRPO),
HgOg and Nal to stimulate PMN in vitro, showed that ascorbate 
and cysteine protected the PMN from iodination by HRPO/H^O^/Nal 
and thus prevented inhibition of motility. Massive uncontrolled 
oxidation has been correlated with a rapid decrease in directional 
motility of PMN, thus the PMN is no longer able to "sense" 
the leuko-attractant gradient. Jones and Anderson (1983) 
suggest that these agents' protective effect results from 
their ability to protect PMN sulphydryl groups from oxidation 
by HRPO. Therefore these agents protect the PMN -S?I groups 
by acting as reducing agents. The necessity of maintaining 
the PMN in a reduced state for purposes of motility and 
viability is well documented (Absolom and Oss, 1979; Bank 
£t al, 1980).
MMI could act in a similar way to ascorbate and cysteine, as 
a reducing agent, to protect the PME*! against auto—oxidation 
and thus loss of chemotactic activity.
11:
Instead of exerting no affect at all, Mil and its metabolites 
may in fact be acting to protect the PMN primary function, 
allowing the first step towards elimination of micro-organisms 
to procédé unhindered.
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CHAPTER 3
THE EFFECT OF M I  ANT ITS PUTATIVE METABOLITES ON 
THE PHAGOCYTOSIS OF A NUMBER OF SPECIES OF MICRO­
ORGANISMS BY hitman P M .
3.0 Introduction.
PMN are easily damaged by impurities or rough handling; 
excessive clumping is a sign of such damage, therefore 
several methods for their isolation were investigated to 
obtain cells as undamaged as possible.
It was important to assess to what extent if any MÎ.I or any 
of its putative metabolites affected the phagocytosis of 
bacteria or yeasts, as impaired phagocytosis can result in 
the proliferation of infections. Clinical isolates obtained 
from Glasgow Dental Hospital (GDH) and Glasgow Royal Infirmary 
(GRI) microbiology departments were used along with a reference 
strain of Candida albicans as phagocytic stimuli.
3.1 Materials And Methods.
1. Isolation Of PMI
Venous blood was withdrawn, at the same time each morning, 
between 9 and 10 a.m. from healthy, human, male volunteers, 
aged between 20 and 30 years. The blood was immediately 
mixed with preservative-free heparin in phosphate buffered
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saline (rES). The blood was mixed with Flasmagel (Laboratoire 
Roger Bellon) in a ratio of 1 part Plasmagel to 2 parts blood, 
and the red blood cells were left to sediment at 37°C for 30 
minutes. The top layer containing leukocytes and plasma was 
withdrawn and layered on to Ficoll-Hypaque (Pharmacia).
The mixture of leukocytes was separated by centrifugation 
at 250 g for 30 minutes. The top layers containing plasma, 
Ficoll-Hypacue and mononuclear cells were removed and the 
pellet containing granulocytes was resuspended in Hanks 
basic salt solution (HBSS) (Oibco). Any remaining erythro­
cytes were hypotonically lysed and the PMN were washed and
7
resuspended in HBSS to give a concentration of 10 cells 
per ml.
The cell preparations were stained with Wright's stain 
(Gurr), and contained on average 95% M .  Viability was 
checked by trypan blue exclusion.
2. One Sten PMN Separation From Whole Blood 
Materials
A 9% (w/v) solution of Ficoll 400 (Pharmacia) made up in 
distilled water.
Ficoll-Hypaque (Histopaque, Pharmacia).
50% Conray solution made by diluting Conray 480 (May and Baker 
Ltd) with an equal volume of distilled water.
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Method
A dense Ficoll-Hypaque solution was made by adding 10 parts
of the 50?^  solution to 20 parts of %. Ficoll. The dense 
solution was aliquotted in two ml amounts into test tubes.
Two ml of Histopaque was layered carefully on to the dense 
solution in the test-tubes. On to this was layered 5-4 ml 
of whole blood pre-diluted with medium to 4/5 of original.
The tubes were spun at 200 g for 20 minutes at room temperature.
Step Separation Of PMN From Blood (Ferrante and Thong, 1978) 
Materials
85% solution of Hypaque (Pharmacia)
9% solution of Ficoll 4OO (Pharmacia)
Method
20 ml of Hypaque was mixed with 90 ml of Ficoll to give a 
density of 1.095 g/ml. The Ficoll-Hypaque was aliquotted 
into test tubes in three ml amounts. Five ml of whole blood 
was gently layered on to the Ficoll-Hypaque and the tubes 
were spun at 200 g for 20-50 minutes. The cell pellet was 
washed three times in medium.
4. A Single Step Centrifugation Method For Separation Of 
Granulocytes And Mononuclear Cells From Blood Using A 
Discontinuous Gradient Of Percoll (Giudicelli et al, 1982)
Materials
Stock isotonic solution (SIS) was made by diluting 9 volumes 
of Percoll with 1 volume of 1.5 M NaCl
116
Solution A with a density of 1.078 g/ml was made by diluting 
SIS to 62% (w/v) in calcium and magnesium-free Hanks basic 
salt solution (Oibco).
Solution B with a density of 1.094 g/ml was made by diluting 
SIS to 76% (w/v) in Ca and Mg-free HBSS.
Method
Three ml of solution A was aliquotted into tubes, on to this 
was layered three ml of solution B. Whole blood diluted 
twice in HBSS was carefully layered on to solutions A and B. 
The tubes were centrifuged at 6OO g for 20 minutes at 15°C. 
The cells from the bands were washed twice with PBS.
5. An Improved Method For Rapid Layering Of Ficoll-Hypaque 
Double Density Gradients Suitable For Granulocyte Separation 
(Madyastha et al, 1982)
Materials
1% methylcellulose-15 (Sigma).
9% Ficoll-400 (Pharmacia).
50% and 53.9% Hypaque (Pharmacia).
Method
Solution A was made by mixing 10 parts of 50% Hypaque with
20 parts of 9% Ficoll, to give a specific gravity of 1.12.
Solution B was made by mixing 10 parts of 33*9% Hypaque with
24 parts of 9% Ficoll, to give a specific gravity of 1.077*
Both solutions were stored at 4 C in suitable aliquots 
(1.5 ml). Tubes containing solution A were covered with 
parafilm and refrigerated. Blood was mixed with 1%
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me^Tvlcellul08e-15 in a ratio of 4:1 and centrifuged at $0 g 
for 7*"10 minutes at room temperature. The leukocyte—rich 
plasma was withdrawn and used for granulocyte separation.
The Ficoll-Hypaque gradients were prepared by using 20—gauge, 
one inch needles attached to disposable syringes at a 45° 
angle on top of the test tubes to gently layer solution B 
on to solution A already in the test tubes. This results in 
a sharper interface.
Maintenance Of Cultures
The organisms Staphylococcus aureus (NCTC 6571, Oxford strain). 
Streptococcus pyogenes (clinical isolate GDH 1554), Escherishia 
coli (clinical isolate GRI 020?), Lactobacillus casei (NCTC 
6375) and Candida albicans (î-TRL 3153) were freeze dried and 
a fresh ampoule of each was opened every 3 to 4 months, 
inbetween times the micro-organisms were maintained on 
nutrient agar slants at 4^ 0.
The micro-organisms were sub—cultured from the agar slants 
on to horse blood agar plates and incubated overnight at 
57°C. An innoculum from these plates was used to seed 
2.5% nutrient broths in 25 ml aliquots in glass universals, 
these were also incubated at 37°C overnight. The Candida 
t/as grown in Sabouraud broth (Difco) at 30°C for five days, 
to prevent germ tube formation when exposed to serum.
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The cultures were centrifuged at I50O g and the pellet was 
washed three times in phosphate buffered saline (FBS). The 
micro-organisms were counted using a Neubauer counting 
chamber, and the concentration adjusted to give 10^  cells 
per ml of medium. (Hanks basic salt solution plus 0.1% 
gelatin (HBSSG)).
Opsonisation
The micro-organisms were pre-opsonised in normal human serum. 
The optimum concentration of serum required to give maximum, 
phagocytosis was determined. The micro-organisms were 
suspended in HBSSG, plus serum giving final concentrations, 
of 10, 20 and 40 or 50%. The cultures plus serum were 
incubated at 37°C with shaking for 15 to 30 minutes and the 
micro-organisms sedimented by centrifugation at I5OO g for 
10 minutes and resuspended in HBSSG.
Phagocytosis Assay
Equal volumes of PMN and micro-organism, both at concentration: 
of 10^  per ml were mixed together and incubated at 37 0 witn 
end—over—end rotation to ensure efficient mixing. Aliquots 
of 0.5 ml were removed after 0, 30, 60 and 120 minutes and 
added to 1.5 ml of ice-cold HBSSG in plastic test tubes.
The tubes were centrifuged at 110 g for 4 minutes. The 
supernatant was withdrawn and serially diluted, aliquots of
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the dilutions were spread onto blood agar plates, and 
incubated overnight at 57°C. The colonies were counted and 
averaged over several dilutions to give a measure of the 
number of organisms remaining un-phagocytosed in the PKN- 
micro—organism mixture. Controls were included to monitor 
the effect of serum on the viability of the bacteria and 
yeast, and separately to see the effect of shaking on the 
phagocytic mixture. The mixture was also examined micro­
scopically.
Determination Of The Effect Of MMI, 3-MTH, MH And 1 -MI On 
The Phagocytosis Of Micro-organisms
The various compounds were added in concentrations of between 
10  ^M and 10  ^M dissolved in HBSSG to the micro-organism/ 
PMN mixture and the assay carried out as above. Controls 
were included to assess the effect of the compounds on the 
viability of the micro-organisms. The PMN were examined 
microscopically and their viability, after treatment was 
assessed by trypan blue exclusion.
3.2 Results.
Comparison Of Methods Used To Isolate PMN
Five different methods for the isolation of PÎ'TN from whole 
blood were compared. Of the five methods, method 1 proved
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to be the most reliable. Methods 2 and 3 were not readily
reproducible, the FMN band of cells tended to be rather 
'fuzzy', and only after repeated attempts using different 
spin speeds did a tight band of FMN appear after centrifugation. 
These methods were discarded as being too inconsistant.
Method 4 proved to be a relatively expensive way of separating 
cells as it used Percoll density gradients to separate the 
PMN from other blood cells. Method 5 was reproducible and 
gave tight bands of cells, however the Ficoll-Hypaque 
solutions rapidly deteriorated, even whilst refrigerated at 
4°C, and it was very time-consuming to have to make fresh 
solutions daily. Method 1 was the method of choice, despite 
being longer to carry out and resulting in a mixture of 
granulocytes and erythrocytes. A number of ways to remove 
the erythrocytes were tried,to find a method that caused a 
minimum of damage to the PMN. Hypotonic saline was chosen 
in preference to distilled water and dilute ammonium chloride 
as the former caused much cell damage and the latter appeared 
to cause aggregation of the PMN.
Ousonisatlon
Opsonisation, with 10% normal human serum incorporated into 
the phagocytic mixture of micro-organisms and Pi-TN was initially 
used, but the serum in the mixture appeared to provide essential 
growth substances for the organisms and as a result of its
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addition, the micro-organisms grew within the incubation 
times used, eventually overwhelming the PMN. This method 
of opsonisation was therefore discontinued.
Pre—opsonisation of micro-organisms in normal human serum 
overcame the problem of the organisms reproducing whilst 
in the phagocytic mixture. Each of the micro-organisms 
were pre-opsonised in 10, 20 and 40 or 50% serum, to gauge 
the optimal concentration resulting in optimum phagocytosis 
of the various m.icro-organisms. For S.aureus, S.pyogenes,
L.casei and C.albicans the optimal serum concentration of 
those tried was 10%, concentrations of serum greater than 
this did not result in a significantly greater amount of 
phagocytosis. E.coli differed from the other organisms in 
requiring 4031 serum to give optimal phagocytosis, however 
even using pre-opsonisation, this concentration of serum 
allowed the organisms to reproduce and a correction factor 
to take account of this had to be calculated. However 
the maximum incubation time for this organism had to be 
reduced from 120 minutes to 60 minutes as after this lengtn 
of time the E.coli had over-grown the phagocytic mixture.
The Effect Of MMI On The Phagocytosis Of S.aureus, S.pyogenes, 
E.coli, L.casei And C.albicans
The effect of 10"^  M MMI on the phagocytosis of a number of 
micro-organisms was assessed as a preliminary stud./, -
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Table 3
Table of mean values + standard deviation for determinations 
of the percentage organisms phagocytosed over periods of time. 
Students' t-test applied to the results. The figures represent 
the means of 3 separate determinations performed in triplicate. 
MMI was used at a concentration of 10 M.
Using t-test, phagocytosis was found to be unaffected by MMI 
at a concentration of 10  ^M.
*
Opsonised with pooled, frozen, human serum
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Table 4
Table of mean + standard deviation of the percentage reduction 
in numbers of S.aureus over 30 and 60 minutes incubation.
The figures represent the mean of 3 separate determinations 
performed in triplicate. Correlation coefficient statistics 
were applied to the results. No significant dose-related 
effect was found due to any of the compounds. .
Opsonised in fresh, normal human serum
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Table 5
Table of mean + standard deviation of the percentage reduction 
in numbers of S.pyogenes over 30 and 60 minutes incubation.
The figures represent the mean of 3 separate determinations 
performed in triplicate. Correlation coefficient statistics 
were applied to the results. No significant dose-related 
effect was found due to any of the compounds.
*
Opsonised in fresh, normal human serum
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results are shown in Table 3. (Students' t-test statistic 
was applied to the results, and it was found that IŒI did not 
significantly affect the phagocytosis of any of the micro­
organisms . )
The Effect Of MTH, T'TH And MI On The Phagocytosis Cf S.aureus 
And S.pyogenes
S.aureus and S.nyogenes were chosen as representatives of 
HgOg- and ncn-H^O^- producing organisms to investigate the 
influence of MTH, MH and MI, some of the putative metabolites 
of 1141, on the phagocytosis of bacteria. The results are 
shown in Tables 4 & 5. Correlation coefficient statistics were 
applied to the results to see if there was a dose-related 
effect due to the drugs over a concentration range 10 to 
10  ^M. The analysis indicated that MTH, MH and MI do not 
affect phagocytosis of either organism in a dose-related or 
any other manner, over 60 minutes incubation.
Viability Cf Organisms In The Presence Of MMI, MTH, MH And MI
The compounds were found to have no effect on the viability 
or growth of any of the organisms over a 60 minute inoubation 
time.
3.3 Discussion.
There are a number of methods which have been describee, in
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the study of phagocytosis by FMIJ. These include assays 
measuring the removal of a test particle from the fluid 
medium surrounding the cells, quantitative assays counting the 
number of particles taken up by a cell, and indirectly by 
assays measuring metabolic change during the phagocytic 
process such as measurement of chemiluminescence and flow 
cytometry, the former in which phagocytosis is estimated by 
measurement of luminescence using a liquid scintillation 
spectrometer or luminometer, the latter a fluorescence 
activated cell sorter.
The method used in this study involves measurement of the 
removal of micro-organisms from the medium surrounding the 
PMN. The technique is simple to perform, and has an immediate 
relevance to the problem of PMN-micro-organism interaction: 
there is scope for examining the effects of drugs or inhibitors 
on the system. However it is limited by its laboriousness, 
and long incubation times that foster cell—cell, particle— 
particle and cell—particle clumping, and does not differentiate 
between non-specific attachment of particles to cell surfaces 
from actual internalisation of the particles by the cells.
The alternatives such as direct counting by lignt microscopy 
or electron microscopy or measurement of radioactivity of 
radio-labelled phagocytosed particles also have these draw­
backs, but in addition are more time consuming and expensive.
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The need for opsonisation of micro-organisms for ingestion 
to occur has been extensively studied since Wright and Douglas 
(1903) first described the opsonic effect of serum. They
demonstrated that the action of the serum was on the bacteria
rather than on the phagocytic cell.
In contrast Wood, Smith and Watson (1946) reported that
phagocytosis and killing can occur in the absence of opsonins
when the bacteria are trapped by the P M  against a surface.
This mechanism of phagocytosis is termed ’surface phagocytosis' 
More recently it has been shown that the surface charge and 
hydrophobicity of the bacteria are important factors that 
determine whether micro-organisms need opsonins or not for 
uptake by the PMIJ (Van Oss and Gilman, 1972a,b; Stendahl and 
Edebo, 1972; Stendahl £t al_, 1979).
Uptake of opsonised bacteria and triggering of PMN activation 
proceeds via a receptor on the PMN membrane for the Fc 
fragment of the Ig molecule and via a receptor for the C3b 
molecule. Under conditions where PMN are incubated with 
bacteria with constant shaking, virtually no uptake is 
measured when opsonins are absent (Verhoef at ad, 1977; 
Verbrugh et al, 1979). Thus the need for opsonisation 
during determination of phagocytosis has been shown. Peterson 
et al (1977) investigating the phagocytosis of different 
strains of S.aureus demonstrated that increasing the
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concentration of serum from to 1CX# did not change the
opsonic activity of heat inactivated serum, Vandenbroucke— 
Graulls et al (1984) showed that uptake of S.aureus proceeds 
at a slower rate, but induced respiratory burst activity to 
the same extent as opsonised bacteria. In the present study 
opsonisation using serum concentrations from 103t to 50%. did 
not significantly alter the amount of phagocytosis of S.aureus, 
S.pyogenes, L.casei or C.albicans. E.coli was exceptional 
in requiring 40% serum for optimum opsonisation. In the 
assays determining the effect of M I  on the phagocytosis of 
the various micro-organisms, frozen, pooled, human serum was 
used for opsonisation, whereas in the assays determining the 
effects of MTH, MH and MI on the phagocytosis of S.aureus and 
S.nyogenes fresh serum was used. The fresh serum appears to 
result in more phagocytosis of micro-organisms than does the 
frozen serum, where the complement components will have 
perished. This perhaps demonstrates the need for opsonins 
from both the classical and alternative complement pathways.
Phagocytosis of micro-organisms by PMN is accompanied by 
changes in the cell membrane and cytoplasm of the PiN, and 
by an increase in oxygen consumption and metabolic activity 
(Cohn and Hirsch, I96O; Ingraham et 1981; Lane et 
1981; Root et 1975; Borregaard and Herlin, 1982) although 
this oxygen consumption is not required for phagocytosis 
(Koch, 1978). Thus phagocytosis is the initiating event for
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tne respirâtory curst during which a number of toxic oxygen
species are produced, Lam and Lindsay (l979) showed that
phagocytesing FMN accumulate ^^C-MMI and ^^ C-PTU. They found
that PTU accumulation was accompanied by an increase in
availability in phagocytosing PMN, and suggested that PTU
accumulation was related to its oxidation, presumably brought
about by the increased production of reactive oxygen species
by the stimulated FMN. It seems likely that the same would
apply to MMI. MMI is known to be metabolised by the PMN,
a
and . MI has-, been identified as^ metabolite. .
(Skellern, in pres s . Thus it was important to assess 
whether MMI or any of the putative metabolites of the drug 
would exert any effect on phagocytosis, especially as it 
initiates the respiratory burst.
Micro-organisms are phagocytosed at different rates. The 
differences observed can be explained by the possession of 
the organisms of anti-phagocytic properties. S.aureus has 
protein A as a cell wall component of most strains. It 
binds to the Pc portion of human IgG subclasses IgG1, IgG-2 
and IgG4 (Kronvall and Williams, 1969)* Protein A is believed 
to be anti-phagocytic ; by binding IgG molecules at their 
Fc portion, protein A would prevent these molecules from, 
participating in IgG-mediated phagocytosis, which is Fc 
receptor-dependent. However, in tne presence of complement.
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the phagocytosis-inhibiting properties of protein A are 
dependent on the amount of IgG present. This may be why the 
amount of phagocytosis of S.aureus increased from to 
90% when fresh serum was used for opsonisation rather than 
frozen where most of the complement components were destroyed,
A substance functionally analogous to but immunologically 
distinct from protein A has been reported on group A Streptococci 
(Schalen e_t ad, 1978), the S.uyogenes used in the phagocytic 
assays here was a group A Streptococcus, and a similar increase 
was found to that seen with S.aureus, when fresh serum was 
used for opsonisation, from QJ/: to 97-98%. Group A Streptococci 
also contain M proteins, which are cell surface antigens and 
major virulence determinants. Their enhancement of virulence 
is believed to be related to an anti-phagocytic effect 
(Lancefield, I962), possibly as a result of masking cell wall 
constituents capable of fixing complement to the cell surface 
(Horwitz, 1982).
Micro—organisms have a range of strategies used to avoid 
phagocytosis and killing, which include pili, capsules and a 
host of enzymes. Thus these and other factors determine the 
rate and amount of phagocytosis of micro-organisms by PKN.
The chemiluminescent response of normal human FMN to a range
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of pathogenic micro-organisms was investigated by Robinson 
_et ad (1984). They found that measuring the luminol—enhanced 
chemiluminescence response of PMN to a number of organisms 
gave reproducible response patterns, and correlating 
chemiluminescence with phagocytic and bactericidal activity, 
deduced that the response patterns reflected differences in 
cell wall and membrane characteristics of the micro-organisms 
being phagocytosed.
Initially, the phagocvtosis of five micro-organisms was in­
vestigated, however after assessing the effect of MMI on 
phagocytosis and killing, the original five organisms were 
reduced to two, S.aureus and S.pyogenes. These were taken as 
being representative, both being highly pathogenic and there­
fore clinically relevant, the Streptococcus being an HgOg-
producing organism and the Staphylococcus a non—producer.
Klebanoff and White (I969) found that M I  did not significantly 
affect the phagocytosis of Lactobacillus acidophilus by normal 
human PMN, and in 1972, Klebanoff and Ham.on determined that 
the phagocytosis of S.aureus was unaffected by Mil. Ferguson 
at al (1984) found that the phagocytosis of opsonised zymosan 
by human P M  was unaffected by KKI. Lehrer (1975) investigating 
the fungicidal mechanisms of human monocytes found that 
phagocytosis of Candida albicans by human monocytes was
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unaffected by M I .
In this study, MMI and its putative metabolites did not 
significantly affect the phagocytosis of S.aureus, S.uyogenes, 
L.casei, E.coli or C.albicans.
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CHAPTER 4
The Effect Of M I  And Its Putative Metabolites On The Intra- 
cellular_Killing Of S.aureus, S.pyogenes, l.casei, E.coli And 
C.albicans
4.0 Introduction.
Intracellular killing can be investigated in many different 
ways. In this study several methods are used, killing is 
monitored directly: by a plate count method measuring the 
decrease in numbers of phagocytosed micro-organisms, visualised 
microscopically using a vital stain to differentiate between 
viable and nonviable micro-organisms, and indirectly using a 
luminometer to detect luminol-enhanced chemiluminescence 
from stimulated PM.
4.1 Materials And Methods.
Preparation of PM, micro-organisms and drugs was as previously 
described^(3.1 ).
Killing Assay ( 1 )
Equal volumes of PKM and micro-organism a u concentrations of 
10^/ml were incubated together with end-over-end mixing at 
57°C for up to two hours. Samples were removed at various 
intervals and diluted one in five in ice cold HBSSG. The tubes 
were centrifuged at 800 g for four minutes. The supernatant 
was removed, and further serial dilutions were performed and
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aliquots plated out, to give a measure of phagocvtosis. The 
pellet was resuspended in ice-cold distilled water plus 0.01% 
bovine albumin (Sigma), and pipetted gently for about JO seconds 
to lyse the PIM. Serial dilutions of the lysed PMH were made 
and plated onto horse blood agar plates and incubated overnight
at J7°C.
Killing Assay (2)
Equal volumes of P M  and micro-organism at concentrations of
y
10 /ml were incubated together with end-over-end rotation at 
37°C for 15 minutes (to allow phagocytosis to take place).
The PMK-m.icro-organism suspension was centrifuged at 110 g 
for four minutes, to sediment the P M  containing micro-organisms, 
The supernatant containing un-phagocytosed organisms was 
discarded, and the pellet was washed twice with HBSSG to remove 
any organisms left un-phagocytosed. After washing, the pellet 
was resuspended in fresh HBSSG and incubated with end-over-end 
shaking at J7°C, samples were removed at various time intervals, 
diluted in ice-cold HBSSG and centrifuged at 800 g for four 
minutes. The supernatant was discarded and one ml of ice- 
cold distilled water plus 0.01% bovine albumin was added and 
the suspension was pipetted for JO seconds to disrupt the PMl. 
Serial dilutions were made and plated as before.
Pluorochrome Microassay (Assessment of blood leukocyte micro­
bial killing)
Method modified from Pantazis and Knicker, 1979.
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F M  preparation was as before, except that the cells were 
suspended in PBS at a concentration of 10^PMN/ml, Micro­
organisms preparation and opsonisation was as before except 
that the cells were suspended in McCoy's medium 199 (Gibco) 
to give a concentration of 8 X 10^ /ml.
Pluorochrome Microassay
Two hundred yil of the PMîî suspension was dripped onto washed, 
circular 18 mm-diameter coverslips. Each of the coverslips 
was supported by a saline-moistened sponge, 9 mm in diameter 
and 5 mm high, and placed in a petri dish. The petri dishes 
were then covered and carefully placed in a humidified,
5% COg incubator for 60 minutes to allow the PMN to adhere 
to the coverslips. After JO minutes several coverslips were 
withdrawn and stained with filtered Wright's stain. After 
60 minutes the coverslips were washed gently in HESS warmed 
at J7°G and carefully returned to the petri dishes. One 
hundred ul of the opsonised C.albicans suspension was added 
to each of the coverslips, which were returned to the 
incubator. At various time intervals a coverslip was removed 
from the petri dishes, washed gently in warmed HBSS and 
transferred monolayer side up to a petri dish containing JO 
to 50 ml of a freshly—made 0.01% solution of acridine orange 
(Gurr) made up in 0.1 M citric acid/NaOH buffer (pH 5) .The 
coverslips were stained for 60 seconds, then removed from, 
the stain and excess dye removed by touching the edge of 
the coverslip to a dry paper towel. The coverslips were
1J6
then mounted onto glass slides and sealed with clear nail 
polish and examined with a UV fluorescent microscope using 
a halogen light source and with a \100 water immersion objective,
MMI at a concentration of 10  ^M was incorporated into the 
assay to test its effect on phagocytosis and killing of 
C.albicans.
Chemiluminescence Assay
Preparation of FMN, opsonised micro-organisms and drugs as 
before _ ( 3 . 1 ).
Preparation Of Opsonised Latex And Zymosan
Zymosan A (Sigma) was suspended in sterile, normal human 
serum at a concentration of 10 mg/ml. The suspension was 
incubated with shaking at J7°C for JO minutes. At the end 
of this period the zymosan/serum mixture was centrifuged at 
1800 g for ten minutes, the supernatant removed and the pellet 
of opsonised zymosan resuspended in Hanks basic salt solution 
plus gelatine, without phenol red.
The latex spherules (0.8 yu diameter. Sigma) were prep-red 
similarly, to give a concentration of 10^  particles/ml.
Preraration Of Luminol
Luminol (Sigma) was dissolved in dimethylsulphoxide (LMSO)
1J7
to give a final concentration of 10 M, This was kert as 
stock solution at —20 0, From this a working solution was 
made up in FES to give a concentration of 1.2 X lO"^  M, this 
was further diluted 1 in 10 during the chemiluminescence assay. 
The luminol was always freshly prepared on the day of use.
Chemiluminescence Assay
Two hundred /al of P M  at a concentration of 1.0 - J.O X 10^  
cells/ml in HBSS without phenol red indicator, plus JO yil of 
either test compound at concentrations ranging from 10  ^to
n
10 M, or HESS were added to glass tubes and placed in the 
chamber of the Packard Pico-lite Luminometer which was 
maintained at J7°C. Phagocytosis was initiated by injecting 
opsonised latex or zymosan into the glass tubes within the 
luminometer using a Hamilton syringe. The luminometer was 
programmed to measure chemiluminescence for JO seconds every 
60 seconds for up to 60 minutes.
Viability Of Micro-organisms In The Presence Of The Various Drugs
All combinations of the drugs and micro-organisms were in­
cubated together at 37 0 for 60 minutes. Samples were with­
drawn at 1J minute time intervals and plated onto blood agar 
plates to check viability in the presence of the various 
compounds.
1J8
4.2 Results.
Effect Of 10  ^M M I  On The Intracellular Killing Of Various 
Micro-organisms
The intracellular killing of S.aureus. S.pyogenes. E.coli.
L.casei and G.albicans by human PM, and the effect of 10~^  M 
MMI on it was assessed by killing assay 2. The results are 
expressed as the percentage of phagocytosed organisms rendered 
non-viable after JO, 60 and 120 minutes incubation. (Table 6)
MMI appeared to stimulate intracellular killing of all five 
micro-organisms to greater and lesser extents over JO minutes, 
however following 60 and 120 minutes, S.aureus and C.albicans 
showed slightly less killing in the presence of M M  and L.casei 
and S.pyogenes a slightly greater percentage.
Effect Of mi, MTH, TLH and MI On The Intracellular Killing Of 
S.aureus and S.pyogenes
-J -4
The effect of the four compounds at concentrations of 10 ,10
and 10  ^M on the intracellular killing of S.aureus and S.pyogenes 
over JO and 60 minutes incubation periods are shown in Tables 7 
and 8 respectively.
The intracellular killing of S.aureus showed significant dose- 
related inhibition in the presence of M U  and MTH, the inhibition 
shown was slight but consistant. MI and ME had no apparent effect
1J9
The Effect Of liMI On The Killing Of Various Micro—organisms 
By Human Polymorphonuclear Leukocytes.
Percentage Reduction In Numbers Of Organisms
JO minutes 60 minutes 120 minutes
incubation incubation incubation
S.aureus
Control 48.JJ 75.67 77.67
MMI 6J.67 74.JJ 77.JJ
S.pyogenes
Control 61.67 81.67 94.67
MMI 82.67 86.00 97.JJ
C.albicans
Control 76.JJ 95.JJ 97.97
MMI 87.JJ 9J.JJ 96.00
L.casei
Control J7.5O 90.00 98.90
MMI 78.00 96.00 99.50
E.coli
Control J5.I9
MMI 46. JO
Table 6
Table of the mean of two separate determinations performed in 
duplicat^ percentage reduction in numbers of organisms over 
time, and the effect of MMI at a concentration 10  ^M on 
intracellular killing.
110
on the ability of human PEN to destroy ingested micro-organisms 
(Figs 15&16_). None of the compounds tested had any significant 
effect on the intracellular destruction of S « pyogenes *
Assessment Cf Intracellular Killing Of C.albicans By Fluorochrome 
Microassay
Viable C.albicans fluoresced either green or orange in colour 
under a U.V. microscope. FMN stained green, ingested Candida 
stained orange and non-viable C.albicans stained red. After 
60 minutes incubation, it was found that cn average 55.2% 
of ingested C.albicans were non-viable-, however it was difficult 
to differentiate clearly between viable and non-viable cells, 
particularly as some tended to stain brownish ie. between 
orange and red.
The correlation between methylene blue staining (vital stain) 
and acridine orange as a vital stain in extracellular organisms 
was 100%, however it was not possible to extend this assay to 
intracellular organisms.
Influence Of MMI, MTH, ME And MI On The Generation Of Chemi­
luminescence By PMN Stimulated By Opsonised Zymosan Or Latex 
Particles
Opsonised zymosan tended to form aggregates, and when used to 
stimulate PMN, the chemiluminescence generated reflected the
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Table ?
Table of -ean + standard deviation of the percentage redaction 
in numbers of S.aareus over 30 and 60 minutes incubation. The 
figures represent the mean of 9 separate determinations performed 
in triplicate. Correlation coefficient statistics were applied 
to the results, the r values are shown, along with the correspond#
value.
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FIGURES 15 and 16 
LEGEND
#  - #  30 minutes incubation
■ 60 minutes incubation
Each point represents the mean + standard deviation 
of nine determinations.
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Influence of MI and MH on the intracellular killing of S.aureus 
after $0 and 60 minutes of incubation.
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Effect Of MEi, MI And MMI On The Killing Of S.pyogenes.
Percentage reduction in numbers of organisms
Log drug 
concentration
Methylthiohydantoin
0
-5
-4
-5
Methylhydantoin
0
-5
-4
M e thylimidazole 
0
-5
-4
Methimazole
0
-5
-4
-3
30 minutes 
incubation
x+s
92.08+6.66
92.51+6.22
92.92+6.11
92.66+5.65
98.47+1.74
98.95+0.67
98.58+1.21
99.04+0.54
96.56+5.13
94.85+6.58
96.76+4.82
95.95+5.99
97.88+1.62
98.21+1.29
97.99+1.18
9 7.59+0.97
r
value
0.018
N.S.
0.161
N . S .
0.251
N.S.
N.S.
60 minutes 
incubation
x+s
95.85+5.50
95.70+5.47
94.92+5.74
96.78+2.62
99.51+0.28
99.42+0.20
98.22+2.55
99.55+0.50
98.29+1.87
97.95+2.52
97.51+1.99
98.55+1.05
99.03+0.10
99.24+0.88
99.21+0.96
99.06+0.98
r
value
0.186
N . S .
0.149
N . S .
0.179
N . S .
N . S ,
Table 8
Table of the mean + standard deviation of the percentage reduction in 
numbers of S.pyogenes over 50 and 60 minutes incubation. The figures 
represent the mean of 5 separate determinations performed in triplicate. 
Correlation coefficient statistics were applied to the results, the r 
values are shown, however no significant dose-related effect was found. 
N.S. = not significant
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Figure 1?
Legend
0 - 0  5 Minutes incubation
0 - 4* 15 Minutes incubation 
JL- ▲  50 Minutes incubation 
■ - ■  60 Minutes incubation
The values shown represent the mean + standard 
error of the mean of seven separate determinations. 
Correlation coefficient statistics were applied to 
the results and MMI and MTH at concentrations between 
10”  ^and 10  ^were found to significantly inhibit 
chemiluminescence in a dose-related manner. P values 
of 0,001 were obtained for each incubation time.
Fisiire 17
Cheïïîiluir.inescence response of MMI- and MTK-treated latex-
stixT.ulated PMM expressed as percentage inhibition or stimulation 
over control levels, measured after 5, 15, 50 and 60 minutes incubation
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ingestion of ciumps by displaying erratic counts. Opsonised 
latex was therefore chosen for the study of the effect of 
MTH, MH and MI on PMM chemiluminescence, as this problem did 
not occur whilst using it as phagocytic stimulus. None of the 
compounds were found to alter background chemiluminescence 
generation. MMI and MTH at concentrations between 10”  ^and 
10  ^M produced dose-related inhibition of luminol-enhanced 
chemiluminescence between 5 and 60 minutes incubation. MH 
and MI did not significantly affect chemiluminescence generated 
over 60 minutes.
However, using untreated, latex-stimulated PMN as a reference, 
the inhibition decreased over time, thus 10  ^M I#II produces 
$0^ inhibition after 5 minutes, but stimulates chemiluminescence 
production by 20°{ after 60 minutes. With MTH at the same 
concentration chemiluminescence is stimulated by 40^ alter 5 
minutes and inhibited by 20/'- after 60 minutes.
In addition, the chemiluminescence of 5% ^ 2^2 inhibited
and/or stimulated by MMI and MTH at concentrations between 
10~^ and 10”  ^M, however no reproducible results could be 
obtained.
4»3 Discussion.
The techniques used to monitor the killing capacity of PMN 
are limited, due to the fragile nature of the cells, their
144
activity, once isolated, diminishes with time. They have a 
lifetime of about six to eight hours. Direct methods of 
measurement tend to be laborious, therefore several methods 
were investigated in this study; reduction in viable numbers 
as seen by serial dilution and plate counts of lysed PMÎT or 
whole PMN plus micro-organisms, fluorescence microscopy 
differentiating viable and non-viable intracellular micro­
organisms and indirectly by measuring generation of reactive 
oxygen species in response to stimulation by opsonised latex.
The blood fluorochrome microassay is based on the ability of 
acridine orange to intercalate with nucleic acids and exhibit 
metachromasia ie. the colour of the dye changes, towards the 
red, when bound to certain cellular components. Depending on 
the concentration of DNA and RMA in the cell, it fluoresces 
orange and green. When the cell becomes non-viable it fluoresces 
red or brown (half red, half orange). The precise mechanism 
behind this is unknown. The assay was extremely difficult 
to evaluate using bacteria due to their size, therefore the 
killing of G.albicans was investigated, however as the cells 
were not fixed, even at room temperature further inter action 
between the PMN and the yeast was possible. The assay was 
therefore felt to be unsuitable for the investigation of the 
effects of the various compounds on intracellular killing 
due to the time necessary for counting significant numbers 
of organisms within PMN, as well as the difficulties involved 
in enumerating bacteria. The assay also did not allow for 
shaking within the system, therefore the plate method for
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assessing killing was used. This assay was more suitable, as 
counts of organisms did not have to be taken immediately, instead 
the number of micro-organisms surviving intracellularly 
(Method 2) or total surviving micro-organiems (Method I) after 
various intervals of time were enumerated by plating diluted 
samples on to agar plates and incubating them overnight, one 
viable cell being taken as a single colony-forming unit. Once 
it was established that MI, MTH, MH and MI did not alter 
phagocytosis or the viability of the micro-organisms, method 1 
was used exclusively.
A preliminary study of the effect of 10  ^M MMI on the intra­
cellular killing of micro-organisms showed that MMI stimulates 
killing over 30 minutes incubation, this stimulation however 
was not evident after 60 and 120 minutes. S.pyogenes and 
L.casei were rendered non-viable in the presence of MMI at 
rates considerably greater than those seen with S.aureus,
E.coli,and C.albicans. S.uyogenes and L.casei are H^O^- 
producing micro-organisms, the others are not. One representative 
was taken from each group for further investigation. Tne 
effect of MI, MTH, MH and MI, at concentrations between 10 
and 10  ^M, on the ability of human rMN to kill S.aureus and 
S.pyogenes was determined. MMI and MTn caused inhibition of 
killing of S.aureus in a dose-related manner, 10 M being 
responsible for approximately a. 10% decrease in killing by 
M I  and MTH, MI was less inhibitory and MH showed no effect.
The killing of S.pyogenes, in contrast, was completely 
unaffected by any of the compounds.
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Chronic granulomatous disease is a syndrome in which the uatients 
are unusually susceptible to infection. Their PMN are less 
efficient than normal in the killing of certain micro-organisms, 
due to the complete absence of activity of the microbicidal 
oxidase system (Holmes _et al, 196?). Their PMN phagocytose 
the micro-organisms normally, but organisms such as S.aureus, 
E.coli and several other enteric bacilli are not killed 
normally. In contrast, S.pyogenes and S.faecalis are killed 
readily and do not play a role in the recurrent infections 
of these patients (Kaplan et al, I968). Studies have shown 
that these PMN do not demonstrate the normal post-phagocytic 
increase in H^Og formation (Holmes _et al, 196?). Mandell and 
Hook (1969) correlated susceptibility to intracellular killing 
with HpOg production, ie. organisms producing H^O^ were killed 
normally, non-H^O^ producing organisms remained viable and 
caused infection. Klebanoff and White (19&9) postulated that 
intraleukocytic formation of H^O^ by bacteria could make up 
for the defect in H^O^ generation by PMN, and thus explain 
the ability of CGD PMN to kill certain bacteria.
The pattern of killing of micro-organisms by MI- or MTH- 
treated PMN mimics that of CGD PMN, suggesting that the 
mechanism of action of these compounds involves H^O^. Klebanoff 
and White (1969) found that MMI did not significantly affect 
the killing of Lactobacillus acidophilus by normal PMN, but 
consistently decreased the rate of killing of the organism 
by c4:^PMN, thus MMI inhibits in a different way from the
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ÏÏ2C2“deficient wGD FMN. Klebanoff (1972) subsequently found 
MMI to have a small but significant inhibitory effect on 
staphylocidal activity in normal FMN. Antithyroid compounds 
act by blocking thyroid peroxidase (TFO). FMN contain the 
enzyme myeloperoxidase (MPO), agents which inhibit intra­
cellular utilisation of (eg. by inhibiting MPO) favour
greater recovery. The proportion of oxygen consumed which 
was recovered as has been reported as 3%, 20-30%, 50-70%
and nearly ICO^ c during the early phagocytic period in different 
studies (Zatti et 1968; Baehner et 1970; Klebanoff and 
Eamon, 1972; Homan-Muller et al, 1975). MMI has been shown 
to stimulate oxygen consumption in latex-stimulated PMN (Ch. 5.2), 
therefore E-Op is available within the cell, however the MPO 
activity of MMI-treated PMN is significantly decreased (Ch. 6.2). 
Thus it would appear that MMI acts by inhibiting MPO utilisation 
of HpOp to effect microbial killing. Klebanoff and Pincus 
(1971) suggested that the inhibition or absence of MPO results 
in an increased utilisation of HpOp in non-MPO-mediated H^Op- 
dependent reactions, including formate oxidation, HI'^iPS 
activation and the iron—F^Og-iodide cytotoxic system. Evidence 
for this came from patients with hereditary MPO deficiency, 
who are often asymptomatic, in vitro studies witn their PMN 
show delayed but ultimately effective microbicidal activity 
(Lehrer and Cline, 19^ 9? Klebanoff and Ham.on, 1972; Klebanoff, 
I98O). Phagocytosis induced formate and glucose 0—1 oxidation 
by the PMN of a patient with MPO deficiency was greater than 
normal (Klebanoff and Pincus, 1971). The HKPS activity of
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Mill, MTH and MI treated stimulated PMN has also been shown to 
be increased (Ch. 5.2).
Thus the PMN has an overkill capacity and even although part 
of its killing capacity has been inhibited, it has many backup 
systems, possibly accounting for the absence of inhibition 
seen in the killing of S.uyogenes. However non-H^Op-producing 
micro-organisms generally possess catalase, an enzyme which 
catalyses the degradation of H^Op to oxygen and water, thus 
it would be able to resist killing to some extent by the 
attack of backup systems using H^Op. The S.aureus and E.coli 
used in this study possessed catalase activity.
Peroxidases such as MPO, and catalase form an enzyme substrate 
complex with HpO^; the affinity of this complex for a second 
molecule of H.Og is low as compared to its reactivity towards 
a variety of other compounds. Certain electron donors are 
oxidised by peroxidase and HpO^ with the formation of highly 
toxic products. y .
MMI has been demonstrated as being capable of 
scavenging OH*, however the products of this reaction are 
likely to include the drug radical cation (MMI.; (Taylor 
et al, 1984). Thus the positive effect of removing OH* may 
be counter-balanced by the production of a potentially damaging 
radical. Radicals are capable of interacting with, and 
subsequently damaging the entire array of macromolecules 
which make up a cell.
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m i  is metabolised by human PM, MI has been identified as a
metabolite (personal communication from G.G. Skellern) MTH 
and MH are also possible metabolites, m i  and MTH cause dose- 
related inhibition of staphylocidal activity, but MH and MI 
have no effect on the killing of S.aureus. Thus a time scale 
wherein MMI may exert an effect on PMH function could be 
created. It is known that MMI can be converted to MMit, 
which presumably would act on the PMN in a different manner. 
Depending on the amount, rate and type of metabolite produced 
in the course of a bactericidal assay, after a certain amount 
of time, the effects seen may be the result of an entirely 
different compound.
The preliminary studies in which MMI appeared to stimulate 
killing of all five micro-organisms following $0 minutes 
incubation, may be as a result of MT4I being acted on by the 
active oxygen species produced by stimulated PMN. In these 
assays, PMN were allowed to phagocytose the test micro-organisms 
for 15 minutes, following this, unphagocytosed micro-organisms 
were removed by differential centrifugation and washing, the 
MMI was then added to assess its effect on intracellular 
killing of phagocytosed organisms, thus the respiratory burst 
had. already taken place, and many toxic products were available 
to act on the PMN, the ingested organisms and the Ml.I. The 
second set of experiments measured the total effect on reduction 
in bacterial count, as it had been established that MMI, MTH,
MH and MI did iK)t significantly affect phagocytosis. MMI ard
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its putative metaoolites were therefore present in the assay 
immediately prior to stimulation by S.aureus or S.uyogenes, 
and before production of reactive compounds from the respiratory 
burst. This may have influenced the course of metabolism of 
the compounds.
The stimulatory effect of 10"^  M MMI on the killing of ingested 
micro-organisms diminished over time, after 120 minutes no 
significant stimulation was detected, perhaps due to the meta­
bolism of MMI to MMit, MTH or MI. MTH was found to inhibit 
staphylocidal activity to a slightly greater degree than MMI 
or MI.
The oxygen intermediates produced by stimulated PMN can be 
measured indirectly by quantitating the light emission, or 
chemiluminescence, that occurs when excited electrons present 
in these intermediates return to ground state and release 
photons (Allen _et 1972). Lum.inol (9-amino-2,3-dihydro- 
1,4-phthalazinedione ) amplifies the chemiluminescence 
response and allows the use of lower numbers of cells (Allen 
and Loose, 19?6). Luminol is presumed to be oxidised by 
some reactive species of oxygen generated during the respiratory 
burst, although the exact reaction is not defined. The 
oxidation of luminol results in the production of an excited 
aminophthallate anion that relaxes to the ground state with 
the production of light (Allen and Loose, 19?é).
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The results oütained in this study illustrate that the technique 
of chemiluminescence detection is not suitable for the study 
of certain compounds. The nature of MMI and MTH, ie. its 
conversion to MMit or MI, the readiness of MTH to oxidise and 
the ability of MMI to scavenge OH* makes the assay very difficult 
to interpret as the compounds may be in a different state on 
addition to the test system. The compounds do not affect 
background chemiluminescence, but do interfere with the detection 
of chemiluminescence, as seen by their interaction with H^Og
and luminol. The effect of MMI on the detection system is
probably due to the production of the MMI radical which may 
react with luminol, possibly MTH behaves in a similar way.
As it is not possible to estimate with any accuracy the extent
to which MMI and MTH are responsible for quenching or stimu­
lating chemiluminescence, the results obtained from stimulated 
PMN cannot be interpretted with any confidence, and are mentioned 
here only briefly.
Therefore in a clinical situation, it would appear that MMI 
probably does not exert any deleterious effects on the response 
of PMN to invading micro-organisms, and unless MMI treatment 
was coupled with some other immunological defect, is probably 
not responsible for any clincial disease.
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CHAPTER 5
the effect op MMI AND ITS PUTATIVE METABOLITES ON 
THE OXYGEN CONSUMPTION AND HEXOSE MONOPHOSPHATE SHUNT 
ACTIVITY OF LATEX-STIMULATED HUMAN PMN.
5.0 Introduction.
The monitoring of both oxygen consumption and hexose mono­
phosphate shunt (HMPS) activity of PMN (Pig 16) have been 
used as indirect methods of assessing the killing capacity 
of the PMN. These methods allow for the use of inhibitors in 
the systems, which can be used to identify specific effects 
of compounds on the PMN’s capacity for phagocytosis and 
killing.
Phagocytosis is accompanied by a number of metabolic changes, 
within the PMN, refered to as the respiratory burst. These 
include a cyanide-insensitive increase in 0^ uptake and 
stimulation of the HMPS.
The oxidation of glucose via the HMPS results in the production 
of HgOg and superoxide. This event is usually measured by 
the conversion of -7,-glucose to in the presence
of stimulated PMN.
The increase in consumption occurring during the respiratory 
burst can be measured using an oxygen electrode, which detects 
the percentage level of 0^ saturation of a solution. In
153
1- +  NADP
H O OH HO
OH
gIucose-6-phosphate
C H ,0 ®
\0 H  ) —0  -f HjO X— -
H o P f
OH
CHnO®
} = 0  4* NADPHj 
OH
6-phosphogIuconoIactone
COOH
HCOH
HOCH
HCOH
HCOH
CHgOO
6-phosphogluconoIactone 6-phosphogIuconic acid
3.
COOH 
HCOH 
HOCH  
HCOH 
HCOH 
CH^O©
6-phosphogIuconic acid
NADP NADPH
COOH
HCOH
I
CO
I
HCOH
I
HCOH
C H ,0®
C H .O H
K
HCOH
HCOH
CHgO©
+  CO,
4.
CH.,OK 
CO 
H CO H  
HCOH
ribulose-S-phosphate
CH,OH
^H O C H
HCOH
C H ,0 ®  C H ,0 ®
ribuIose-5-phosphate xyluIose-5-phosphate
5.
CHgOH
CO
I
HCOH
I
HCOH
CH^O©
CHO
I
HOCH
HCOH
I
HCOH
CHgO©
I.e.
©OHgC OH
IH H
OH OH
ribulose-S-phpsphate ribose-5-phosphate
Figure 18. The hexose monophosphate (pentose phosphate) 
pathway.
this case an arbitrary value of O^Cfî■■: is assigned to a suspension
of PMN prior to stimulation by opsonised latex particles.
The results of these tests provide additional information on 
the nature of the inhibition seen on treatment of normal human 
PMN with MMI and its putative metabolites.
5.1 Materials And Methods.
Determination Of The Effect Of Treatment With 10~^ M MMI, MTH,
MH And MI On The Oxygen Consumption Of Resting And Latex- 
Stimulated PMN
Preparation of PMN and test compounds was as previously 
described (chapter The measurements of oxygen consumption
were made using an oxygen electrode (Rank Brothers, Cambridge, 
England), the membrane of which was changed daily. Three ml 
of a PMN suspension containing 10^  cells per ml, was pipetted 
into the chamber of the oxygen electrode, which was maintained 
at a constant temperature of To this was added 300 jul
of opsonised latex spheres, of 0.8 ,um diameter, at a concent­
ration of 10^  per ml and the mixture was constantly stirred.
Test runs contained 10“  ^M MMI, MTH, MH, or MI. The amount 
of dissolved oxygen in the chamber was monitored over 60 
minutes for oxygen depletion.
Determination Of The Effect Of 10 M MMI, MTH, MH And MI On 
The Hexose Mononhosphate Shunt Activity Of Latex—stimulated 
Human PMNT
Preparation of PMN and the test compounds was as previously
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described (Section3.1). The HMFS assay was performed in 
Warburg flasks in one ml volumes. Into each flask was put 
100/il of a PMN suspension containing lo'^ cells per ml PBS,
50 yUl of fresh, autologous serum, 700 yil PBS (contains no 
glucose), 10 yul of either PBS or 0.1 M solution of the test 
compound and 50 ^ 1 of 1.4 X lO^^M glucose-l-^^C (Amersham). 
One hundred yul of 5 N NaOE was pipetted into the centre well 
of the flask, containing a folded piece of Whatmans No.4 
filter paper 0.5 X 6 cm. The side arm of 'stimulated' flasks 
received 100 ul of 0.8 yum diameter latex particles (Sigma)
9
at a concentration of 10 per ml PBS. 'Unstimulated' flasks 
received 100 yil of PBS. The experiment was performed five 
to six times with each condition repeated in triplicate. To 
initiate the respiratory burst, the contents of the side arm 
were tipped into the main body of the flasks, which were 
tightly sealed with rubber stoppers, and incubated in an 
orbital incubator (Gallenkamp) at 57°0 for two hours. The 
released ^^COg was "captured" by the NaOH in the centre well. 
At the end of the incubation period, the filter papers were 
removed and dried overnight. Ten ml scintillant was added 
to eachvia.1 and the amount of radioactivity trapped was 
measured in a liquid scintillation spectrometer.
5.2 Results.
The oxygen consumption of unstimulated PMN was very low and 
was not found to be significantly affected by the addition 
of any of the compounds tested at a concentration of 10 M. 
Resting levels were between two and five percent of the
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arbitrary ^Q0% value assigned to a suspension of PMN.
The oxygen consumption of stimulated PMN, however was 
markedly increased on addition of opsonised latex particles. 
The amount of oxygen consumed over a 60 minute period rose 
to between J>ÇP/o and
The effect of the addition of 10”  ^M MMI, MTH, MH and MI on 
the oxygen consumption of the stimulated cells is shown in 
Table 9*
Only MMI was shown to significantly stimulate the oxygen 
consumption of stimulated PMN after 30 minutes, and the 
increase was of the order of 309^ . After 60 minutes, 
however both MMI and MI significantly stimulated the 0^ 
consumed by the PMN, again the increase was of the order 
of 50/1. MH did not appear to affect the stimulated PMN at 
all and 0^ consumption levels were on a par with untreated 
stimulated PMN. MTH also had no significant effect, however 
in this case the observed increase in the amount of oxygen 
present in the PMN suspension during the first five minutes 
of stimulation did not reflect the pattern seen in the cases 
of MMI, MH and MI. On stimulation by latex particles, the 
amount of oxygenation of the suspension rose (respiratory 
burst), but after five to ten minutes as was the usual case, 
the oxygen did not appear to be depleted from the medium and 
instead the percentage of dissolved oxygen in the suspension 
drooped only slightly over 3^  minutes, or not at all, thus
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after 60 minutes of incubation, the MTH-treated suspension 
contained between 95/^  and 105% dissolved oxygen.
The HMPS activity of resting PMN was not significantly
affected by the presence of either MMI, MTH, MH or MI at 
10  ^M. However the glucose oxidation of stimulated PMN was 
increased by MMI, MTH and MI at a concentration of 10  ^M, 
MMI-treatment resulting in around a 20% stimulation of the 
HMPS, and MTH and MI causing 15% stimulation over control
levels (See Table 10 ). MH did not affect the glucose
oxidation of stimulated PMN.
5.3 Discussion.
During the respiratory burst, an increase in oxygen consumption 
is noted in stimulated PMN. This oxygen is reduced by the 
PMN microbicidal oxidase system where NADPH is thought to be 
the immediate electron donor to the oxidase system. The 
activity of the HMPS, the main pathway of electrons to NADPH, 
is markedly increased in association with oxidase activity.
Thus the two processes, oxygen consumption and glucose 
oxidation, are intimately bound. Impaired function of the 
HMPS has been shown to result in failure of oxidase activity 
(Gray et al, 1975).
Of the four compounds tested, only MMI exerted an effect on 
oxygen consumption following 30 minutes incubation with 
opsonised latex particles. MMI stimulated oxygen consumption
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by 5O/C, sugges uing that there would be a similar increase in 
the production of active oxygen species available to combat 
phagocytosed micro-organisms, thus boosting the PMN's 
microbicidal capacity. After 60 minutes incubation, both 
MMI and MI were responsible for a 50% increase in oxygen 
consumption. This could suggest that the imidazole part of 
the compounds is responsible for the increase in oxygen 
consumption. It is surprising that MTH did not significantly 
alter the rate or amount of oxygen consumption of the PMN, 
as it does inhibit the microbicidal function, but this may 
be due to the nature of MTH, which is an unstable compound 
in aqueous solution, oxidising rapidly at room temperature.
The HMPS activity of stimulated PMN was shown to be 
significantly stimulated by MÎ4I, MTH and MI by between 15% 
and 20%, MH did not significantly affect glucose oxidation.
It would be expected that if oxygen consumption by the PMN 
was increased, the HT4PS activity also would be stimulated.
Tsan and McIntyre (1975) showed that PTU and Mil, at similar 
concentrations used in this study, caused stimulation of 
glucose-l-^^C oxidation by stimulated human PMN by between 50^  ^
and 100% for PTU at a concentration of 10  ^M and 61% for MMI 
also at 10"4 M. They similarly found HMPS activity in unstimulated 
cells to be unaffected by PTU and MMI, however on addition of 
HgOg to the resting cells, an increase in HMPS activity was 
noted and they concluded that HgOg 3-^ d not phagocytosis was
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responsible for the stimulation of glucose oxidation. This 
could provide an explanation for the results observed here. 
Mill is known to inhibit thyroid peroxidase, and the slight 
but consistent innibition of bacterial killing shown here 
is thought to be as a result of impaired myeloperoxidase 
activity. Therefore if the MFO was inhibited, HgO would 
not be used up by the cells as normal, in the production of 
HOCl, it would instead by used by the glutathione peroxidase 
system and remain to stimulate the HMPS. Thus more glucose 
oxidation would occur, being detected as The lower
values of 15%-20% stimulation obtained with 10~^  M MMI in 
comparison to the figure of 61% with 10  ^M found by Tsan 
and McIntyre (1975) may be as a result of the different 
methods of detecting labelled CO^ .
Tsan and McIntyre (1975) examined the effect of a number of 
compounds on HMPS activity of stimulated PMN, such as PTU, 
MMI, thiouracil, thiourea, uracil, urea and adenine. They 
conclude that a minimal common structure of "thiourea", or 
a thiourylene group was necessary for this stimulatory effect, 
The results shown here indicate that the thiol group is not 
necessary to cause stimulation of HMPS activity, as MI is 
responsible for a similar amount of 0^ consumption and 
glucose oxidation as MMI. Possession of either the imidazole 
or the thiol group may be enough, as MTH also stimulated 
glucose oxidation. MH had no effect on either oxygen 
consumption or glucose oxidation and is known not to affect 
microbial killing by the PMI'J. Therefore, although these
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parameters of function are thought of as reliable indicators 
of the level of microbicidal function of the PMN, careful 
interpretation is necessary, as although 0^ consumption is 
stimulated by MMI, a similar increase in microbicidal function 
was not seen.
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CHAPTER 6
The Effect Of M I  And Its Putative Metabolites On The Release 
And Activity Of PMN Lysosomal Enzymes; Myeloperoxidase, Lysozyme, 
Alkaline Phosphatase And Lactoferrin.
6.0 Introduction.
The 'killing apparatus' of the PMN consists of oxidative and 
non-oxidative-components. The oxidative mechanisms and the 
effect of MMI, MTH, MH and MI have been examined, in order to 
examine the actions of the compounds MMI, MTH, MH and MI on 
the non-oxidative aspect of the PMN's killing capacity, human 
PMN were stimulated to release lysosomal enzymes. These 
enzymes include myeloperoxidase, lysozyme, alkaline phosphatase 
and lactoferrin. The effect of MMI, MTH, MH and MI on the 
activity of these enzymes has been assessed.
6.1 Materials And Methods.
Stimulation Of PMN To Release Lysosomal Enzymes
The PMN were isolated as before and suspended in HESS (Gibco)
g
to a final concentration of 2 X 10 per ml. Cytochalasin B 
(Sigma) at a concentration of 5 /ig/ml and 10  ^M N-f-mlp were 
added to one ml of the PMN suspension and incubated at 37 0 
with shaking for 15 minutes. The PMN were sedimented by 
centrifugation at I5OO g for two minutes at 4 C, The super­
natant containing the released lysosomal enzymes was.. withdrawn 
and stored at -20°G, where it was stable for at least one month.
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^TH, MH And MI On The Release Of Lysosomal
Enzymes
Concentrations of MMI, MTH, MH and MI ranging from ICT? to 
10“  ^M were pre-incubated with PMN for $0 minutes before 
being included in the reaction mixture consisting of PMN, 
cytochalasin B and f—mlp as above. The released enzyme 
preparation was assayed immediately for its MPO content 
spectrophotometrically as described below. The procedure 
was performed in duplicate with three separate samples of 
PMN from different donors.
Measurement Of Myeloperoxidase Activity
The reaction mixture consisted of PMN supernatant containing 
released lysosomal enzymes, 1.6 mM tetramethylbenzidine (TMB)
(Sigma), 0.3 mM H^O^, 80 mM sodium phosphate buffer (pH 5*4)
8% N, N-dimethylformamide and 40^  ^PBS in a total volume of 
500 yul. A range of volumes of PMN supernatant was assayed to 
establish optimal assay conditions. The volumes of PMN super­
natant ranged from 10yul to 100 yul. The mixture was incubated 
at 37°C with shaking for times between one and fifteen minutes. 
At the end of the incubation period, the tubes were immersed 
in an ice-bath and 1.75 ml of 200 mM sodium acetate buffer 
(pH 3.0) was added to terminate the reaction. The MPO 
product was measured in a Unicam SP 500 spectrophotometer at
a wavelength of 655 nm. The effect of the various compounds 
at concentrations of between 10 and 10 M was assessed by 
including them in the reaction mixture,
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Assay Ox Lysozyme In Human PMN, And The Effect Of MMI, MTH,
MH And MI.
The preparation of PMN and drugs was as before. Micrococcus 
lysodeikticus (Sigma) was grown overnight in 2.5% nutrient 
broth (Difco) at 37 0. One loopful of the broth culture was 
streaked down the centre of a nutrient agar plate and swabbed 
over the entire surface of the plate to produce a uniform 
distribution of organisms. PMN suspended in PBS to give a
y
concentration of 10 /per ml were pre-incubated with concentrations 
of diug ranging from 10”  ^to 10”  ^M for 10 minutes at 37°C. 
Following this pre-incubation, 20 yul of the PMN/drug mixture 
was dropped onto the nutrient agar plates lawned with 
M.lysodeikticus, four drops per plate, this was performed 
in triplicate. The plates were incubated overnight at 37°C.
The zones of inhibition of growth of M.lysodeikticus caused 
by the lysozyme content of the PMN were measured. The zone 
diameters of drug treated and control PMN were compared.
Assay Of Egg V/hite Lysozyme Activity And The Effect Of MMI,
MTH, MH And MI.
The assay procedure was as described on the Sigma bulletin 
accompanying lysozyme Product No.L-6876: into a quartz
cuvette was pipetted 2.5 ml of a Micrococcus leisodeikticu^ 
suspension in 0.066 M potassium phosphate buffer (pH 6.2).
The A,cn of the suspension was between 0.6 and 0.7. To
450
this was added 0.1 ml of a lysozyme solution (Sigma) containing
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200 to 400 ïï per ml. The cuvette was immediately inverted 
to mix the contents and the decrease in absorbancy was 
charted.
Alkaline Phosnhatase Assay
Five hundred yil each of 2—amino—2—methyl—1—propanol buffer
(Sigma) and p-nitrophenylphosphate (Sigma) were incubated
at 37°C in a water bath to equilibrate. To the blank tube
was added 100 yul of distilled water or concentrations of 
—7 —3drug from 10 - 10 M, to the control tubes was added
100 yul of PMN supernatant (containing released lysosomal
enzymes), and to the test tubes was added 100 yul of PMN
plus either MMI, MTH, MH.or MI at concentrations between 
_7 -5
10 ' and 10 M. The tubes were mixed gently and placed 
in a water bath at 37°C for 15 minutes. At the end of the 
incubation period 10 ml of O.O5 N sodium hydroxide was 
added to each tube. The optical density was read at
4OO-42O nm in silica glass cuvettes.
Lactoferrin Assay 
Preparation Of Micro-organisms
A light innoculum of S. aureus and S. pyogenes was grown up 
overnight in 2.5% nutrient broth (Difco). The cultures were 
centrifuged and the pellet resuspended in 1.0 ml of phosphate 
buffered saline. Five hundredyil of this was used as the 
innoculum for a 100 ml culture, which was incubated at 57 0
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under conditions of constant shaking in a Gallenkamp orbital 
incubator for 2—3 hours. Growth curves had previously been 
constructed for both organisms, and the incubation time was 
chosen to ensure that the bacterial cells were in the 
logarithmic phase of growth. The cultures were centrifuged 
at 1500 X g and the pellet washed three times in PBS and 
resuspended to give a concentration of 2.0 X 10^  colony- 
forming units (c.f.u) per ml.
Preparation Of Ano-lactoferrin And Iron-saturated Lactoferrin
Purified human lactoferrin (Sigma) was suspended in PBS at 
a concentration of 1.0 mg per ml. The apo- (iron-free) 
lactoferrin was prepared by dialysis against 0.1 M citric 
acid (pH 2.3), the iron-saturated lactoferrin by dialysis 
against saturated ferrous ammonium sulphate. Each was then 
dialysed against double distilled water.
Assay Of Lactoferrin Activity
In sterile bijoux, 100 yul of the bacterial suspensions were 
incubated with 200 yul of various concentrations of lactoferrin, 
(0 to 1 000 yug per ml) for one hour at 37°C. After this 
incubation time portions of the incubation mixture were 
serially diluted and plated onto chocolate agar plates 
(lysed horse blood) and incubated for 18 hours at 37 C. The 
number of colonies on each plate were counted, and the mean 
c.f.u per ml worked out.
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6.2 Results.
The Effect Of MMI, MTH, MH And MI On The Release Of Lysosomal 
Enzymes (As Assessed By The Release Of MPO)
It was found that the compounds tested did not significantly 
affect the release of MPO from stimulated PMN by the method 
used.
The Effect Of MMI, MTH, MH And MI On MPO Activity
The optimum amount of lysosomal enzyme preparation used in 
the assay was found to be 100 yul, which enabled the showing 
of dose-related inhibition by the compounds over a wide 
range of concentrations.
The optimum incubation time for the MPO assay was found to 
be 12 minutes, after this time no further development of 
colour was observed.'
It was found that W!I, M  and MI caused dose-related 
inhibition of MFO activity whereas MH did not significantly 
affect MPO activity. The compounds affected MPO activity 
to different degrees, with MTH causing the greatest amount 
of inhibition, followed by MMI and MI. The compounds at 
concentrations of 10”  ^and 10"^  M did not affect MPO 
activity as measured by this assay. The inhibition seen was 
not overcome by addition of excess (Table 11)
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Table 11
Table 11 shows the percentage inhibition of MPO activity, 
as measured spectrophotometrically, caused by various 
concentrations of MMI, MTH, MH and MI, Correlation 
coefficient statistics were applied to the results and the 
r values are shown, along with this converted to a t value 
(student’s t-test) and the P value.
The assay was performed in triplicate and the results shown 
represent the mean of three separate determinations.
NS - not significant
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FIGURE 19
LEGEND
#- e MMI
M - m MTH
0 - 0 MH
MI
Each point represents the mean + standard deviation 
of three separate determinations.
Figure a9
Effect of concentrations of MI. MTH. MR and MI between 10~^ and 
10 M on MPO activity. Compound concentration versus optical density 
measured at 655nm.
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Table 12
Table 12 shows the effect of the various compounds on the 
lysozyme activity of human FMN. The zone diameters recorded 
represent the mean of three separate determinations and the 
standard deviations are also shown.
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The percentage inhibition caused by the various compounds 
are shown in table 11.
Effect Of MMI, MTH, MH And MI On Human PMN Lysozyme Activity 
(Assayed In Whole Human PM)
The compounds at concentrations in the range 10“  ^to 10“  ^M
did not significantly affect the lysozyme activity of human
P M  as assayed by the clearance of M. leisodeiktikus from
agar plates. The zone diameters of the areas cleared by the
human P M  were not significantly different in control and
drug treated PM. It was noted that the cleared zone
diameter was proportionally related to the amount of PMN
applied to the agar plates lawned with M. leisodeiktikus. (Table 12)
Effect Of IdMI, MTH, MH And MI On The Activity Of Hen Egg-white 
Lysozyme And The P M  Lysozyme From The Released Lysozomal 
Enzymes
It was found that the compounds tested at concentrations 
between 10  ^and 10  ^M did not affect the activity of 
either the egg-white or P M  lysozyme as measured by a drop 
in optical density of a suspension of M. leisodeiktikus.
Effect Of MMI, MTH, MH And MI On Alkaline Phosphatase Activity
MMI and MTH inhibited alkaline phosphatase activity in a dose- 
related fashion. Correlation coefficient statistics were 
applied to the data and r values of -0.393 aiih —0.49& were
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FIGURE 20.
LEGEND
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Each point represents the mean + standard deviation 
of three separate determinations.
nrure
Effect of MMI and MTH on PM!T alkaline phosphatase 
activity.
Molar concentration of compound versus optical density function 
measured at 420nm.
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found for W I  and MTH; these correspond to P value of 0.05
and 0.01 respectively, indicating a high probability of MMI
and MTH being responsible for the inhibition shown. ME did
not significantly affect alkaline phosphatase activity, and
MI was shown to significantly affect activity at a concentration
of 10  ^M only. Student's t-test statistics were applied
to the results and a t—value of 2.174 was found, the corresponding
P value is O.O5.
Results Of Lactoferrin Assay
Concentrations of lactoferrin ranging from 0 to 1000 ug per 
ml were incubated with S .aureus and S.pyogenes, however, none 
of the concentrations appeared to have a cidal effect on the 
organisms treated, and there was no apparent dose-related 
response, therefore it was concluded that lactoferrin may 
have a role to play in the bactericidal action of the PMM, 
and the effect, if any of MMI, MTH, MH and MI was not assessed.
Measurement Of The pH Of The Compounds Used In Enzyme Assays
The compounds were made up in PBS which had a pH of ?.4*
Solutions of methimazole of concentrations from 10 to 10 M 
had a pH of 7.45. 10”  ^ M methylthiohydantoin had a pH of 
7.55» however solutions of 10 to 10 ^ had a pH of 7«4« 
Methylhydantoin at all concentrations had a pH of 7«4« 
Methylimidazole's pH at IO” "’ M was 9.0 but this dropped to 
7.7 at 10"^ M and to 7.4 from ICT^ to 10"^.
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6.3 Discussion.
The mechanisms of the microbicidal function of PMN have been 
extensively investigated by many groups over the last twenty 
years. The generation of reduced oxygen products and the 
release of lysosomal enzymes are responsible for them. How­
ever in recent years a. great deal of attention has been 
focused on the oxidative side of the PMT’s killing capacity. 
The non-oxidative role is one which should not be overlooked 
and the interaction between oxidative and non-oxidative 
mechanisms remains to be thoroughly investigated.
On stimulation by particulate or non-particulate agents, such 
as PMA and f-mlp, PMN are induced to release their lysosomal 
enzjmies. The effect of MMI and its putative metabolites was 
investigated, as SH- containing compounds are known to be 
capable of modulating PMN response (Rajkovic and Williams, 
1984). However, they were found not to alter enzyme release, 
therefore this can be ruled out as being a factor in the 
inhibition of the PMMs microbicidal activity. MMI-treated 
PMN therefore appear to degranulate normally. The effect of 
MMI, MTH, MH and MI on these enzymes’ functions could then 
be assessed.
Myeloperoxidase is a dimeric enzyme, containing two haem 
prosthetic groups (Agner, 1958) which bind small anions 
(Eglinton _et 1982; Vever and Bakkenist, I98O) and react
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with (Harrison _et al, 1980). It is fundamentally unique
in its capacity to catalyse the peroxidation of chloride ion 
(Harrison and Schultz, 1976). The reaction produces 
hypochlorous acid, whose ability to cause extremely rapid 
oxidative degradation of a wide variety of biological 
substrates, including porphyrins, haems and haem proteins 
(Albrich e^ sT^, 1981), suggests that it is the ultimate MPO- 
generated toxin (Klebanoff and Clark, 1978). MMI and MTH 
were found to inhibit human MPC activity in a dose-related 
manner at concentrations between 10*"^  and 10~  ^M, MI also 
inhibits MFO activity, but to a lesser extent, and MH has no 
significant effect. The pattern of inhibition reflects 
that of bacterial killing, providing more evidence of the 
crucial role played by MPO in the destruction of micro­
organisms.
Kle.banoff and Hamon (1972) found that MMI inhibited 
peroxidase-catalysed iodination by intact leukocytes, and 
they suggested that iodination reaction is to some extent 
a measure of MPO and ^2^2 intact cell. The results
shown here also suggest that MMI and its metabolites MTH and 
MI inhibit myeloperoxidase-catalysed reactions. There are 
a number of possible ways in which this inhibition could 
occur. The MMI could act as a substrate for MPO, and bind 
or link closely with the enzyme, competing with H^Og for 
binding sites, or with MPO—H^O^ for reaction with Cl • 
Alternatively it could react reversibly or irreversibly
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with î*;PO, inac üivating it somenow, eg. by modifying part of 
the enzyme’s active site or prevent the MPO-K^O^ from reacting 
with Cl to form HOCl. A further possibility is that MMI 
acts on or is acted upon by HOCl.
Addition of excess H^O^ did not overcome the inhibition seen, 
which suggests that the compounds do not act as competitive 
inhibitors. From the results of the HMPS assay, it was 
concluded that H^O^ was probably not being used up normally 
by the cell, instead taking part in alternative oxidation 
reactions, and via the glutathione peroxidase system, 
stimulating HMPS activity. In the presence of MMI, MTH and 
MI at 10 M concentrations, HI'IPS activity was significantly 
stimulated. The amount of H^O^ and other active oxygen 
species produced by stimulated PMN is probably increased in 
the presence of MMI and MI, as oxygen consumption was doubled. 
Therefore it seems likely that MMI, MTH and MI inhibit MPO 
to differing degrees by binding to the enzyme in such a way 
as to prevent further reaction with HgOg or Cl . Thyroid 
peroxidase is thought to be inhibited by MMI in a similar 
way, by a reaction between MMI and the oxidised haem group 
produced by interaction between TFO and H^Og (Sngler _et al, 
1982).
Klebanoff and Pincus (1971) suggested that inhibition or 
absence of MPC resulted in increased utilisation of H^O^
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in non-MiO-mediated H^O^-dependent reactions such as formate 
oxidation and Hi.PS activation. They also considered the 
possibility that microbicidal activity of MPO is offset in 
part by an increase in the non-enzymatic microbicidal 
activity of HgOg.
Lysozyme was found to be unaffected by any of the compounds 
tested. It is one of a class of enzymes that hydrolyse 
bacterial cell walls (Salton, 1952) and as such is probably 
more important in the degradation of phagocytosed micro­
organisms than in killing.
Alkaline phosphatase, which catalyses the hydrolysis of 
organic phosphate esters was inhibited by MMI, MTH and MI.
The inhibition was of the order of 60^ c at 10  ^M concentrations, 
and was dose-related. Neutrophil alkaline phosphatase activity 
may serve as a very sensitive index of a discrete inflammatory 
state not reflected in the physical state of a patient. The 
inhibition of alkaline phosphatase activity by MMI and its 
metabolites reflects the decrease in microbicidal activity 
of the PMN and as such MMI may be thought of as an anti­
inflammatory compound. Imidazole compounds have been 
implicated in cases of liver damage. One report claims m i  
to be responsible for inducing drug—hepatitis in an unstated 
number of their hyperthyroid cases, J>CP/c of the patients had 
altered serum alkaline phosphatase activity (Hackenberg
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Gt al, 1971). The mechanism of action remains to be 
examined.
Lactoferrin does not have any effect on the viability of the 
S.aureus or S.pyogenes strains tested here, and it was 
concluded that lactoferrin alone probably plays a very minor, 
if any role in the microbicidal function of the human PMN, 
Leffell and Spitznagel (1975) reported that 80c of the 
lactoferrin discharged during phagocytosis is secreted into 
the extracellular media rather than into the phagosome, 
suggesting that lactoferrin may exert its effects primarily 
in the extracellular location. Wang-Iverson et al (l978) 
reported that cells depleted of specific granules by pre­
treatment with PMA retained significant bactericidal 
capacity when the particle to cell ratios were low, implying 
that lactoferrin as well as other products of specific 
granules may be of secondary importance in the microbicidal 
reactions of PMH.
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CHAPTER 7
THE EFFECT OF FOSFESTROL OH SELECTED PARAMETERS OF 
PMN FUNCTION
7,0 Introduction.
Fosfestrol (Fig 23) is a synthetic, non-steroidal, water- 
soluble oestrogen compound, used clinically in the treatment 
of prostatic carcinoma. Oestrogenic compounds are known to 
exert an effect upon various parameters of the immune response. 
Studies with PMN indicate that both steroidal and non-steroidal 
compounds stimulate the bactericidal and fungicidal activity 
of human and animal PMN (Mitchell and Sbarra, 1965» 1966;
Jacobs ejk a^ , 1973» Sulwicz . _et al, I98I).
Peroxidase has an oxidation potential of approximately 1,000 mV, 
for the compound I to compound II couple. Therefore, this 
enzyme should have the capacity of oxidising I'TMI, PTÜ and 
fosfestrol, all of which have oxidation potentials in the 
region 45O-6OO mV. This suggests that the action
of thiourylene drugs and fosfestrol on PMN may be related at 
least in part to their oxidation potential. Oestrogens are 
also known to serve as a substrate for peroxidase (Ball and 
Knuppen, I98O). There are no oestrogen high affinity receptors 
in leukocytes (Personal communication from Dr M.M. Ferguson).
Therefore the effect of fosfestrol on selected parameters of
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7.1 Materials And Methods.
The techniques used to investigate chemotaxis, phagocytosis, 
microbicidal capability, oxygen consumption, HI'IPS activity, 
lysozyme, alkaline phosphatase and myeloperoxidase activity 
were as described in previous chapters.
Electron Microscopy
Two hundred and fifty ^ 1 of a PMN suspension containing 8 X 10^  
cells/ml was placed in a BEEM 00 capsule with a conical tip.
To this was added 250 yul of a Candida albicans suspension 
containing 8 X 10 cells/ml and either 5 yil of 0.1 M fosfestrol 
(W.B. Pharm. Ltd.) in HBSS or HBSS (pH 7«5)» The PMN/Candida 
mixture was incubated at 57°C with shaking for 50 or 60 
minutes. At the end of the incubation period the tubes were 
centrifuged at 110 g to sediment the PMN, the supernatant 
was removed and the PMN pellet was fixed in phosphate-buffered 
5% glutaraldehyde, pH 7.5, for 5 hours at room temperature. 
After fixation the glutaraldehyde was carefully pipetted off, 
leaving the sediment as a moderately firm pellet in the tip of 
the capsule. Processing was carried out in the capsule rather 
than cause possible disruption and damage to the cells by 
transferring them to another vessel. The PMN pellet was 
washed in several changes of Millonig's phosphate buffer 
over a period of 12 hours and then post—fixed in 1/6 osmic
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acid in Millonig s phospnate ouffer for 1-? hours at room 
temperature. Further rinsing in buffer over a three hour 
period was followed by dehydration through ascending grades 
of ethanol, which was completed by four changes of absolute 
ethanol of J hour duration each. The pellet was cleared in 
two changes of propylene oxide each of * hour duration, it 
was next soaked in propylene oxide/Araldite resin mixture of 
equal amounts for 6 hours, then put into propylene oxide/
Araldite resin 25/75 for 12 hours, before being soaked in 
pure Araldite resin mixture for a further 12 hours. Finally 
fresh Araldite resin mixture was added to the capsule which 
was placed in an oven at 45°C for 12 hours; the temperature 
was raised to 60°C for 15 hours to complete polymerisation 
of the resin.
Care was taken to ensure that both test and control specimens 
received identical treatment. Survey semi-thin sections 
0.5“1.5 um thick were cut on a Reichert Autocut and stained 
with Azur Blue II. Areas were selected and thin sections 
cut on an L.K.B. ultotome. Grids with thin sections were 
stained for 5 minutes with a 50^ ethanolic solution of uranyl 
acetate, then after washing in distilled water and diy/'ing, 
stained in a lead citrate solution based on the Reynolds 
(1963) method. Sections were examined in a Jeol 100S trans­
mission electron microscope.
7.2. Results
Tables 13 to 16 show the effect of fosfestrol on the chemotaxis, random 
movement, phagocytosis and intracellular killing of micro-organisms
by PMN.
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Table 1%
Table of mean - standard deviation of the reduction in numbers 
of organisms over time expressed as the percentage reduction of 
original inouukim over $0, 60 and 120 minutes. The figures 
represent the mean of 3 separate determinations performed in 
triplicate. Correlation coefficient statistics were applied 
to the results, however no significant dose-related effect 
was seen due to fosfestrol.
Table 13
Effect or Fosfestrol On The Phagocytosis Of Various Organisms 
Percentage Reduction In Numbers Of Organisme
IsOfc druR cone"/ 
orRanism
S.aureus 
0
-3
-4
S.pyogenes 
0 
-3 
-4
E.coll
0
-3
-4
L.carei
0
-3
-4
30 minutes 
incubation
97.45^ 0.69 
95.64^1.21 
97.82^0.53
97.52^0.24
98.57^ 0.51
98.67-0.19
98.65^0.15 
97.63^1.20 
98.52±0.13
9 6.64-0 .0 7
94.26 1^.02
95.33-2.73
value
NS
NS
NS
NS
60 minutes 
Incubation
T^a
9 8.36fo .1 0
98.ooio.05
98.ieio.i9
9 9 .00i0 .2 0
9 8.57io.1 4
9 8.61io.1 3
9 7.93i0 .0 9
9 7.70io.11
9 7.52i0 .0 4
9 8.45i0 .0 7
9 0.42i0 .2 3
97.66io.76
r
value
MS
NS
NS
NS
120 minutes 
incubation
xia
98.7310.20 
90.l8io.i3
98.3610.21
9 8 .64i0 .0 7
97.3eio.i2
9 8.2910 .0 4
9 2.22io.2 5
94.8lio.6l
93.70io.39
99.0710.04 
9 7.fl3il.i3 
9 8.Olio. 09
r
value
NS
NS
NS
NS
C.albicans 
0 
-3 
-4
98.00io.24
qq.76io.i3
99.ioio.i0
NS
99.54io.i3
99.79io.i7
99.7ifo.i5
NS
9q.80=0.08
99.0010.09
99.8010.09
NS
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Table 16
Table of the mean - standard deviation of the reduction in 
numbers of organisms expressed as the percentage reduction 
of original innoculum over 30, 60 and 120 minutes. The 
figures represent the mean of 4-6 separate determinations 
performed in triplicate. Correlation coefficient statiscis were 
applied to the results, the r value and P value are shown.
*Not done
Table 16
Effect Of Fosfestrol On The Intracellular Killing Of Various Organisms By Human PMN 
Percentage Reduction In Numbers Of Organisms
Log drug cone"/
organisms
S.aureus 
0 
- 3  
- 4  
- 5
S.pyogenes 
0 
- 3  
- 4  
- 5
E.coll
0
- 3
- 4
- 5
30 minutes 
Incubation
73.99^4.77 
59.2Btl5.l6 
77.79t4.26 
73.75^0.18
57.98tl4.12
47.36ti5.92
55.40tll.32
57.lOti3.90
44.i7t5.OO
5B.0Bt20.64
5i.lltl8.36
45.OOt6.25
value
-0.732 
P 0.05
-0.129
NS
-0.252
NS
60 minutes 
Incubation
79.52t4.64
79.7itlO.42
77.93tlO.39
78.55tO.i3
7i.73t6.47
6 7 .1Bt1 0 .8 9
89.9itl.39
70.20t6.20
9O.54tl.24
94.52t2.i9
93.42t4.43
9i.IOt3.27
r
value
0.131
NS
0.444
NS
120 minutes 
Incubation
xis
9O.24t5.ll
89.93t6.64
9O.39tO.54
79.73t8.24
86.33t3.i3
85.73t3.O5
N.D.
value
0 .0 2 8
NS
0.224
NS
0.019
NS
L.easel 
0 
- 3  
- 4  
- 5
C.albicans 
0  
- 3  
- 4  
- 5
53.51-6.24
47.62ilO.53
6 2.73^6 .8 2
53.50i6.40
63.42ii2.OI
75.20ii5.20
6l.i5il.36
70.32i8.64
-0.304
NS
0 .366 
NS
6O.7ii8.2O
69.45-6.54
66.52ilO.24
6O.OOi7.96
O2.O6i3.32
87.i2i3.9O
82.O2i2.i7
8O.O8i5.i5
0.245
NS
0 .5 8 1  
P= 0.05
70.O4i7.7i 
78.37i6.O7 
7 4.75^5 .7 9
86.40i3.39
93.64i2.57
9i.75i5.l8
0.302
NS
0.314
NS
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Effect—Of—10 M Fosfestrol On The Chemilumunescence Resconse
Of Human PMN To S.aureus, S.pyogenes, E.coli, L.casei And 
C.albicans
S.aureus, S.pyogenes, E.coli, L.casei and C.albicans at 10^  
organisms per ml, as a stimulus for human PMN, gave similar 
patterns of chemiluminescence (CL) regardless of the organism 
used. Fosfestrol appears to inhibit CL from 0 to 30 minutes, 
and to stimulate CL from 30 to 60 minutes with C.albicans, 
L.casei and S.aureus as stimuli. It did not appear to affect 
the chemiluminescence of S.pyogenes- or E.coli-stimulated 
PMN, or unstimulated PMN. The results were reproducible and 
are represented graphically in fig'~24.
Effect Of Fosfestrol On The Oxygen Consumption And Glucose 
Oxidation Of Latex-stimulated Human P’^ ’
Fosfestrol at a concentration of 10  ^M stimulated glucose—
1-^^C oxidation via the HMPS by 7^.76%. This figure corresponds 
to a value of 9.64. The probability of this amount of 
stimulation occuring by chance is 2—5°'^, indicating that treat­
ment of the opsonised, latex-stimulated PMN by 10 M fosfestrol 
significantly increases the amount of glucose oxidised to 
COg.
The oxygen consumption of fosfestrol-treated latex-stimulated
PMN was inhibited by 18.22^  ^and 15»91?^ - over 30 and 60 minutes
2
respectively. However on application of X statistics.
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f i g u r e : 24
LEGEND
Chemiluiiiinescence of PMN treated and untreated with 
10~^ K fosfestrol and stimulated by S.aureus, E.coli, 
S.pyogenes  ^I.casei and C.albicans respectively.
■  - ■  Control PMN
# - %  10  ^M fosfestrol-treated PMN
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values of 5*59 and 4»32 were obtained, these correspond to 
probaDilities of 10-25%. Values of greater than 5% are deemed 
to be non-significant. The assay was performed three times 
and on two of these occasions, after 60 minutes the stimulated 
PMN suspension had a dissolved oxygen content of greater than 
100%, the arbitrary value assigned to a suspension of human 
PMN at a concentration of 10° per ml. It was noted that on 
addition of the latex particles the amount of dissolved 
oxygen in the PMN suspension rose, however in the suspension 
containing fosfestrol the output of oxygen by the PMN was 
stimulated by 10-15%.
The Effect Of Fosfestrol On The Activities Of Lysozyme, 
Myeloperoxidase And Alkaline Phosphatase
Concentrations of fosfestrol of between 10”  ^and 10~^ M had 
no significant effect on the activities of any of the tested 
enzymes.
The Effect Of Fosfestrol On The Release Of PMN Lysosomal Enzymes
Fosfestrol was found to have no significant effect on the 
release of lysosomal enzymes from stimulated human PMN.
The Effect Of Preincubation Of Fosfestrol At Various Concentrations 
With 0.3% Hydrogen Peroxide On Mveloueroxidase Activity
Lysosomal enzyme release and myeloperoxidase activity were 
found to be unaffected by fosfestrol which had been preincubated 
with 0.5% EgOg.
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Electron Microscopical Examination Of C.albicans Within 
Fosfestrol Treated And Control Human PMN
After 30 minutes incubation, both control and fosfestrol-
treated PMN were still intact. A number of PMN were without
either engulfed or partially engulfed Candida cells, a valid 
determination of the proportion of these cells could not be 
calculated, as the number of sections screened did not allow 
for statistical analysis. Some PMN were in the process of 
phagocytosing Candida and exhibited extended pseudopodia 
around the yeast cells. The majority of PMN had engulfed 
one yeast cell and some had ingested two cells, fosfestrol 
did not appear to influence the rate or amount of phagocytosis 
after 30 minutes incubation.
There was little evidence in control and fosfestrol-treated
preparations of intracellular degradation of the C.albicans.
Plates 5-I7 show Candida ingested by both control and fosfestrol- 
treated PMN.
After 60 minutes incubation the majority of PMN surveyed were 
still intact, although some of the cells had started to 
aggregate. Of over 50 PMN examined, only two cells had not 
engulfed at least one Candida. There was a wide spectrum in 
the degree of degradation of the Candida cells within PMN.
This variation in degradation could even be seen within a
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single FIN. Plates 10, 15» 16. Differences in the type of 
vacuole enclosed the Candida were noted, some in loose and others 
in tight vacuoles. Plate 5» Fusion of granules with the 
phagocytic vacuole could he clearly seen, and extensive 
folding of the enclosing vacuole membrane was noted in a 
number of PMN. Plate 9.
Following 60 minutes incubation, some differences were 
observed in thé morphology of the Candida within fosfestrol 
treated PMN.
There was some loss of integrity of the plasma membrane, 
and within some PMN it was seen to have detached from the 
yeast cell wall, this sort of degree of degradation was seen 
within only one of the control PMN. The cytoplasm of all 
the ingested Candida within both control and fosfestrol- 
treated PMÎ'I appeared to be less electron dense, there was a 
distinct lack of organelles within the Candida in most cases. 
However this intracellular deterioration had proceded still 
further in some fosfestrol-treated PMN, such that large 
'empty' areas could be seen within the Candida. Plates 16 and 
17. The distinct striations of the Candida cell wall were less 
visible within drug-treated PMN than within control PMN.
In general the yeast cells within fosfestrol-treated PMN 
appeared to be more degraded than in control PMN, and the 
most deteriorated Candida were invariably found to be within 
fosfestrol-treated PMN, and the least degraded Candida within 
control PMN.
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Micrograph of a typical, unstimulated human FMN,
PLATE 2
Human PMN: note the tvpical multi-lohed nucleus
PIgt-e 1
Plate 2
Control PMN from after 30 minutes incubation with C.albican; 
The PMN contains large intracellular granules.
The ingested, C.albicans does not show signs of degradation, 
the cytoplasm is electron-dense and striations on the cell 
wall are visible.
PLATS 4
Control PMN after 50 minutes incubation.
The PMN has phagocytosed a budding yeast which contains inac" 
intracellular organelles. The C.albicans are within "loose" 
vacuoles.
%piste 4
PLATE
Control PMN after 50 minutes incubation with C.albicans
The PMN contains two yeast cells, the larger cell is within 
a "tight" phagocytic vacuole. The PMN has a number of 
pseudopodia extended. Granules can be seen fused with the 
phagosome, where they release their contents.
PLATE 6
Fosfestrol-treated PMN after 50 minutes incubation with 
C.albicans.
The PMN contains an intact C.albicans cell, showing no signs 
of degradation.
VPlafe 5
Plate b
PLATE 7
Fosfestrol-treated PMN after 50 minutes incubation with 
C.albicans.
The ingested yeast cell appears undegraded.
PLATE 8
Fosfestrol-treated PMN after 50 minutes incubation with 
C.albicans.
The yeast cells contain chromatin which is very hard and 
sometimes causes tears when sections are cut through it, as 
seen here.
P\ôVe 1
if i v  -y'
P b t e  8
PLA'
Control PMN after 60 minutes incubation with C.albicans. 
The yeast cell wall does not appear to have such sharply 
defined striations.
PLATE 10
Fosfestrol-treated PMN after 50 minutes incubation with 
C.albicans.
Four yeast cells have been ingested and show differences in 
their stage of degradation.
"S
Plate ^
i w r
K
Plate/ 10
i-LA
Control FMN after 60 minutes incubation with C.albicans,
PLATE 12
Fosfestrol-treated PMN after 60 minutes incubation with 
C.albicans.
The yeast is enclosed within the PMN by a very thin membrane,
10 i'
Plate 11
. I t
%
Plate 12
PLATE 15
Fosfestrol-treated PMN after 60 minutes incubation with 
C.albicans.
The membrane enclosing the phagocytosed yeast cells is very- 
thin. The C.albicans show little evidence of degradation.
PLATE 14
Fosfestrol-treated PMN after 60 minutes incubation with 
C.albicans.
Plate 13
»
m
Pla+e 14
PLATE
Control PEN after 60 minutes incubation with C.albican:
PLATE 16
Fosfestrol-treated PMN after 60 minutes incubation with 
C.albicans.
The PMN contains one cell showing some signs of degradation, 
and an extensively degraded yeast; the cell membrane has 
detached from the cell wall.
inf ^
I
Pbte 15
Plate 1 (o
PLATE 17
Fosfestrol-treated PMN after 60 minutes incubation with 
C.albicans,
The yeast cell within the PMN is held in a "tight" vacuole, 
the cell wall has lost its rigidity, the plasma membrane has 
detached and the cytoplasm containing the cell's organelles 
has become "patchy", indicating extensive degradation.
Plate 17
7.3 Discussion.
During pregnancy, total oestrogen of plasma increase, this 
is accompanied by a greater ability to combat certain infections, 
and an increased susceptibility to others, such as urinary 
tract infections. The total white blood cell count in 
peripheral blood rises and this change is mainly accountable 
to PMN and monocytes. The PMN of pregnant females exhibit 
hyper-phagocvtic and bactericidal activities (Mitchell _et al, 
1965, 1966). The stimulation of PMN activity during pregnancy 
has been attributed by some authors to oestrogens, although 
progesterone and peptides cannot be discounted. Fosfestrol 
is a water soluble oestrogen compound, and as such can be 
used at concentrations as high as 10  ^M, which are impossible 
to reach in vitro in aqueous solution with steroid oestrogens.
In this study selected parameters of PMN function were 
examined for their response to treatment with fosfestrol. 
Chemotaxis and random movement were found to be unchanged, 
as was the phagocytosis of S.aureus, S.uyogenes, E.coli,
L.casei and C.albicans. However the PMNs' ability to kill 
these organisms was affected. After 30 minutes incubation, 
fosfestrol at a concentration of 10  ^M inhibited the killing 
of S.aureus, S.nyogenes and L.casei, however the results 
did not show significant dose-related inhibition, except in 
the case of S.aureus (P=0.05). F.coli and C.albicans were 
apparently killed more efficiently, but the results did not
reacn statistical significance. After 60 minutes incubation, 
there was no significant difference between control and 
fosfestrol treated PMNs' killing of the bacteria, but 
microbicidal activity against C.albicans was increased and 
was significantly dose-related. E.coli and L.casei also 
appeared to be killed more efficiently.
Thus it would seem that fosfestrol stimulates the PMN to 
kill E.coli and C.albicans more efficiently from 30 minutes 
onward, L.casei from 60 minutes onward, S.pyogenes only after 
120 minutes and S.aureus not at all. The results did not 
reach significance, but there appears to be a general pattern 
of inhibition followed by stimulation. The chemiluminescence 
studies showed a similar pattern of inhibition followed by 
stimulation.
The oxygen consumption of fosfestrol-treated PMN was not 
significantly different from control cells, however it was 
interesting to note that the initial response of the PMN to 
the opsonised latex particles was greater than in control 
PMN. This large output of oxygen species may have masked 
the amount of oxygen consumed by the PMN. This result 
appears to conflict with the evidence from the chemilumine— 
scence results of decreased production of reactive oxygen 
species, however it is possible that fosfestrol somehow 
quenches the amount of chemiluminescence detected, as it 
was not possible to establish adequate controls to cover the
possicility of fosfectrol interfering with the detection of 
chemiluminescence« However it is interesting to note the 
parallel with results from the microbicidal assays.
HKPS activity was stimulated over a period of two hours 
incubation, this suggests that more HgO would be available 
in the FWI to take part in the killing of micro-organisms 
via the MFO—H^O^—halide system or in non-enzymatic ways such 
as by reacting to form hydroxyl radicals (Repine et al, I98I).
Neutrophil peroxidase activity in women during the perinatal 
period has been found to increase (Sulowicz ejk al, I98I). 
Jacobs _et ^  (1973) and Selvaraj e_l (^ 980) have suggested 
that oestrogens stimulate MFO- mediated amino acid decarbo­
xylation, although they did not observe stimulation of 
guaiacol oxidation. They proposed that oestrogens influence 
the MFO-HgOp-halide system, stimulating the first step of 
the decarboxylation reaction, chloramine formation, possibly 
by altering the affinity of the enzyme for Cl ions. However, 
their results may be questionable due to the limits of 
solubility of steroid compounds. They used putative concent­
rations of up to 10 yug/ml, equivalent to a concentration of 
around 10  ^M, and even using absolute ethanol as diluent, 
this seems very much higher than the 10  ^M limit of aqueous 
solubility. Fosfestrol at concentrations of between 10 
and 10"^ M had no significant effect on MFO activity as 
measured in this study.
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It is known that oestrogens are a substrate for, and can be 
altered by, peroxidases (Klebanoff and Clark, 1978). During 
phagocytosis, oestrogen is converted to an "alcohol-precipitable" 
form by PMN, and can be visualised autoradio-graphically, 
bound to the cells ie. it is protein bound. Oestrogens are 
'inactivated’ by peroxidase and H^O^ and can stimulate certain 
reactions catalysed by peroxidase of plant origin, raising the 
possibility that the interaction of oestrogens and FMN may 
influence the turnover of oestrogen and neutrophil function 
(Klebanoff and Segal, I96O). The interaction of oestrogens 
with peroxidase results in the formation of catecholoestrogens 
(Ball and Knuppen, 1980). Thus although fosfestrol did not 
significantly affect MFC activity as assayed in this study, 
it is possible that the compound, on contact with products 
of the respiratory burst, becomes chemically altered, and 
'activated', accounting for the observed stimulation of the 
FMNs' microbicidal function. The reactive oxygen species 
generated during the respiratory burst include HgOg, 0 g,
OH* and 0^ , these compounds are known to be capable of 
transferring their electronic energy to acceptor molecules 
or use it to oxidise target molecules. Radical initiated 
processes are particularly deleterious because being con­
servative and propogative, they can produce secondary and 
tertiarary free radicals derived from lipids, amino acids, 
glutathione, ascorbic acid and components of nucleic acids 
(Trush et aT, 1982). Superoxide from xanthine oxidase can 
convert 2—hydroxyoestrogens to reactive intermediates, possibly
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quinones and/or semi-quincnes capable of covalently binding 
protein. In addition, radicals, quinones and/or semi-quinones 
which ai%! intermediates in the oxidation of diethylstilboestrol 
(des) by peroxidases have been implicated in the toxicity of 
DES to the hamster kidney and mouse uterus (Mezler and 
McLachlan, 1978, Klicka et al, 1985)» However on preincubation 
with HgOg, fosfestrol still failed to significantly alter 
MPO activity, therefore possibly one or more of the other 
respiratory burst products alters the compound.
Lysozyme and alkaline phosphatase are involved in the cidal 
and degradative function of the P M  and their activity was 
unaffected by fosfestrol, however there has been a report of 
stimulated alkaline phosphatase activity in PNN under the 
influence of stilboestrol (Moszczynski, 1976). Neutrophil 
alkaline phosphatase activity also increases in the second 
half of the menstrual cycle (Radwanska et al, 1971)» 
Fosfestrol—stimulation of these enzymes may also occur 
through a mechanism similar to that proposed for MFO.
C.albicans was chosen for more extensive study, as fosfestrol— 
treated FMN killed this organism more efficiently than control 
cells. Also, as an eukaryotic organism, its structure is 
more complex, it contains organelles whose integrity might 
be affected by the degradative enzymes of the PMN. Early 
investigations into the ability of human PMN to kill ingested 
C.albicans in vitro indicated some failure in intracellular
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killing following ingestion of the organisms. This was due 
to up to 6451 of the PMN being lysed by germ-tube production 
by the Candida (Leijh ^  al, I977). in the present study 
germ-tube formation on exposure to serum has been prevented 
by incubating the Candida for five days at a temperature of 
30°C, as recommended by Leijh et al, (1977). Despite this, 
considerable variation in the percentage of ingested yeast 
cells killed by human and animal PMN has been reported, 
ranging from 18.5 to 75% (Rogers and Balish, I960). The 
figures obtained in this study indicate that up to 80% of 
ingested Candida may be killed within 60 minutes. However, 
on treatment with 10  ^M fosfestrol, this figure rose sign­
ificantly to 87%. Fosfestrol in aqueous solution has a pH 
of 7.2-7.5, and as such would not be expected to exert a pH 
effect on any of the degradative enzymes of the PMN.
On electron microscopical examination, it was found that 
fosfestrol, did not appear to affect phagocytosis, although 
after 60 minutes incubation fosfestrol-treated PMN contained 
more extensively degraded Candida cells. After treatment with 
lysosomal enzyme extracts, morphologic alterations are produced 
in the cells, such as an increase in granularity and vacuolation 
of the yeast's cytoplasm (Lehrer, 1969)* However, Taschdjian 
et aJ (1971) using an anti-Candida fluorescent test, concluded 
that the outermost layers of the cell wall were the initial 
targets in the process of intracellular destruction. It is 
well recognised that fixation is a key factor in the ultra-
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structural demonstration of fungal cell wall detail, and in 
electron microscopical studies this nay contribute to the
lack of definition of intracellular organisms. However in 
the sections examined extracellular organisms' cell walls 
appeared to be intact, showing defined striations and a 
dense cytoplasm, therefore the effects of the fixatives used 
in this study appear to have been minimal.
Incubation times of greater than 60 minutes were not used, 
as after this time the IKN tended to form aggregates. It was 
interesting to note the different types of phagolysosomes 
formed by the PMN around the Candida, some within tight and 
others within loose vacuoles: the more extensively degraded 
organisms were generally within tight vacuoles. Cech and 
Lehrer (1984) described unsealed- and sealed vacuoles, they 
proposed that approximately 40?r of the total phagolysosomes 
formed "maintain functional', communication to the cell's 
exterior" and as such support antimicrobial processes sub­
stantially less well than do completely sealed ones. During 
phagocytosis the PMN's plasma membrane is known to undergo 
substantial remodelling, if fosfestrol affected the rate of 
acylation of lysophosphatides, a higher proportion of sealed 
vacuoles could result, however there is no evidence to cupporo 
this idea, but it could in part account for the stimulatory 
effect of fosfestrol on intracellular killing by PMN.
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